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Abstract 
 The skeletal dysplasia domain is characterised by highly complex, heterogeneous and sparse data. 
In this domain, the analysis and interpretation of new patient cases relies on comparisons to past 
case studies due to the absence of defined guidelines and the lack of mature domain knowledge for 
this group of genetic disorders. In order to carry out the analysis and interpretation of new patient 
cases, practitioners currently query many heterogeneous data sources and aggregate diverse types of 
data. This integration represents a significant challenge due to the extreme heterogeneity of the data 
models, metadata schemas, vocabularies and data formats and inconsistencies in naming and 
identification conventions. Therefore, there is an urgent need to investigate the development of 
medical decision support systems which can assist clinicians and researchers to improve their 
understanding of the causes, behaviours, symptoms and attributes of the diseases and assist them in 
the decision-making process (e.g., diagnosis). 
In the skeletal dysplasia domain, the absence of mature domain knowledge and the lack of 
documented and well-structured past cases, in addition to the general sparseness of skeletal 
dysplasia data, hinder the development of reliable decision support methods. In this thesis, the first 
step is taken towards developing a decision support framework in order to assist clinicians, doctors 
and researchers in this domain. 
The developed framework is a phenotype-disorder lifecycle to assist practitioners in finalising 
patient cases by going from phenotypes to disorders and vice versa. The framework was developed 
in four phases and combines ontological techniques with inductive and statistical reasoning 
techniques. In the initial phase, the underlying data characteristics were analyzed and a novel 
machine learning approach was developed to produce probabilistic candidate rankings, which can 
serve as support for medical decision-making (e.g., diagnosis). In the second phase, the semantics 
encoded in the domain were exploited in order to find possible disorders for a new patient case by 
developing a semantic similarity-based approach. In the third phase, to discover the implicit 
relationships between different ontological concepts (e.g., phenotypes and disorders), semantic 
similarity methods, formulated using the intrinsic structure of a given ontology, were combined 
with traditional interestingness measures in the process of discovering association rules. The final 
phase proposes a data mining approach for discovering characteristic features in the context of a set 
of disorders.  
From the data and domain knowledge perspective, the developed approaches and evaluation 
strategies led to a number of significant findings towards building a fully-fledged decision support 
framework; (i) the properties of data in the domain are rareness, sparseness, and high 
dimensionality; (ii) the domain knowledge introduced more noise compared to the noise produced ii  
by patient cases; and (iii) semantic similarity improves the overall accuracy in comparison with 
term-based matching.  
From the algorithmic perspective, there are three significant findings; (i) tailoring the machine 
learning approach so it takes the sparseness of the data into consideration improves the overall 
accuracy of the disorder classification results; (ii) mining features which are common to a given 
class (as opposed to the entire dataset) and rare in the other classes helps to discover more accurate 
characteristic features for disorders in comparison to the class association algorithm; and (iii) 
applying semantic interestingness measures as opposed to the traditional measures for discovering 
association rules results in considerable improvements in accuracy.  
The outcome of this research enables clinicians and researchers to acquire a critical mass of 
structured knowledge that will facilitate a better understanding of these genetic diseases and foster 
advances in the field. Furthermore, it will advance the discipline of medical informatics as it can be 
applied to other rare diseases. 
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Chapter 1: Introduction 
1.1 Background 
Skeletal dysplasias are a heterogeneous group of genetic disorders affecting skeletal development. 
Currently, there are more than 450 recognised types, categorised in 40 groups, with around 360 
types of gene mutations affecting over 250 genes known to be the cause of the development of these 
disorders. Patients with skeletal dysplasias have complex medical issues including short stature, 
skeletal deformities and other complications. However, since most skeletal dysplasias are very rare 
(<1:10,000 births), the data on clinical presentation, natural history and best management practices 
is sparse. Due to the rarity of these conditions and the lack of mature domain knowledge, the 
decision-making process (e.g., diagnosis) is often difficult. In addition, only a few centres around 
the world have expertise in the analysis and management of these disorders. As there are no defined 
guidelines, the analysis and interpretation of new cases rely strictly on comparisons with past case 
studies. Molecular genetics research on skeletal dysplasias has advanced considerably over the 
years, enabling the genetic defects responsible for more than 200 skeletal dysplasias to be 
identified. However, the lack of interoperable knowledge bases and a decision support framework, 
capable of providing meaningful insights in the existing knowledge and data, hinders collaborative 
analysis and research in this area.  
1.1.1 Skeletome Project 
For skeletal dysplasias, several systems123 have been developed to enable the management of case 
studies and foster the exchange of knowledge between domain experts. Their main role is to 
promote diagnostic support via interactive discussions. However, their capabilities consist mainly of 
a discussion forum and lack any real support for decision support methods. Moreover, their 
underlying content is static and lacks formally defined semantics, thus making it difficult to be re-
used, reasoned across and re-combined for different purposes. To illustrate existing capabilities and 
limitations, four such case study management systems are discussed. 
In 2002, the European Skeletal Dysplasia Network1 (ESDN) was created to alleviate, at least partly, 
the paucity of data in the skeletal dysplasia domain, and at the same time to provide a collaborative 
environment to help with the diagnosis of skeletal dysplasias and to improve information exchange 
between researchers. It is an online knowledge base, which is an ideal approach for encouraging 
1 http://www.esdn.org/ 
2 http://qbdc.org/bone-dysplasia-registry 
3 http://www.isds.ch/ 1  
                                                        
community-driven content exchange and curation. Each patient case includes prenatal information, 
clinical data, radiographs and diagnosis. However, the underlying content is static, lacks formally 
defined semantics, and lacks decision support methods; thus, making it difficult for the content to 
be reused, reasoned across and recombined for different purposes. 
The International Skeletal Dysplasia Society (ISDS)3, established in 1999, is a non-profit 
organisation to promote scientific progress in the field of skeletal dysplasias and dysostoses. The 
ISDS Nosology [1] lists all recognised skeletal dysplasias and groups them by common clinical-
radiographic characteristics and/or molecular disease mechanisms. The ISDS Nosology is revised 
every four years by an expert committee and the updated version is published in a medical journal. 
The latest version is from 2010 and is presented in [1]. The ISDS Nosology is widely accepted as 
the “official” nomenclature for skeletal dysplasias within the biomedical community. However, the 
ISDS Nosology is also static and does not have formally defined semantics, which makes it difficult 
to evolve, be reused or be employed in further knowledge discovery operations.  
Other registries for skeletal dysplasia include the International Skeletal Dysplasia Registry (ISDR) 
[2] and the Queensland Bone Dysplasia Registry2 (QBDR). The ISDR was established in 1968 and 
is a proprietary database for skeletal dysplasias and dysostoses. The database is not online and does 
not have a Web interface, but the QBDR is online. The QBDR is an example of online database 
which encourages community-driven content exchange and curation. However, both the ISDR and 
QBDR suffer from the lack of decision support methods and the lack of formally defined semantics, 
which once again hinders interoperability, information sharing, reuse of informational resources and 
further knowledge discovery. 
The Skeletome4 project aims to create an online, expert-curated, community-driven knowledge base 
with the goal of supporting researchers and clinicians in decision-making and in gaining a better 
understanding of skeletal dysplasias and related disorders such as osteoporosis and osteoarthritis. 
This project also aims to provide services to enable the long-term expansion of the integrated but 
distributed knowledge base through a combination of community participation, automatic 
processing and semantic inferencing.  
Figure 1.1 presents the high-level building blocks of the Skeletome project. The underlying 
foundation of the platform is an ontology-driven knowledge engineering process introduced to 
bridge the current knowledge about the domain and the continuously growing pool of patient cases. 
The semantic annotation process is used to link domain expert knowledge to specific cases. The 
process relies on clinical and radiographic findings grounded in the Human Phenotype Ontology 
4 http://itee.uq.edu.au/~eresearch/projects/skeletome/ 2  
                                                        
(HPO) [3] which is one of the only phenotype ontologies for rare disorders. Within the Skeletome 
platform, the Bone Dysplasia Ontology5 (BDO) [4] was developed to capture the essential 
knowledge of the skeletal dysplasia domain. The BDO not only plays the role of a patient case 
repository but also models the available domain knowledge in the skeletal dysplasia domain.  
 
Figure 1.1: Building blocks of the Skeletome project 
In fulfilling its role as a patient case repository, the Skeletome knowledge base also stores past and 
newly emerging patient cases. To model the available domain knowledge, it captures the complex 
relations between the phenotypic, radiographic and genetic elements that characterise all skeletal 
dysplasias and addresses the specific knowledge representation shortcomings of the ISDS 
Nosology. The successful treatment of a patient suffering a rare disorder often depends on finding 
the most appropriate practitioner to diagnose the patient. Expertise modelling aims to build the 
expertise profiles of skeletal dysplasia domain experts to identify, acknowledge and recommend 
experts within an online community. 
In addition to the building blocks, the Skeletome project also aims to develop a number of medical 
decision support methods, namely, disorder reasoning, association rule mining and characteristic 
feature discovery. Medical decision support systems can assist clinicians and researchers both in 
undertaking research into skeletal dysplasias and in the decision-making process. The disorder 
reasoning building block aims to devise techniques for semi-automated diagnosis from an existing 
5 http://purl.org/skeletome/bonedysplasia 3  
                                                        
pool of patient cases that are shared and discussed in the Skeletome community-driven knowledge 
curation platform. The association rule mining building block enables researchers to verify known 
patterns and to discover new, previously unknown patterns among clinical attributes associated with 
this class of diseases that can be used to assist and inform the decision-making processes and further 
research. A characteristic feature is a feature (or phenotype) that is deemed highly characteristic of a 
specific skeletal dysplasia (for example, short fingers are a characteristic of platyspondylic lethal 
skeletal dysplasia). Discovering the characteristic features of a skeletal dysplasia disorder from 
diverse phenotypic or genetic information is critical for the diagnosis of new patients. The purpose 
of the characteristic feature discovery building block of the project is to discover such characteristic 
features indicative of a specific skeletal dysplasia. 
1.2 Motivation and Significance 
Medical decision support systems can assist clinicians and researchers both in improving their 
understanding of the causes, behaviour, symptoms and attributes of diseases and in the decision-
making process (e.g., diagnosis or treatment). In the skeletal dysplasia domain, the absence of 
mature domain knowledge and lack of documented, well-structured past cases, in addition to the 
general sparseness and dispersed nature of skeletal dysplasia data has hindered the development of 
reliable decision support methods. Such methods would enable the analysis of historical patient 
data, the verification of known facts and relationships and the discovery of new and previously 
unknown facts and relationships among the phenotypic, radiographic and genetic attributes 
associated with existing and new cases. In order to do this, practitioners currently need to query 
many heterogeneous data sources and effectively aggregate diverse types of data relating to 
phenotypic, radiographic and genetic observations. This integration step represents a significant 
challenge due to the extreme heterogeneity of the data formats, data models, metadata schemas and 
vocabularies, as well as the inconsistencies in naming and identification conventions. Given 
appropriate decision support tools and integrated, curated datasets, clinicians would be able to 
deduce, for example, that “platyspondylic lethal skeletal dysplasia is associated with short fingers in 
90% of patients”. 
As mentioned in the background section in this chapter, the Skeletome project aims to create an 
online, expert-curated, community-driven knowledge base with the goal of supporting researchers 
and clinicians in the decision-making process. Within the scope of this thesis, the research goal is to 
build a decision support framework that enables researchers to perform disorder reasoning, 
association rule mining and characteristic feature discovery. The resulting decision support 
framework uses the knowledge and patient data formalised within the Skeletome project to provide 4  
a probabilistic view on the correlations between skeletal dysplasias and their underlying features 
and to create new possible evidences based on these correlations. The output of the framework will, 
ultimately, serve as the foundation for a set of tools that will support the decision-making and 
disease-understanding processes. The outcome of the research will also enable clinicians and 
researchers to acquire a critical mass of structured knowledge that will sustain a better 
understanding of these genetic diseases and foster advances in the field. At the same time, it will 
also advance the discipline of medical informatics since it will be applicable to other areas that deal 
with rare diseases, such as neuromuscular disorders or dysmorphology. 
1.3 Use Case  
Following a series of discussions with skeletal dysplasia domain experts from the University of 
Queensland and the European Skeletal Dysplasia Network, a practical use case for the decision 
support framework was defined. The use case can be divided into five scenarios or requirements:  
• Assisting practitioners in the diagnosis of new patient cases by improving the speed, 
accuracy and reliability of the decision-making; 
• Improving the objectivity of decisions; 
• Training learners (early career specialists) or non-specialist practitioners in disease 
diagnosis;  
• Learning or discovering domain knowledge; 
• Validating experts’ opinions on the characteristic features associated with specific disorders 
and discovering previously unknown characteristic features. 
Each of these scenarios is described in more detail as follows. 
Assisting the practitioners when diagnosing new patient cases in order to improve decision-
making speed, accuracy and reliability: 
A clinician or practitioner attempts to diagnose a new patient case. As the analysis and 
interpretation of new cases rely strictly on comparisons with past case studies in the skeletal 
dysplasia domain, the clinician would try to remember past cases or search similar cases in his or 
her past case studies or within an online forum. The manual matching of the phenotypes of the new 
case to the phenotypes of existing cases in order to find relevant cases is a tedious and time-
consuming process and it also poses the risk of missing relevant cases. Moreover, manually 
combing the matched cases to get a conclusive result for the practitioner is also a time-consuming 
process and prone to inaccuracy. As machines can do repetitive tasks faster and with fewer mistakes 
than humans, the development of computer programs to automate the manual matching and 5  
combing steps of the diagnosis process can improve the diagnostic speed, accuracy and reliability. 
Therefore, practitioners will be able to diagnose new patients more efficiently and accurately 
through the resulting decision support framework proposed via this research. 
Improving the objectivity of decisions:  
Medical decision-making is known to be subjective and is dependent not only on the available data 
but also on the prior experience of the practitioner, their intuition and biases, and even on the 
psycho-physiological condition of the practitioner [5]. Research has shown that the diagnosis of one 
patient can differ considerably if the patient is examined by different practitioners or even by the 
same practitioner at different times (such as a different day of the week or different hour of the day) 
[5]. The decision support framework proposed for skeletal dysplasias will enhance the objectivity of 
decisions (diagnoses) by providing access to integrated existing domain knowledge as well as 
automatically derived knowledge from past patient cases. 
Training learners (early career specialists) or non-specialist practitioners: 
The decision support framework developed for the skeletal dysplasia will assist early career 
specialists (who are still learning) and non-specialist practitioners in the diagnosis of patients in the 
skeletal dysplasia domain. As only a few centres around the world have expertise in the analysis 
and management of these disorders, these tools will help to train new students and non-specialist 
practitioners in carrying out diagnoses. 
Learning or discovering domain knowledge: 
As previously stated, there is a lack of mature domain knowledge and there are no defined 
guidelines to diagnose patients in the domain. The decision support framework proposed for the 
skeletal dysplasias will help identify the characteristic features for a specific disorder and identify 
which features are more characteristic than other features in the context of specific disorders. The 
proposed framework will also help to identify previously unknown trends or relationships among 
medical attributes or verify known trends through the specification of association rules. 
Validating experts’ opinions on characteristic features and discovering previously unknown 
characteristic features: 
A characteristic feature is a feature that is deemed to be highly characteristic for a specific disease. 
The knowledge of characteristic features plays an important role in the manual diagnosis process. 
Knowing the characteristic features of rare genetic diseases requires mature domain knowledge, 
which is absent in the case of rare genetic diseases such as skeletal dysplasia. Inferring the 
characteristic features of a disease from multiple phenotype medical data provides a very useful tool 6  
for diagnosing dysplasia patients. Characteristic features can be further subdivided into “experts’ 
characteristic features” (ECFs) and “calculated characteristic features” (CCFs). An ECF is a feature 
that has been declared by a group of experts (because they think the feature is highly characteristic 
of a disease). A CCF is a feature that has been calculated by a computer by screening the feature 
annotations of a large patient case archive and identifying the features for each disease that are: 1) 
common to this disease; and 2) rare in other diseases (i.e., specific for this disease). The significant 
distinction between an ECF and a CCF is that an ECF is objective and a CCF is subjective. The 
proposed decision support framework will enable the validation of ECFs (by comparing them with 
computed CCFs) and the discovery of previously unknown characteristic features. 
1.4 Hypothesis, Aims and Objectives 
The hypothesis underpinning the research described in this thesis can be expressed as follows: 
Representing the knowledge and data associated with skeletal dysplasias using Semantic Web 
formalisms, and applying inductive and statistical reasoning to the resulting knowledge base, will 
improve the data exploration and decision making processes for skeletal dysplasia researchers and 
clinicians. The added value will be measured by comparing the proposed methods against basic 
statistical methods and human judgement, when applied to specific use-cases. 
This hypothesis can be further decomposed into the following research questions:  
• How can a machine learning approach be developed to compute the probabilistic 
associations between sets of clinical features and disorders (through analysis of available 
skeletal dysplasia data)? 
• How can semantic similarity methods be developed to compare/align the concepts (e.g., 
features, phenotypes, disorders) used within the skeletal dysplasia domain? 
• How can a semantic similarity-driven decision support method be developed to predict 
disorders on undiagnosed patient cases in the skeletal dysplasia domain? 
• How can the relationships between the concepts of the skeletal dysplasia domain be 
leveraged in the process of association rule mining? 
• How can we take advantage of the labelled datasets available in the skeletal dysplasia 
domain, in discovering characteristic features for disorders in this domain? 
These research questions can be refined into the following concrete objectives: 
O1. Determine the data characteristics (rareness, sparseness, and dimensionality) of skeletal 
dysplasia past patient cases and develop a machine learning approach that uses the data 7  
characteristics to provide a ranked list of diagnoses, given a set of features. Determining the 
correct disorder for skeletal dysplasia patients is a major problem, as clinicians usually do not 
have an adequate number of similar cases due to the relative rareness of these diseases. The aim 
is to expedite the decision-making process by automating the analysis of existing case studies 
and presenting the most likely ranked candidate(s), given a set of symptoms/clinical features, 
for human consideration. 
O2. Develop semantic similarity methods to compare/align concepts (features/phenotypes, 
disorders) used within the skeletal dysplasia domain and employ these methods to build a 
semantic similarity-driven decision support method to provide a ranked list of disorders, given a 
set of features. 
O3. Combine concept similarity metrics, formulated using the intrinsic structure of domain 
ontologies, with traditional interestingness measures to compute semantic interestingness 
measures in order to discover association rules in the skeletal dysplasia domain. 
O4. Provide a ranked list of characteristic features for a given disorder. A characteristic feature is a 
feature that is deemed highly characteristic for a particular skeletal dysplasia. Inferring the 
characteristic features of a skeletal dysplasia from multiple phenotypes is a critical step in the 
overall decision-making process. In particular, this generates the evidence to justify that a 
patient has a particular disorder or to discriminate between two candidate disorders. 
1.5 General Overview of the Research Framework 
This thesis proposes decision support services for the skeletal dysplasia domain that builds on an 
ontology-based interoperable framework. The proposed approach combines ontological techniques 
with inductive and statistical reasoning techniques, integrated within the Skeletome6 community-
driven knowledge curation platform. Figure 1.2 displays the high-level building blocks of the 
framework. The Bone Dysplasia Ontology [4], developed to capture the essential knowledge of the 
skeletal dysplasia domain, is a foundational prerequisite of the proposed framework. The BDO 
stores past and newly emerging patient cases and also stores domain knowledge of the skeletal 
dysplasia domain. Another vital prerequisite of the framework is the Human Phenotype Ontology 
(HPO) [3], a controlled vocabulary that captures and represents clinical and radiographic findings 
(or phenotypes in general). For the purposes of this research, it is used to measure the semantic 
similarity value between two phenotypes. The semantic annotation process used in this research 
also relies on the clinical and radiographic findings grounded in the HPO. 
 
6 http://itee.uq.edu.au/~eresearch/projects/skeletome/ 8  
                                                        
  
 
Figure 1.2: High-level building blocks of the decision support framework 
The framework (Figure 1.2) aims to support the scenarios outlined in the use case described above 
in Section 1.3. It provides an evolving knowledge base and decision support framework for the 
phenotype-disorder lifecycle. As each new patient case is investigated and a diagnosis is 
determined, the case becomes part of the knowledge base, and is used for further decision-making 
and feature characterisation. The proposed decision support framework comprises four phases:  
1) Disorder classification via machine learning  
2) Disorder classification via semantic similarity  
3) Association rule mining using semantic similarity and semantic rule interestingness 
measures  
4) Characteristic feature mining via class association rules  
Before discussing the phases of the decision support framework, in order to enable a better 
understanding of the technical aspects, some definitions are introduced. From an ontological 
perspective, the terms: concept, relationship and similarity measure are defined, while from a data 
mining and machine learning perspective, the terms: association rules and classification task are 
covered.  
From an ontological perspective, in general, concepts denote classes of entities within a domain. 
For example, phenotypes and disorders are generic concepts in the skeletal dysplasia domain, while 
‘Short stature’ or ‘Abnormality of body height’ are concrete concepts defined by the Human 
Phenotype Ontology (HPO). Ontologies capture and model domain knowledge by defining such 
concepts, together with the way in which they relate to each other - i.e., the relationships between 
concepts. Among these relationships, one is present by default in all ontologies - the Is-A 9  
relationship which enables the creation of hierarchies - and the rest are defined specifically by each 
ontology (e.g., the Part-Of relationship defined in the Gene Ontology). For instance, HPO defines a 
Is-A relationship between ‘Short stature’, ‘Abnormality of body height’ and ‘Growth delay’, 
respectively, and “Growth abnormality” (i.e., the latter is the parent of the former three concepts).  
Similarity measures are used to compare two or more concepts defined by the same or different 
ontology. Furthermore, in order to take into account the semantics imposed by the underlying 
ontologies, semantic similarity measures can be employed, i.e., functions that take as input two or 
more ontological concepts and return a numerical value that reflects the degree of similarity 
between them. These usually rely on some form of distance between the given concepts, e.g., the 
shortest path between them. For example in HPO, ‘Progressive macrocephaly’ and ‘Relative 
macrocephaly’ can be seen as highly (semantically) similar, because they have a direct common 
ancestor in (i.e., a Is-A relationship with) ‘Macrocephaly’ - and implicitly a very short path between 
them. 
From the data mining and machine learning perspective, association rules externalize knowledge in 
the form of probabilistic "if-then" statements. For example, the presence of ‘Short stature’ and 
‘Frontal bossing’ may signal a ‘Cleidocranial dysplasia’ diagnosis, with a likelihood of 14%. The 
head of the rule is called antecedent, while the body of the rule is called consequent. The antecedent 
and consequent of an association rule are always disjoint. From a symbolic perspective, association 
rules are represented in the following form: Antecedent -> Consequent (interestingness measure), 
e.g., { 'Short stature’, 'Frontal bossing’} −> {Cleidocranial dysplasia’} (14% support). One 
application area of association rules is the classification task, where they can be used, for example, 
to find potential dysplasias that match phenotypes listed in patient clinical reports. 
In the first phase, the framework employs machine learning to analyse a set of existing patient cases 
and identify the candidate disorders for a given set of phenotypes. The first phase meets the first 
research objective, as described above in Section 1.4. In the second phase, the semantics encoded in 
the datasets is exploited to identify disorders corresponding to a set of phenotypes by looking 
deeper into the data characteristics and developing a semantic similarity-based approach for 
disorder reasoning. More concretely, phase two leverages HPO in the concept similarity process for 
the purpose of classification. This phase meets the second objective (Section 1.4). Practitioners can 
leverage both the first phase and the second phase of the decision support framework to improve 
their decision-making speed, accuracy and reliability. The other two goals that are addressed in 
these two phases are objective decision-making and the training of learners/early-career specialists 
and non-specialist practitioners. 
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The third phase of the framework investigates whether semantic similarity-based rules can extract 
more accurate knowledge than exact matching-based rules. It does this by leveraging relationships 
between concepts that are identified through association rule mining. It then applies the discovered 
association rules to the classification task in the skeletal dysplasia domain. The dotted line in Figure 
1.2 indicates the application of the semantic rule interestingness measures within the classification 
task. The third phase employs the HPO and BDO ontologies in determining semantic rule 
interestingness measures. Practitioners can employ this phase to verify known associations and to 
discover new, previously unknown associations among clinical attributes associated with specific 
disorders. The third phase of the framework meets the third research objective (Section 1.4).  
The fourth phase of the decision support framework analyses existing patient cases and determines 
the characteristic features/phenotypes for a given disorder. To discover the characteristic 
phenotypes for a disorder, this phase employs a novel rule mining technique and also takes 
advantage of the fact that the dataset is labelled. This phase of the framework meets the fourth 
research objective (Section 1.4). Practitioners can leverage the fourth phase to validate experts’ 
characteristic features (ECFs) and discover previously unknown characteristic features. The 
implementation of the decision support framework is briefly discussed below. 
1.5.1 Disorder Classification via Machine Learning 
Machine learning techniques can facilitate the objective interpretation of medical observations for 
the purposes of decision support. The research described here uses data available from the ESDN 
for training and testing purposes. Patient clinical summaries in the ESDN are represented in free 
text format. The patient phenotypes were first extracted by annotating the text with corresponding 
terms from the HPO. Next the underlying data characteristics were analyzed in order to obtain 
meaningful results from a corpus that is smaller than the datasets usually required by decision 
support systems. A brief analysis of the data revealed three significant characteristics: (i) rareness, 
(ii) sparseness, and (iii) high dimensionality. 
Given the characteristics of the skeletal dysplasia data (rareness, sparseness, high dimensionality), 
the proposed solution combines association rule mining with Dempster-Shafer theory (DST) [6] to 
compute probabilistic associations between sets of clinical features and disorders. Given the lack of 
mature domain knowledge, the decision support framework induces generalised evidence by mining 
association rules from patient descriptions (i.e., clinical features and diagnosis). Reasoning over the 
induced generalised evidence using the DST facilitates the development of a targeted decision 
support method to find possible disorders. The proposed approach is evaluated by comparing the 
results with initial diagnoses made by clinicians who relied solely on clinical summaries. 11  
Experiments were also conducted comparing the performance of this approach with alternative 
machine learning algorithm. Chapter 3 of this thesis presents a detailed analysis of the proposed 
decision support method. 
1.5.2 Disorder Classification via Semantic Similarity 
The aim of this phase (Phase 2) is to predict candidate disorders for a given patient case, annotated 
using the HPO. More concretely, given a background knowledge base (i.e., the BDO or the 
annotated patient dataset) and a set of HPO concepts (representing the clinical and radiographic 
findings of a new patient case), the goal is to predict the most plausible skeletal dysplasias, ranked 
according to their probability.  
Biomedical ontologies have become a mainstream topic in medical research. The adoption of 
biomedical ontologies for annotation purposes provides a means of comparing or aligning medical 
concepts that would otherwise be incomparable. For example, the annotation of a set of patient 
cases using the same ontology enables us to compare them, via the ontology-based annotations. The 
actual comparison is subject to a semantic similarity measure - a function that takes two or more 
ontological concepts and returns a numerical value that reflects the degree of similarity between 
these concepts. In this phase, such similarity measures are investigated for predicting the most 
likely disorders associated with undiagnosed patient cases in the skeletal dysplasia domain. More 
specifically, different methods for computing semantic similarity were implemented and evaluated 
according to their prediction accuracy.  
Two sources of knowledge, annotated ESDN patient cases (annotated using HPO) and domain 
knowledge from the BDO (associated with HPO) were used. The use of HPO combined with 
semantic similarity measures enabled the calculation of probable disorders. Three different 
experiments were performed: 
– Firstly, the annotated ESDN patient case dataset was used as the knowledge source and semantic 
similarity measures were applied to calculate probable disorders; 
– Secondly, the BDO (Bone Dysplasia Ontology) was used as the knowledge source and semantic 
similarity measures were applied to calculate probable disorders; 
– Thirdly, the semantic similarity-based prediction was compared with an exact-term matching-
based prediction method (i.e., an approach that uses only the frequency of the patient findings in the 
context of each disorder) for the ESDN patient case dataset.  
Each experiment tested different semantic similarity measures (applied in a HPO concept-to-
concept setting). To assess the efficiency provided by each semantic similarity method, the overall 12  
accuracy of the disorder prediction was calculated. The outcome of this research enables us to 
understand the feasibility of developing decision support methods based on ontology-driven 
semantic similarity in the skeletal dysplasia domain. Chapter 4 of this thesis focuses on the 
implementation and evaluation of this decision support method. 
1.5.3 Association Rule Mining using Semantic Similarity and Semantic 
Interestingness Measures 
The concepts defined and described by biomedical ontologies, such as the HPO, enable us to 
compare medical terms at a semantic level – a comparison that would otherwise not be possible. For 
example, two ontological concepts, namely, HP:0004481 (progressive macrocephaly) and 
HP:0004482 (relative macrocephaly) from the HPO, would be treated differently by any classical 
data mining algorithm because of their symbolic (i.e., lexical grounding) difference. However, these 
two concepts are to a certain extent semantically similar and this similarity can be encoded via an 
existing or tailored metric. Replacing exact matching with semantic similarity measures provides 
novel and exciting opportunities in knowledge discovery and decision support on annotated 
datasets. In this decision support method, the similarity of semantic relationships between patient 
phenotypes is used to mine association rules. More specifically, a method is proposed that 
incorporates concept similarity metrics when computing traditional interestingness measures, and 
applies it to extract association rules in the skeletal dysplasia domain. This method is applied to an 
annotated patient dataset using domain-specific semantic similarities. 
This phase investigates both traditional and semantic interestingness measures in the context of 
association rule mining, to discover the implicit relationships between clinical features and 
disorders in the skeletal dysplasia domain. The main contributions of this research phase are as 
follows: (i) analysis of existing traditional interestingness measures for the discovery of association 
rules in the skeletal dysplasia domain; (ii) proposal of semantic interestingness measures based on a 
combination of semantic similarity metrics and traditional interestingness; and (iii) extensive 
empirical evaluation to measure the quality of the resulting rules, using an annotated dataset built on 
real patient data. Chapter 5 of this thesis focuses on the implementation and evaluation of this 
decision support method. 
1.5.4 Characteristic Feature Mining via Class Association Rules 
Finding, capturing and describing characteristic features (or symptoms) is a critical step in the 
definition, diagnosis and management of disorders/diseases. In general, such features are recognised 
by experts via repeated observations of patient cases. However, when the disorders are very similar, 13  
and share most of the same phenome space, determining the discriminative features is done in a 
pair-wise differential manner. This process is particularly important for rare disorders, as it provides 
an initial screening step which can save significant time and effort. However, the sparse nature of 
the phenome space in rare disorders, and the usually limited number of experts, makes this process 
very challenging. 
Moreover, the high degree of subjectivity involved, makes understanding and capturing of attributes 
that define such phenotypes, problematic even for human experts. Hence, in order to provide a 
computationally tractable definition for characteristic features, the definition is a feature that is: (i) 
common for the disorder under scrutiny (i.e., its absence would rule out the current disorder); and 
(ii) rare in other closely-related disorders (i.e., the feature is specific or discriminative for the 
current disorder). The ESDN patient case data is used to automatically infer characteristic 
phenotypes for a set of skeletal dysplasias.  
In Chapter 6, a clear definition for characteristic phenotypes is defined and a novel algorithm is 
presented for mining characteristic phenotypes for skeletal dysplasias. Next a set of measures is 
proposed, together with an associated class-driven algorithm, to discover the top K such phenotypes 
in the context of a set of disorders and patient cases. Finally the lessons learned from both an 
automatic and human-based validation of our approach are discussed. Chapter 6 provides details of 
the implementation and evaluation of this decision support method. 
1.6 Original Contributions 
This thesis makes a series of original contributions to the current state of the art: 
1. The data characteristics of the skeletal dysplasia domain have not been analysed prior to this 
research. Our analysis of the bone dysplasia data revealed three important characteristics: (i) 
rareness, (ii) sparseness, and (iii) high dimensionality. Based on the data characteristics, this 
research work proposes a novel solution that combines association rule mining with the 
Dempster-Shafer theory to compute probabilistic associations between sets of clinical 
features and disorders, which provide valuable support for medical decision-making (e.g., 
diagnosis) in the skeletal dysplasia domain. 
2. This is the first research work which attempts to develop and evaluate an original semantic 
similarity-driven decision support method to predict disorders on undiagnosed patient cases 
in the skeletal dysplasia domain. 
3. While previous research exists on applying traditional association rule mining on ontologies, 
no approach has, to date, exploited the advantages brought by using the structure of these 
ontologies in computing rule interestingness measures. This research work develops and 14  
evaluates a novel method that combines concept similarity metrics, formulated via a given 
ontology, with traditional interestingness measures to compute semantic interestingness 
measures that improve association rule mining in the skeletal dysplasia domain. 
4. Finally, this is the first research work which provides a clear definition of characteristic 
phenotypes and proposes a novel algorithm for mining the characteristic phenotypes 
associated with skeletal dysplasia disorders. 
1.7 Thesis Outline 
The remainder of this thesis describes the decision support methods developed to facilitate informed 
decision-making steps associated with disease diagnosis and characterisation. These methods are 
evaluated using knowledge and patient data formalised within the Skeletome project. 
Chapter 2 discusses background research related to knowledge representation, biomedical 
ontologies and databases, semantic similarity, data mining and machine learning. These are the 
foundational concepts that underpin the research work reported in the core chapters. 
Chapter 3 describes an approach that combines association rule mining with the Dempster-Shafer 
theory to compute probabilistic associations between sets of clinical features and disorders. Such 
extracted knowledge is essential to enable informed medical decision-making (e.g., diagnosis). This 
chapter also analyses the data characteristics (rareness, sparseness and multi-dimensionality) to 
provide meaningful results from a set of inputs that are much smaller than the datasets usually 
required by decision support systems. In addition, this chapter evaluates the results by comparing 
them against the initial diagnoses performed by clinicians and against a set of well-known machine 
learning techniques. 
Chapter 4 describes the use of semantic similarity measures to predict disorders on undiagnosed 
patient cases in the skeletal dysplasia domain. Two sources of knowledge, domain knowledge from 
the BDO and raw knowledge from annotated ESDN patient cases, together with the HPO, were 
employed to investigate several semantic similarity measures. More specifically, this chapter 
presents: (i) an analysis of different semantic similarity methods performed on the two types of 
data, and (ii) the outcomes from an extensive empirical evaluation of the application of these 
semantic similarity methods for disorder prediction, using a real-world dataset. 
Chapter 5 presents a method that combines semantic similarity metrics with traditional 
interestingness measures to compute semantic interestingness measures for association rule mining 
in the skeletal dysplasia domain. To measure the improvements achieved by using semantic 
interestingness measures over the traditional ones, this chapter also compares the experimental 15  
results from using traditional measures with the results from using semantic interestingness 
measures applied to a real-world dataset. 
Chapter 6 presents a novel approach to discovering and ranking characteristic features associated 
with a given disorder, through analysis of past patient cases. In order to observe the improvements 
contributed by using this approach over traditional class association rule mining, this chapter also 
describes the experimental results. 
Chapter 7 is the concluding chapter. It summarises the research reported in this thesis, describes its 
contribution to the field and highlights the conclusions that can be drawn. 
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Chapter 2: Foundational Aspects 
This chapter provides a high-level overview of the relevant technologies and concepts that form the 
foundation on which the work presented in this thesis was built. First, Section 2.1 explains the 
general foundational technologies required to understand the terminology and the solutions 
proposed within the thesis. Section 2.2 provides an overview of medical decision support systems, 
because the aim of this thesis is to develop a novel decision support framework for the skeletal 
dysplasia domain. Section 2.2 discusses prior applications of data mining and machine learning 
technologies to medical decision support. Section 2.3 describes pre-existing ontologies and data sets 
of relevance to the skeletal dysplasia domain. Finally, Section 2.4 presents a high-level architectural 
view of the proposed framework, which consists of four layers: Data Layer, Data Pre-Processing 
and Data Characterization Layer, Decision Support Layer and Application Layer. 
2.1 General Foundational Aspects 
This section provides a detailed description of the general foundational aspects relevant to the 
decision support framework reported in this thesis. It begins, in Subsection 2.1.1, by exploring the 
use of ontologies to capture domain-specific knowledge, i.e., the concepts and relationships that 
provide the controlled vocabulary for the data pre-processing step of the framework and capturing 
machine-processable domain. Subsection 2.1.2 provides an overview of concept recognition which 
is used by the framework to convert unstructured free-text patient cases to structured and 
standardized patient cases. Subsection 2.1.3 describes the topic of semantic similarity which is 
employed by the framework in order to enable comparisons of concepts. Subsection 2.1.4 
introduces data mining techniques which are used by the framework for discovering patterns from 
past patient cases. Finally, Subsection 2.1.5 discusses machine learning techniques which are used 
by the framework for classifying new patient cases based on the past patient cases. 
2.1.1 Ontologies 
In the past ten years, ontologies have become a mainstream topic in biomedical research. In the 
biomedical domain, their major role is to provide a controlled vocabulary, (i.e., a list of the concepts 
and relationships) that defines the domain knowledge. Concepts, such as phenotypes, genotypes and 
disorders are facts in the context of knowledge. Relationships in an ontology specify how concepts 
are related to each other. Between them, concepts and the relationships form a conceptualized, 
simplified view of a part of the world. Nilsson [7], defined the notion of conceptualization as: “A 
body of formally represented knowledge is based on a conceptualization: the objects, concepts, and 
other entities that are assumed to exist in some area of interest and the relationships that hold among 17  
them. A conceptualization is an abstract, simplified view of the world that we wish to represent for 
some purpose. Every knowledge base, knowledge-based system, or knowledge-level agent is 
committed to some conceptualization, explicitly or implicitly.” 
In 1993, Gruber originally defined the notion of an ontology as an “explicit specification of a 
conceptualization” [8]. In 1998, Studer et al. [9] defined an ontology as a “formal, explicit 
specification of a shared conceptualization” The backbone of an ontology consists of a 
generalization/specialization hierarchy of concepts, i.e., a taxonomy. The ontology practitioners 
analyses relevant entities in a domain and organizes them into concepts and relations. For instance, 
in the medical domain, Person, Patient, and Doctor might be relevant concepts, where the first is a 
super concept of the latter two. Treats can be considered a relevant Relation that holds between a 
Doctor and a Patient. A real-life patient with a patient case would then be an instance of the Patient 
concept. There are a number of different languages(e.g., RDF[10], RDFS[11], and the OWL[11] 
family of languages) that can be used to define an ontology. These languages use XML syntax, and 
have varying degrees of expressivity.  
 The decision support framework proposed in this thesis benefits from ontologies in two principal 
ways. Firstly, as mentioned earlier, ontologies provide a standardardized vocabulary for mapping 
biomedical texts describing patient cases to the concepts of the ontologies via concept recognition 
techniques, (as discussed in the next subsection). Secondly, ontologies provide machine-processable 
representations of domain knowledge that can be exploited by the framework via semantic 
similarity measures, (as discussed in Subsection 2.1.3). 
2.1.2 Concept Recognition  
Clinical concepts such as symptoms, disorders, and treatments, are important types of clinical data 
in patient cases. Obtaining clinical concepts from free text patient cases enables many translational 
discoveries because free text patient cases typically do not use standard terminologies and 
ontologies to annotate their elements. In the context of this thesis, annotating means supplementing 
entities in the text with a reference to a concept or relation in the ontology. This enhances the search 
process by finding results that are not explicitly related to the original search and enables the 
inferencing process to infer new knowledge.  
Annotations can be performed in three possible ways: manual (created by users), semi-automatic 
(based on automatic suggestions), and fully automatic. In the manual process, users interactively 
attach annotations or tags (from controlled vocabularies). In the semi-automatic approach, users 
attach annotations based on automatically-generated suggestions. In the fully automatic approach, 
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software automatically analyses/processes a resource (e.g., using machine learning techniques) to 
automatically classify and tag the resource or some part of the resource.  
In 2009, Shah et al.[12] describes concept recognition as follows: “the task of concept recognition 
can be understood as mapping biomedical text to a representation of biomedical knowledge 
consisting of inter-related concepts, usually codified as an ontology or a thesaurus. A concept 
recognizer takes as input a resource and a dictionary – which can be a flat list or taxonomy of 
hierarchically related terms – and produces annotated files”. For instance, a concept recognizer 
can recognize the string “reduced body height” in the free text patient case and maps it to the 
concept “short stature” in the ontology. To recognise such concepts from free text patient cases, 
automatic semantic annotation tools (e.g., the National Centre for Biomedical Ontology (NCBO) 
Annotator [13]) are employed as concept recognizers.  
In this thesis and in the biomedical application (skeletal dysplasias) that is used to evaluate the 
outcomes, semantic concept recognition via the NCBO annotator is used to relate terms in relevant 
ontologies to textual documents describing patient cases. The NCBO annotator provides a web 
service that allows scientists to utilize most of the public biomedical ontologies for annotating their 
datasets automatically. The annotations produced by the annotation process of the framework 
provide a means for comparing concepts via semantic similarity, discussed in next Subsection 2.1.3. 
For example, the annotation of a set of phenotypes using a particular ontology enables us to 
compare these phenotypes, by looking at their underlying annotation concepts. 
2.1.3 Semantic Similarity 
Similarity plays a central role in medical knowledge management. Like most scientific knowledge, 
medical knowledge is also inferred by comparing different concepts (such as phenotypes, 
populations and species) and finding their similarities and differences. Semantic similarity is the 
quantification of two or more concepts within ontology in terms of how alike they are in meaning. 
There are two approaches for comparing concepts in ontologies: node-based, and edge-based. The 
node-based approach uses the nodes and their properties as the data source, and the edge-based 
approach uses the edges and their types as the data source. 
Node-based approaches use the notion of information content (IC) to quantify the informativeness 
of a concept. IC values are usually calculated by associating probabilities to each concept in an 
ontology by computing the negative likelihood of its frequency in large text corpora. The basic 
intuition behind the use of the negative likelihood in IC calculation is that the more probable a 
concept is of appearing in a corpus, the less information it conveys. The equation of IC is 𝐼𝐶(𝑐) = −  log  𝑝(𝑐). Here, p(c) is the probability of occurrence of c in a specific knowledge base. The 19  
occurrence is calculated by the frequency of annotations. The most widely used node-based 
measures are those proposed by Resnik [14] , Jiang and Conrath [15] and Lin [16] as shown below. 
Resnik was the first to leverage IC to compute semantic similarities.  Resnik ∶ SIMRes(c1, c2) =  IC(cMICA) … … … … … . (2.1) Lin: SIMLin(c1, c2) =  2 × IC(cMICA)IC(c1) + IC(c2)) … … … … … . (2.2) Jiang and Conrath: SIMJC(c1, c2) =  1 − IC(c1) + IC(c2)  − IC(cMICA) … … … … … . (2.3) 
In Resnik’s method, semantic similarity between two terms is the IC of their Most Informative 
Common Ancestor (MICA), which is the common ancestor with the highest IC. It states that 
similarity depends on the amount of information two concepts C1 and C2 share. While this method 
is effective for measuring the amount of information shared by the two concepts, it does not 
consider how different the terms are with respect to information content and hierarchical 
perspective. Following Resnik’s work, Jiang and Conrath [15] and Lin proposed two measures, 
which take into account how different the terms are with regard to information content. 
The edge-based approach measures the distance (e.g. path length) between nodes which 
correspond to the concepts being compared. This distance can be computed by measuring the 
geometric distance between the nodes representing the concepts. Wu and Palmer [17] proposed a 
measure based on the length of the shortest path between the lowest common ancestor (LCA) and 
the root and on the length of the shortest path between each of the terms and that common ancestor. 
It is given by the expression: 
Wu and Palmer ∶ 𝑑𝑖𝑠𝑤&𝑝(𝑎, 𝑏) =  2 × 𝑁3𝑁1 + 𝑁2 + 𝑁3 … … … … … … . (2.4) 
where, N3 – length of path from LCA to root, N1 – length of path from node a  to LCA, N2 – length 
of path from node b to LCA. Other edge-based approaches include Rada et al.[18], Pekar and Staab 
[19] and Pozo et al. [20] Within this thesis, semantic similarity methods are used to compare 
concepts in related ontologies so as to leverage the domain knowledge encapsulated within these 
ontologies. The next subsection (2.1.4) presents an overview of data mining methods that can be 
employed to mine patterns from past patient cases to underpin decision support for diagnosing new 
patient cases. 
2.1.4 Data Mining 
Data mining (DM) is closely related to knowledge discovery in databases (KDD), although 
generally data mining is considered one of the steps in the KDD process. Widely-accepted 20  
definitions for KDD and DM have been provided by Fayyad, Piatetsky-Shapiro and Smyth [32]. 
They defined KDD as the process of extracting interesting, non-trivial, implicit, previously 
unknown and potentially useful information or patterns from data in large databases [21]. The term 
"pattern" they defined as a model that is extracted from data and assigned a number of common 
characteristics. They defined the KDD "process" as comprising many steps, including data 
preprocessing, pattern queries, and result validation. Data mining is the most important step in the 
KDD process and involves the application of data analysis and discovery algorithms using 
computation. One application area of data mining is generating new generalised assumptions from 
existing specific assumptions. Another application area is to discover new information, which is 
hidden in the existing information. The application of data mining within this thesis, focuses on 
generating new generalized knowledge. More specifically it focusses on discovering interesting 
patterns from patient cases by extending and refining a data mining technique (association rule 
mining) in novel ways.  
Association rules provide knowledge in the form of probabilistic "if-then" statements. For instance, 
in a diagnosis context, the association rule { Dwarfism, Shortening of the proximal limbs } → 
{Achondroplasia} may imply that if both { Dwarfism } and { Shortening of the proximal limbs } 
are a patient’s phenotypes, then the patient is likely to have Achondroplasia – subject to the strength 
of the rule in the given dataset. The head of the association rule (i.e., the if part) is called the 
antecedent, while the body (i.e., the then part) is called the consequent. The antecedent and 
consequent of an association rule are disjoint: they do not have any items in common. To express 
uncertainty in association rules, two quantities are used: support and confidence. Support is 
represented by the number of transactions that include all items in the antecedent and consequent. 
Confidence is represented by the ratio between the number of transactions that include all items in 
the consequent and the antecedent (i.e., the support) and the number of transactions that include all 
items in the antecedent. The first pioneering work to mine association rules using a level-wise 
search algorithm [22] was explained by Agrawal et. al. in [23]. After that, many algorithms [24-27] 
were proposed to mine association rules efficiently. The next subsection (2.1.5) briefly discusses 
machine learning techniques that are employed in this thesis to classify new cases based on past 
cases. 
2.1.5 Machine Learning 
While the purpose of data mining is to find hidden patterns in past data or past experiences, the 
purpose of machine learning is to learn from the past data or past experiences in order to classify 
new data. If the instances of past data or past experiences are given with the corresponding 21 
correct outputs, then the learning is called supervised, in contrast to unsupervised learning, where 
the corresponding correct outputs are not provided. Supervised machine learning problems cannot 
be solved without the availability of a comprehensive corpus of past data. For instance, in case of a new disorder, machine learning cannot classify new patient cases if there is an absence of this specific disorder in the past cases. Machine learning is applied in this thesis to identify possible disorders for a newly arrived patient case and hence provide decision support to the clinician performing the diagnosis. Widely used machine learning techniques (Decision Tree, 
Random Forest, Naive Bayes, SVM, K-NN) are investigated and compared against a novel approach proposed in this thesis i.e. a novel combination of association rule mining and the Dempster-Shafer theory [6]. An introduction to these widely used machine learning techniques is provided in the following paragraphs. 
The decision tree is one of the widely used approaches to build a classification model [28]. It 
specifies the sequence of decisions that need to be made along with the resulting recommendation 
[29]. Based on past data, the decision tree learning algorithm constructs a model with a tree-shaped 
structure using inductive reasoning [28, 29]. The benefits of the decision tree approach are that no 
domain knowledge or parameter settings are required and decision trees are easy to read and 
interpret. One of the disadvantages of the decision tree is that it is unstable. In addition, it is a hard 
classification model, that is, it is limited to one output attribute. Quinlan [28] proposed the widely 
employed decision tree learning algorithm named the Interactive Dichotomiser 3 (ID3). ID3 uses 
the information gain to select attributes to build a tree structure. However, this process results in 
bias with respect to the attributes of higher values.  
The random forest is an ensemble classifier which uses multiple models for better predictive 
performance. Breiman and Cutler [43] proposed the random forest learning algorithm. The random 
forest approach constructs a number of decision trees. To classify all the input data, this approach 
feeds the input data points into each of the trees in the forest. Each tree gives a class label, which is 
a tree vote for that class. The algorithm chooses the class label having the most votes (across all of 
the trees in the forest). For standard trees, the nodes are split using the best split among all the 
variables; whereas, for random forests, the nodes are split using the best among a subset of 
predictors randomly chosen at that node. This ML approach has a number of advantages: it can 
handle high-dimensional data; it generates an internal unbiased estimate of the generalisation error; 
and it is an effective method for estimating missing data. One of its downsides is that it is prone to 
over-fitting to noise (e.g. presence of features unrelated to the disorder). 
The naive Bayes classifier[29] is a probabilistic classifier based on conditional probabilities by 
assuming that features are independent of their class. Despite this unrealistic conditional 22 
independence assumption, the resulting classifier is remarkably successful in practice, often 
competing with much more sophisticated techniques [29] . The naive Bayes approach has proved to 
be compelling in most real-world applications, including text categorisation, medical decision 
support, and systems performance management [29] . The naive Bayes classifier is very simple and 
easy to understand and the learning of the predictive model of the classifier is extremely fast, 
requiring only a single pass through the data. Another benefit is that it only requires a small amount 
of training data for learning. In situations where features (e.g., phenotypes) are highly independent, 
it usually provides excellent classification results. When data are sparse, the Laplace estimator can 
be used to assign prior conditional probabilities when an attribute occurs zero amount of the time.  
The support vector machine (SVM) method is another widely used machine learning technique, 
pioneered by Vapnik [30]. SVM trades off accuracy for generalisation errors. For pattern 
classification, SVM constructs a multi-dimensional hyperplane that optimally discriminates 
between two classes by maximising the margin between two data clusters. To achieve high 
discriminative power, SVM employs special non-linear functions named kernels to convert the 
input data into a high-dimensional space. The benefits of SVMs are that they are robust to noise and 
don’t overfit to noise. This means that SVMs can be used in situations where the training sample 
has some bias. The drawback is the lack of transparency of results due to their non-parametric 
nature.  
The k-nearest neighbour algorithm (k-NN) [31] is a method for classifying an object by associating 
each data point of the object with its k-nearest neighbours. The advantage of this approach is that it 
is transparent, very simple to understand and easy to implement. In situations where an explanation 
of the results is necessary, this approach can be very effective. k-NN is unfortunately unable to 
provide a meaningful interpretation of high-dimensional data. As the dimensionality of the data 
increases, the distance to the nearest point approaches the distance to the most distant point. k-NN 
also suffers from the data sparseness problem [32].  
2.2 Medical Decision Support Systems 
Medical decision making by nature is a complex cognitive process, mainly because medical data 
and information can be vague, conflicting, missing or difficult to interpret. Medical decision support 
can provide assistance in critical clinical judgments, particularly for inexperienced medical 
professionals. In 2007, Stylioset et al. [33] presents the notion of medical decision support systems 
as “complex systems consisting of many subsystems and elements, taking into consideration many 
factors that may be complementary, contradictory, and competitive; these factors influence each 
other and determine the overall decision with a different degree. It is apparent that medical decision 23  
support systems require a sophisticated modelling methodology that can handle all these challenges, 
while at the same time, is able to infer a decision.”  
Medical decision support systems are generally either based on domain knowledge (expert 
knowledge or the defined rules of the domain) or based on past examples (past experiences). In the 
presence of domain knowledge, rule-based reasoning [34] is generally employed. Rule-based 
reasoning requires mature and established domain knowledge. For domain knowledge-based 
decision support systems, rule-based reasoning [34] attempts to capture the knowledge of domain 
experts within expressions or rules; an example rule might read, "If the patient has osteoarthritis, 
he/she is at risk of diastrophic dysplasia." Rule-based reasoning has been used for domain-specific 
decision support methods. For example, Lee and Wang [35] present a novel fuzzy expert system for 
a diabetes decision support application. The system depends on mature and established domain 
knowledge, which is absent in the skeletal dysplasia domain. In [36], Hussain et. al present a rule-
based clinical decision support system to provide evidence-guided recommendations after the 
treatment of breast cancer. ControlSem [37], a rule based medical decision support system was 
developed with the goal of controlling medical procedures. Similarly, in [38], Prcela et. al. present a 
medical expert system for heart failure. The three expert systems above also use general purpose 
rule-based reasoning [34] because the underlying domain has well-defined rules and a mature 
domain knowledge. 
Due to the absence of well-defined rules and mature background knowledge in the skeletal 
dysplasia domain, the decision support framework developed for this domain cannot employ rule-
based reasoning. However, the availability of patient cases in this domain allows the employment of 
machine learning techniques for the decision support services of the framework. The availability of 
instance data also enables the generation of generalized knowledge and discovery of interesting 
patterns via data mining (association rule mining). Hence, the framework in this thesis employs data 
mining and machine learning techniques to provide decision support services. Subsection 2.2.1 
discusses some existing applications of data mining in medical decision support area. Subsection 
2.2.2 discusses some existing applications of machine learning in the medical decision support area. 
2.2.1 Data Mining and Medical Decision Support Systems 
Because of the availability of data sets (patient cases, databases, publications) that have been 
annotated with ontological concepts, clinical data exploration often involves the mining of patterns 
or relationships between these ontological concepts. For instance, Kumar et. al. [39] employed 
association rule mining to discover dependence relationships between Gene Ontology [40] 
concepts. Other examples involve detecting adverse reactions to drugs (e.g., diabetic ketoacidosis 24  
[41] and hepatic toxicity [42]). Data mining on ontological annotations of datasets have also been 
used for identifying relations between genotype and phenotype by Butte et. al. [43] and Lussier et. 
al. [44]. Finally, data mining on ontological annotations have also been used for creating and 
interpreting gene networks by Camargo et. al. [45], as well as drug target networks by Yıldırım et. 
al. [46]. 
These past data mining approaches apply traditional data mining algorithms, which were designed 
mainly for relational databases. Such approaches do not take advantage of the semantics encoded in 
the related domain ontologies because existing data mining algorithms use exact matching which 
requires identical terms for the same concept. Whereas the semantic similarity measure will identify 
when two ontological concepts are the same, even when different terminology is used to refer to the 
concept. For instance, two ontological concepts ( e.g., Decreased body height and Short stature 
from the Human Phenotype Ontology [3]) would be treated differently by any traditional data 
mining algorithm because of their terminology difference. However, these two concepts are 
semantically very similar. Employing semantic similarity measures instead of exact matching 
provides greater flexibility, extensibility and recall in knowledge discovery operations. 
2.2.2 Machine Learning and Medical Decision Support Systems  
In the past ten years, machine learning has been increasingly employed in medical decision support 
systems – largely because technological advances have enabled large volumes of biomedical data to 
be captured automatically. 
For example, a variety of machine learning methods [47-51] have been employed for diagnosing 
liver diseases in new patient cases. In [47], Bucak et. al. employ the neural network approach 
leveraging human liver test data that consisted mainly of liver enzymes to diagnose liver diseases, 
and show its effectiveness for medical diagnostic purposes. In [48], Lin et. al. build a classification 
system which integrates artificial neural networks, an hierarchical analysis process and case-based 
reasoning (CBR) methods to determine whether a patient is suffering from liver disease. Chuang et. 
al. [49] combine CBR with a number of machine learning methods such as the back-propagation 
neural network, classification and regression tree, logistic regression and discriminatory analysis, in 
order to develop a more efficient model for the early diagnosis of liver disease and to enhance 
classification accuracy. In [52], Mehdi et. al. employ a combination of two methods: particle swarm 
optimization and CBR to diagnose hepatitis. Liang et. al. [51] employ a genetic algorithm to 
determine whether a patient is suffering from liver disease. 
Similarly, many researchers have employed different machine learning methods [53-59] for 
diagnosing heart disease in new patient cases. For example, Khatibi et. al. [51] employ a hybrid 25  
inference engine comprising Dempster-Shafer theory of evidence and fuzzy sets theory for coronary 
heart disease risk assessment. Shouman et. al. [52] investigate the application of a range of 
techniques to different types of decision trees seeking better performance in heart disease diagnosis. 
In [57], Hsich et. al. employ random survival forests modelling to develop a machine learning 
approach for identifying important risk factors for patients with systolic heart failure who 
underwent cardiopulmonary stress testing. In [58], Gudadhe et. al. employ a decision support 
system for heart disease classification based on the SVM and artificial neural networks. 
Other applications of machine learning for medical decision making include: diabetes [60-62], 
cancer [63-65] and Alzheimers disease [66-68]. 
There has also been a limited amount of research focussing on rare disorders. For instance, 
Srivastava et. al. [69] investigate different machine learning algorithms to classify spinal muscular 
atrophy (a larger number of rare disorders due to a genetic defect in the SMN1 gene subtypes). 
Wang et. al. [70] employ SVM to facilitate Muscular Dystrophy (MD) sub-types classification. 
Eyskens et. al. [71] develop a diagnostic support tool via machine learning technique for Medium-
Chain Acyl-CoA dehydrogenase deficiency (MCADD) disorder.  
Although only a few research centres worldwide have expertise in the analysis and management of 
skeletal dysplasias, to date, no one has focussed on developing decision support methods using 
machine learning techniques. In order to bridge this gap, the research work presented in this thesis 
focuses on developing decision support services (e.g. disorder reasoning and characteristic feature 
discovery) employing different machine learning techniques (e.g. SVM ) in the skeletal dysplasia 
domain.  
2.3 Domain-Specific Data and Knowledge 
In this section, the ontologies and data sets relevant to the skeletal dysplasia domain and the 
research in Chapters 3-6 are described. 
2.3.1 Human Phenotype Ontology  
The Human Phenotype Ontology [3] has become the internationally accepted controlled vocabulary 
that captures and represents clinical and radiographic findings. The ontology consists of around 
10,000 concepts describing modes of inheritance, onset and clinical disease courses and phenotypic 
abnormalities. This last category represents around 95% of the ontology and is the main focus of 
this thesis. Phenotypic abnormalities are structured in a hierarchical manner via sub-class 
relationships from generic abnormalities (e.g., HP 0000929; abnormality of the skull) to specific 
abnormalities (e.g., HP 0000256; macrocephaly). For instance, a “ventricular septal defect” is a sub-26  
class of its parent term “abnormality of the ventricular septum” in the sense that a ventricular septal 
defect is a kind of abnormality of the ventricular septum and every person with a ventricular septal 
defect can also be said to have an abnormality of the ventricular septum.  
The HPO was built using Online Mendelian Inheritance in Man (OMIM) [72]. OMIM is a public 
knowledgebase of human genes and genetic disorders [72] and records human Mendelian diseases 
with a relationship between human phenotypes and their causative genes. Each OMIM record has a 
free text summary of a genetic phenotype and/or gene and has links to other genetic databases such 
as DNA and protein sequences, PubMed references, mutation databases and approved gene 
nomenclature [72]. As of December 14, 2013, OMIM had 22,130 records in total. OMIM disorder 
records usually have a clinical synopsis section that explains the clinical features accompanying the 
disorder in a structured format. They are particularly useful during the decision-making process for 
practitioners in order to determine what features need to be investigated and observed. No 
controlled vocabulary or ontology has been employed for the clinical features. The clinical synopses 
in OMIM have been generated via text mining over scientific publications [73]. 
 
Figure 2.1: Fragment of the Human Phenotype Ontology  
In the construction process of HPO, Robinson et. al. [73] retrieved the clinical synopses, the textual 
descriptions of disorders of OMIM as text and then processed tem with the aid of a number of text 
analysis programs [73]. More concretely, at first the clinical synopses, which are ordered in a 
hierarchical fashion (e.g., in the clinical synopses of Achondroplasia, clinical feature Frontal 
bossing is listed under the category Head, subcategory Head and Neck), were parsed. After that an 
ordered list of features was created based on their frequency and finally OBO-Edit [74] was 
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employed to define concepts and to create the relationships between the concepts. A concept was 
created for each description which occurred two or more times in OMIM clinical synopses. 
Phenotypes are clinically similar to one another because of their shared properties. For example, 
progressive macrocephaly, postnatal macrocephaly and relative macrocephaly in the HPO (Figure 
2.1) are similar to each other because they share a range of clinical properties and they are all types 
of macrocephaly. The phenotypes which show overlapping properties are placed in the hierarchy in 
such a way that they have a common ancestor. In this example, these three phenotypes have the 
same common ancestor macrocephaly, as depicted in Figure 2.1. One obvious advantage of 
capturing phenotypic information in the form of an ontology is that different algorithms can be 
designed to exploit the semantic relationships between phenotypes. For example, the algorithm can 
be designed such that data/text annotated with abnormality of the cardiac septa will not just retrieve 
all data/text annotated with this term, but also all the data/text annotated with related terms such as 
ventricular septal defect or atrial septal defect.  
2.3.2 Bone Dysplasia Ontology 
The Bone Dysplasia ontology (BDO) [4] is a comprehensive and structured knowledge source for 
the skeletal dysplasia domain. It captures the different domain concepts involved in documenting 
the full complexity of the skeletal dysplasia domain. It comprises 1228 own-defined classes, of 
which 515 define bone dysplasias, 254 define genes, 361 define gene mutations and 224 define 
proteins [4]. Its main role is to provide the scaffolding required for a comprehensive, accurate and 
formal representation of the genotypes and phenotypes involved in skeletal dysplasias, together 
with their specific and disease-oriented constraints. The ontology is conceptually structured around 
three main areas: bone dysplasias, genotype information, and phenotype information. 
The bone dysplasia area of BDO [4] aims to address the specific knowledge representation 
shortcomings of the ISDS Nosology [1]. The ISDS Nosology [1] lists all recognised skeletal 
dysplasias and groups them by common clinical-radiographic characteristics and/or molecular 
disease mechanisms. The ISDS Nosology is revised every four years by an expert committee and 
the updated version is published in a medical journal. The latest version is from 2010 and is 
presented in [1]. The ISDS Nosology is widely accepted as the “official” nomenclature for skeletal 
dysplasias within the biomedical community. As opposed to the current ISDS Nosology, the bone 
dysplasia area of the BDO enables a shared conceptual model, formalised in a machine-
understandable description, in addition to a continuously evolving and foundational building block 
for facilitating knowledge extraction and reasoning. The bone dysplasia part of the BDO consists of 
a hierarchy of disorders. The hierarchy starts with the super concept, Bone Dysplasia, which is sub-28  
classed to 40 specific groups of diseases (e.g., Filamin Group) and then to concrete skeletal 
dysplasias (e.g., Achondroplasia) defined within the groups. Figure 2.2 illustrates a small portion of 
the hierarchy.  
The genotype information area and phenotype information area of the BDO are used when it 
encodes domain knowledge and instance knowledge (patient cases). The BDO has been built to 
model and capture essential (and mature) knowledge in the skeletal dysplasia domain. As depicted 
in Figure 2.3, it associates bone dysplasias to gene mutations and phenotypic characteristics, which 
are then further specialised via concepts defined by external ontologies, such as the HPO. In [4], 
Groza et al. provides a comprehensive overview of the design process of the BDO . The BDO 
describes associations (via class axioms) between more than 250 disorders (out of the 450 in total) 
and around 2,000 findings (represented by HPO concepts). These associations have been created 
from the clinical synopses of the corresponding disorders in OMIM and represent, in principle, the 
current state of conceptual understanding of their clinical manifestations.  
 
 
Figure 2.2: Bone dysplasia classification (the main bone dysplasia concept is connected to lower-level concepts via 
rdfs:subClassOf relations) (Adapted from [4])  
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Figure 2.3: Snapshot of the Bone Dysplasia Ontology (from [75]) 
2.3.3 European Skeletal Dysplasia Network 
Skeletal dysplasia data collection is a challenging task. Different research groups around the world 
have, over time, built small patient registries that are neither open nor interoperable. European 
Skeletal Dysplasia Network (ESDN)7 is a pan-European research and diagnostic network aimed to 
provide community-driven help and diagnostic expertise for rare bone disorders. In 2002, the ESDN 
was created to provide a collaborative environment to help with the diagnosis of skeletal dysplasias 
and to improve the exchange of information between researchers. At the time of writing, the ESDN 
had gathered over 1,200 patient cases, which had been discussed by its panel of experts. Among 
these cases, 744 had a bone dysplasia diagnosis (the remaining cases were not thought to be true 
bone dysplasias by the experts), and in total, there were 114 different skeletal dysplasias present.  
The ESDN case workflow consists of three major steps: (1) a patient case is uploaded and an initial 
diagnosis is set by the original clinician who referred the case (the patient cases contain a free text 
clinical summary and associated x-rays); (2) the panel of experts discusses the case until an 
agreement is reached; and (3) the panel of experts recommends a diagnosis. Each ESDN case has 
patient information, a free text description of clinical features, relevant family history, diagnosis 
information and a number of radiographic images. Each ESDN record has a unique identification 
number and an associated discussion section, which contains the experts’ discussion about the 
diagnosis of the patient. 
 
7 http://www.esdn.org/ 30  
                                                        
Data Representation: 
As mentioned above, ESDN stores the clinical summaries associated with patient cases in free text 
form. In order to be able to use the phenotypic knowledge expressed in these cases, we have 
annotated them with Human Phenotype Ontology (HPO) concepts via the NCBO Annotator [13] (as 
shown in Figure 2.4). A bone dysplasia expert has manually validated the resulting annotations. 
This process has alleviated the diverse language-related issues that exist in clinical summaries – 
such as synonymy (several terms having the same meaning) or hyponymy (one term being more 
specific than another). Furthermore, it enabled us to represent patient data using Semantic Web 
formalisms (e.g., OWL), which in turn provided relations between phenotypic concepts (required 
for semantic similarity computation), as well as between phenotypes and disorders modeled via the 
Bone Dysplasia Ontology (BDO). Diagnoses associated with patient cases have also been annotated 
with BDO concepts. Finally, this preprocessing phase enabled us to perform a quantitative and 
qualitative analysis of the data. 
 
Figure 2.4: Processing of ESDN data using HPO and NCBO Annotator 
Data Characteristics of the Skeletal Dysplasia Domain: Prior to this research, the data 
characteristics of the skeletal dysplasia domain have not been analysed. The availability of the 
ESDN patient cases offers opportunities to analyse the data characterisation of the skeletal dysplasia 
domain. The analysis of the data revealed three important characteristics: (i) rareness, (ii) 
sparseness, and (iii) high-dimensionality. Each of these characteristics is discussed as follows.  
Rareness – Firstly, it was found that the patient cases were not evenly distributed: a few disorders 
had a decent number of cases, while the majority of disorders had a low or very low number of 
cases. This has serious implications for any data mining and machine learning algorithm as the 
general tendency will be to give a preference to those disorders (classes) that are better represented. 
Figure 2.5 shows the relative distribution of the disorders according to the number of cases. It can 
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be observed that 70% of the bone dysplasias have a very small number of cases (i.e., 1-2 or 3-5) and 
only 4% of the disorders are very well represented, that is, they have more than 50 cases. 
 
Figure 2.5: Relative distribution of dysplasia diagnoses according to different ranges of number of cases 
Sparseness – By looking at the coverage of the clinical features (Table 2.1), it was found that the 
data was sparse. The coverage of a single feature can be defined as the percentage of cases 
diagnosed with a particular dysplasia in which this phenotype is present. For example, Cystic 
hygroma had coverage of 50% in cases of Achondrogenesis type 1A because it appeared in two of a 
total of four cases diagnosed with this disorder. The maximum coverage achieved was 50% (e.g., 
Subglottic Stenosis), while the minimum was 0.99% (e.g., Immunodeficiency). The average 
coverage was 11.33%, with a median of 8% and a mode of 0.99%. This indicates that the data is 
highly sparse. 
Feature 
 
Total cases of a particular 
dysplasia where this 
feature exists 
Total cases of the 
particular dysplasia 
Coverage 
  (%) 
Cystic hygroma 2 4 50% 
Subglottic stenosis 1 2 50% 
Cyanosis 1 2 50% 
Hypopigmentation  
of the skin 
1 101 0.99% 
Immunodeficiency 1 101 0.99% 
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Clumsiness 1 101 0.99% 
Table 2.1: Features with top 3 and bottom 3 coverage  
High dimensionality – The skeletal dysplasia data emerging from the ESDN cases were 
characterised by a total of 602 unique clinical and radiographic features. Unfortunately, the 
distribution of these features across the different types of dysplasias was heavily skewed. 
Consequently, there were dysplasias characterised by 151 or 128 phenotypes (e.g., Congenital 
spondyloepiphyseal dysplasia and Autosomal dominant multiple epiphyseal dysplasia respectively 
in table 2.2), but there were also dysplasias with four or five phenotypes (e.g., frontometaphyseal 
dysplasia and neonatal Caffey disease). The average count of phenotypes per dysplasia was 21.58, 
with a median of 15 and a mode of 5. This indicates the high-dimensionality of the data. 
Name of Skeletal Dysplasia  Phenotype Count 
Congenital spondyloepiphyseal dysplasia 151 
Autosomal dominant multiple epiphyseal dysplasia 128 
Cartilage-hair-hypoplasia 80 
Table 2.2: Dimension count of Skeletal Dysplasias (Top 3) 
2.4 Technical Overview of the Decision Support Framework 
The decision support framework reported in this thesis proposes a range of decision support 
services for the skeletal dysplasia domain. Figure 2.6 shows the high-level architectural view of the 
proposed framework, which consists of four layers: Data Layer, Data Pre-Processing and Data 
Characterization Layer, Decision Support Layer and Application Layer. The four layers are 
described as follows: 
The bottom layer is the Data Layer and comprises the ESDN free text patient cases, the Human 
Phenotype Ontology and the Bone Dysplasia Ontology. As discussed above, each ESDN case has a 
patient clinical summary, describing different phenotypes in free text and a final diagnosis. ESDN 
patient cases have been manually downloaded and then parsed to extract the patient clinical 
summary, the initial and final diagnoses. Finally, HPO and BDO have been downloaded from the 
Bioportal [76] and stored as OWL files.  
 
 
33  
 
Figure 2.6: High-level architectural view of the proposed framework 
The second layer is the Data Pre-Processing and Data Characterization Layer and is responsible 
for two main aspects: semantic annotation of the free text clinical summaries of the ESDN patient 
cases (using HPO as background knowledge) and data characterization to perform a quantitative 
and qualitative analysis of the data. This layer employs the National Centre for Biomedical 
Ontology (NCBO) Annotator [13] to annotate ESDN free text patient cases with ontological 34  
concepts from HPO. The second aspect of this layer is the data characterization, which applies 
statistical analysis to the annotated dataset to discover its underlying properties. This statistical 
analysis includes the relative distribution of diagnoses according to the number of cases, the 
coverage (the percentage of cases diagnosed with a particular dysplasia in which this phenotype is 
present) of clinical features and the distribution of these features across the different types of 
dysplasias. 
The third layer is the Decision Support Layer, which takes the annotation dataset and the data 
characteristics produced by the second layer, as well as HPO and BDO to provide decision support 
services, organized according to the phenotype-disorder lifecycle introduced in Sec 1.5, :  
1) Disorder classification via machine learning  
2) Disorder classification via semantic similarity  
3) Association rule mining using semantic similarity and semantic rule interestingness 
measures  
4) Characteristic feature mining via class association rules  
Disorder classification via machine learning is realised by first applying standard machine learning 
techniques (Naive Bayes, SVM, Decision tree, Random forest and K-NN), and comparing the 
results to a novel approach (e.g., a combination of association rule mining and the Dempster-Shafer 
theory [6]). WEKA[77] – an open source machine learning software – has been used to perform the 
experiments involving the standard ML techniques. Disorder classification via semantic similarity 
relies on comparing HPO concepts via standard semantic similarity methods (e.g., Resnik, Lin and 
J&C), as well as four novel semantic similarity methods. Two data sources have been used as 
background knowledge: the Bone Dysplasia Ontology (BDO) and the ESDN annotated dataset. 
The third service performs association rule mining using semantic similarity measures. It combines 
semantic similarity methods (e.g., Wu and Palmer [17]) with traditional interestingness measures 
such as Confidence to compute semantic interestingness measures. Finally, the last service 
determines characteristic features for a given disorder via a novel class association rule mining 
approach by applying a new measure called Commonality in the level wise search. This takes into 
account the frequency of feature sets at a class level rather than the widely used Support that 
considers the frequency of feature sets at the dataset level. 
The top layer of the framework is the Application Layer which exposes the decision support 
services provided by the previous Decision Support layer to users (e.g., clinicians / researchers) or 
to external platforms that can integrate these services and extracted knowledge into their workflows. 35  
Chapter 3: Disorder Classification via Machine 
Learning 
3.1 Introduction 
The previous chapter outlined the foundations and application domain on which this research is 
built. This chapter focuses on the first phase of the proposed decision support framework which 
identifies the most likely candidate disorders given a set of phenotypes, by analysing the past 
patient cases. This phase is implemented via a novel machine learning-based approach that 
minimises the impact of the data sparseness issue (as discussed in Sec. 2.2.3). More concretely, this 
approach analyses the underlying data and then builds a novel classifier tailored to accommodate 
the specific characteristics of the data. The proposed ML algorithm combines association rule 
mining with the Dempster-Shafer theory (DST). 
This chapter aims to address the first research objective of the thesis, which is to expedite the 
decision-making process by automating the analysis of existing case studies and presenting the most 
likely ranked candidate(s), given a set of symptoms/clinical features. Consequently, the resulting 
algorithm investigates and provides a response to the research question: “How can a machine 
learning approach be developed to compute probabilistic associations between sets of clinical 
features and disorders based on the underlying data characteristics of the skeletal dysplasia 
domain?” A primary objective of this research phase is to improve the speed, accuracy and 
reliability of decision-making (e.g., diagnosis) by clinicians, doctors and researchers when they are 
investigating a new patient case. The resulting system will also assist early career or non-specialist 
practitioners (with limited expert knowledge) in decision-making, as well as provide objective 
justifications for the proposed results.  
Section 3.2 of this chapter has been published as a regular research manuscript in the peer-reviewed 
journal “Plos One” in 2012 [78] . 
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Abstract
A lack of mature domain knowledge and well established guidelines makes the medical diagnosis of skeletal dysplasias (a
group of rare genetic disorders) a very complex process. Machine learning techniques can facilitate objective interpretation
of medical observations for the purposes of decision support. However, building decision support models using such
techniques is highly problematic in the context of rare genetic disorders, because it depends on access to mature domain
knowledge. This paper describes an approach for developing a decision support model in medical domains that are
underpinned by relatively sparse knowledge bases. We propose a solution that combines association rule mining with the
Dempster-Shafer theory (DST) to compute probabilistic associations between sets of clinical features and disorders, which
can then serve as support for medical decision making (e.g., diagnosis). We show, via experimental results, that our
approach is able to provide meaningful outcomes even on small datasets with sparse distributions, in addition to
outperforming other Machine Learning techniques and behaving slightly better than an initial diagnosis by a clinician.
Citation: Paul R, Groza T, Hunter J, Zankl A (2012) Decision Support Methods for Finding Phenotype — Disorder Associations in the Bone Dysplasia Domain. PLoS
ONE 7(11): e50614. doi:10.1371/journal.pone.0050614
Editor: Andrey Rzhetsky, University of Chicago, United States of America
Received July 6, 2012; Accepted October 26, 2012; Published November 30, 2012
Copyright: ß 2012 Paul et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: Australian Research Council (ARC) under the Linkage grant SKELETOME - LP100100156. The funders had no role in study design, data collection and
analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: tudor.groza@uq.edu.au
Introduction
Skeletal dysplasias are a heterogeneous group of genetic
disorders affecting skeletal development. Currently, there are over
450 recognised bone dysplasias, classified into 40 groups. Patients
with skeletal dysplasias can have complex medical issues including
short stature, skeletal deformities, multiple fractures and neuro-
logical complications. However, since most skeletal dysplasias are
very rare (,1:10,000 births), data on clinical presentation, natural
history and best management practices is sparse. Another reason
for data sparseness is clinical variability, i.e., the small number of
clinical features typically exhibited by patients from the large
range of possible phenotypic and radiographic characteristics
usually associated with these diseases. Due to the rarity of these
conditions and the lack of mature domain knowledge, correct
diagnosis is often very difficult. In addition, only a few centres
worldwide have expertise in the diagnosis and management of
these disorders. This is because, in the absence of defined
guidelines, the diagnosis of new cases relies strictly on identifying
similarities to past cases.
Medical decision support approaches, developed for particular
diseases or groups of diseases (e.g., [1], [2], [3], [4], [5]), have
demonstrated capabilities in assisting clinicians and researchers in
research, as well as in the decision making process (e.g., diagnosis).
Their main weakness is the need for well-documented domain
knowledge built on generalised guidelines and supported by large-
scale patient studies. Until now, this weakness has hindered the
development of decision support methods in the bone dysplasia
domain. Case-based reasoning [6] uses non-generalised evidences
that do not guarantee correctness. Rule based systems [7] and
fuzzy rule-based classification [8] use exact matching on rules that
are built on mature and established domain knowledge – which is
inapplicable in a domain that suffers from data sparseness. Neural
networks [9] cannot provide justification for the resulting
knowledge because they fuse all evidence into internal weights.
In the skeletal dysplasia domain, however, justification is very
important to both clinicians and researchers as it enables a better
understanding of the underlying causal elements. Moreover,
neural network approaches require large amounts of data for
training.
Probabilities are useful when the knowledge required for
inferencing or decision-making is not complete. Bayesian reason-
ing [10] is a widely used probability formalism, but it is
problematic when applied in this domain due to the estimation
of the prior and conditional probabilities. For example, in
Bayesian reasoning, the probability of Fruit = Apple being given
Colour =Green, i.e., Pr(Fruit = Apple | Green) would be zero if the
training data set only contains Fruit = Apple in conjunction with
Colour =Red. Laplace estimator is used to fix this issue by adding
one to each count. This ensures that an attribute value that occurs
zero times receives a probability that is nonzero. Although it works
well in practice for many data sets, there is no specific reason for
adding 1 to the counts. Dempster-Shafer theory (DST) [11], [12] is
an alternative to representing probabilistic uncertainty mathemat-
ically. This is a potentially valuable tool in the decision making
process when precise knowledge is missing [13]. An important
aspect of this theory is the combination of evidence obtained from
multiple sources with the computation of a degree of belief that
takes into account all of the available evidence. Also, as opposed to
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Bayesian reasoning, DST does not require an estimation of the
prior and conditional probabilities of the individual constituents of
the set. Most of the previous applications of DST in medical
decision support methods target bi-polar problems and require the
existence of a domain knowledge base [14], [15].
In this paper, we describe an improved solution that minimises
the impact of the data sparseness issue. Our approach is to analyse
the underlying data characteristics to provide meaningful results
from a set of inputs that are much smaller than the datasets usually
required by decision support systems. The approach relies on
mining association rules from patient descriptions (i.e., clinical
features + diagnosis) and then using the Dempster-Shafer theory to
produce probabilistic candidate rankings. Our goal is not to design
a disease classifier (in the traditional sense), but rather to provide a
data exploration mechanism to support clinicians in their decision
making process. Hence we have chosen to produce probabilistic
rankings associated with the underlying data justification.
Materials and Methods
Ethics Statement
The research and experiments presented in this paper have
been conducted on anonymized data and with the consent of
ESDN Clinical and Radiographic Management Group (ESDN-
CRMG, http://www.esdn.org/).
Data Characteristics
Data acquisition in the bone dysplasia domain is a
challenging task. Different research groups around the world
have, over time, built small patient registries that are neither
open nor interoperable. In 2002, the European Skeletal
Dysplasia Network (ESDN, http://www.esdn.org/) was created
to alleviate, at least partly, the data sparseness issue, and at the
same time to provide a collaborative environment to help with
the diagnosis of skeletal dysplasias and to improve the
information exchange between researchers. To date, ESDN
has gathered over 1,200 patient cases, which have been
discussed by its panel of experts.
The ESDN case workflow consists of three major steps: (1) a
patient case is uploaded and an initial diagnosis is set by the
original clinician that referred the case. Patient cases contain a free
text clinical summary and associated X-Rays; (2) the panel of
experts discusses the case until an agreement is reached; (3) the
panel of experts recommends a diagnosis.
The approach described in this paper uses ESDN’s unique
source of data for training and testing purposes. More specifically,
we extracted clinical features from 1,281 patient clinical summa-
ries and recorded the initial and final diagnoses. Among these
cases, 744 have a bone dysplasia diagnosis (the remaining cases
were not thought to be true bone dysplasias by the experts), and in
total, there are 114 different skeletal dysplasias present. A brief
analysis of the data reveals three important characteristics: (i)
rareness, (ii) sparseness, and (iii) high dimensionality.
Rareness. Fig. 1 shows the relative distribution of diagnoses
according to the number of cases. It can be observed that the vast
majority of bone dysplasias (70%) have a very small number of
cases (i.e., 1–2 or 3–5), while dysplasias well represented (i.e., over
50 cases) are a mere fraction of the total number (4%).
Sparseness. The coverage of clinical features in the patient
clinical summaries provides a good indication of the data
sparseness. The coverage of a single feature can be defined as
the percentage of cases diagnosed with a particular dysplasia in
which this phenotype is present. Table 1 shows a fragment of the
coverage of some phenotypes, i.e., top three and bottom three. We
exclude unique phenotypes occurring in a single case that has only
this case as representative. The maximum coverage achieved is
50% (e.g., subglottic stenosis) and the minimum is 0.99% (e.g.,
immunodeficiency). Hence, the average coverage is 11.33%, with
a median of 8% and a mode of 0.99%.
Figure 1. Relative distribution of dysplasia diagnoses according to different ranges of number of cases. More than 70% of the bone
dysplasias present in the ESDN dataset have a very small number of cases (up to 5), while those that are well represented (i.e., over 50 cases)
represent a mere fraction of the total number –4%.
doi:10.1371/journal.pone.0050614.g001
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High dimensionality. The skeletal dysplasia data emerging
from the ESDN cases is characterised by a total of 602 unique
clinical and radiographic features. Unfortunately, the distribution
of these features across the different types of dysplasias is heavily
skewed. Consequently, there are dysplasias characterised by 151
or 128 phenotypes (Spondyloepiphyseal dysplasia congenital –
SEDC and Multiple epiphyseal dysplasia Autosomal Dominant -
MED (AD), respectively), but there also are dysplasias with four or
five phenotypes (e.g., Frontometaphyseal dysplasia or Neonatal
Caffey disease). The average count of phenotypes per dysplasia is
21.58, with a median of 15 and a mode of 5.
Proposed Classification Approach
We propose an approach that consists of three steps, discussed
in the following sections: (i) data pre-processing, (ii) association rule
extraction, and (iii) DST-based evidential reasoning. The data pre-
processing phase extracts phenotypes from the patient clinical
summaries using the Human Phenotype Ontology (HPO) [16] and
structures the resulting annotations in a format suitable for input to
the second step. The associate rule extraction uses a level wise
search algorithm to infer evidences, which are then input to the
evidential reasoning step. The confidence value of each association
rule (evidence) is the conditional probability or the probabilistic
uncertainty of the rule (the evidence). Based on a given set of
clinical features, a set of suitable rules is selected from the rule base
(that resulted from the rule extraction step). Finally, Dempster-
Shafer theory is applied to compute the belief values for each
candidate hypothesis that results from the selected set of rules.
Data pre-processing. As described above, patient clinical
summaries in ESDN are represented in a free text format. In order
to be able to use this data, we extracted patient phenotypes by
annotating the text with corresponding terms from the Human
Phenotype Ontology (HPO). In recent years, phenotype ontologies
have been seen as an invaluable source of information, which can
enrich and advance evolutionary and genetic databases [17]. HPO
is currently the most comprehensive source of such information,
comprising more than 10,000 terms organised in a hierarchical
structure based on the anatomical localisation of the abnormality.
The actual annotation process was performed using the National
Centre for Biomedical Ontology (NCBO) Annotator [18], [19], an
ontology-based web service for annotation of textual sources with
biomedical concepts.
The annotation of a clinical summary results in a set of HPO
terms, which are then transformed, together with the diagnosis,
into a symbolic vector using a pre-computed domain dictionary.
For example, Short stature is mapped to S1, Cleft palate to S2,
Achondroplasia to D1, etc. The symbolic vector associated with
each patient is used as input for the association rule mining
process.
Association rule extraction. Association rule mining [20]
discovers interesting associations within large sets of features, in
principle, by considering the features that occur frequently
together in a given dataset. For example, the association rule
{Dwarfism} R {Achondroplasia} in a diagnosis context implies
that if {Dwarfism} is present as a clinical feature in a patient, then
the patient is likely to have Achondroplasia. Association rules
provide knowledge in the form of probabilistic ‘‘if-then’’
statements. The head of the association rule (i.e., the ‘‘if’’ part) is
called antecedent, while the body (i.e., the ‘‘then’’ part) is called
consequent. The antecedent and consequent of an association rule
are disjoint – they do not have any items in common. To express
the uncertainty in association rules, two quantifiers are used:
support and confidence. Support represents the number of transac-
tions that include all items in the antecedent and consequent, and
confidence is the ratio between the number of transactions that
include all items in the consequent, as well as in the antecedent
(namely, the support) and the number of transactions that include
all items in the antecedent.
Algorithm 1 Discovery of evidence candidates
Require: DataSet, min_support
Ensure: Itemsets which are strong candidates of Evidences.
K=1, S= w
Ik=Select all 1-itemsets with support greater or equal to
min_support
While Ik?w do
K++
Ck=CandidateGeneration(Ik21)
for all transactions tMDataRows do
Ct=Find subset candidates in t do
for all cMCt do
count(c)++
end for
end for
Ik= SelectDesiredItemSet(Ck, Sk, min_support)
S= S<Sk
end while
Algorithm 2 CandidateGeneration procedure
Require: Ik21
Ensure: Ck
for all Itemsets i1MIk21 do
for all Itemsets i2MIk21 do
New candidate NC=<(i1, i2)
if size(NC) = = k then
if NC contains one or no Diagnosis then
Add NC to Ck if every subset of items is frequent
end if
end if
end for
end for
Our goal in this step is to automatically discover evidences for
evidential reasoning, or more concretely, to find association rules
of the form {S} R {D}, where S represents patient clinical
features, and D is a skeletal dysplasia diagnosis. We have adapted
the Apriori algorithm by adding two constraints, required to
match our data characteristics: (1) every desired itemset must have
Table 1. Coverage of clinical and radiographic features in the
ESDN dataset.
Clinical Feature No. cases
Total
diagnoses
Coverage
(%)
Cystic hygroma 2 4 50
Subglottic stenosis 1 2 50
Cyanosis 1 2 50
Hypopigmentation of the skin 1 101 0.99
Immunodeficiency 1 101 0.99
Clumsiness 1 101 0.99
The table presents the top 3 and bottom 3 coverages. Coverage is computed by
dividing the number of cases that contain the clinical feature by the total
number of diagnoses denoting the bone dysplasias assigned to the cases. For
example, Cystic hygroma appears in 2 of the total 4 cases diagnosed with
Achondrogenesis type 1A.
doi:10.1371/journal.pone.0050614.t001
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one set of clinical features and a single dysplasia, and (2) Both
candidate itemsets and frequent itemsets can have at most one
dysplasia item.
Algorithm 3 SelectDesiredItemSet procedure
Require: Ck, Sk, min_support
Ensure: I
for all Itemsets cMCk do
if c contains only Symptoms then
if c.suport$min_support then
Add c to I
end if
else
if c contains Diagnosis then
if c.suport$min_support then
Add c to I
Add c to Sk
end if
end if
end for
end for
Algorithm 4 Finding rules in the evidence candidate list
Require: S (Desired item sets), minimumconfidence
Ensure: R (set of Evidences )
R=w
for all XMS do
Symptom set P={p1, p2, …, pn}
where pMX and AC(p)?2
Diagnosis set Q={q1}
where qMQ and AC(q)?1
C= calculateConfidence(P, Q)
if C#minimumconfidence
P«Q is a valid evidence
R=R<{P«Q}
end if
end for
The actual extraction process consists of two parts: (1) 
discovering the trend in the instance data by finding a desired 
itemset using the adapted level wise search algorithm, and (2) 
finding rules (evidences) from the desired itemset. Alg. 1 details the 
trend discovery algorithm and Alg. 4 details the rule finding 
algorithm from desired itemsets. Following the discovery of the 
desired itemsets, these are partitioned into two components: a 
component containing the skeletal dysplasia and one containing 
the phenotypes. A boolean function that determines the type of a 
component is used to perform this classification. Subsequently, we 
calculate the confidence between the bone dysplasia component 
and the phenotype set of the rule (evidence) and use its value as the 
basic belief assignment of DST. For a better understanding, 
Appendix A within Supporting Information S1 contains a detailed 
example that illustrates this step.
We have used a relatively low minimum support of 2/N, where
N is the total number of cases, because we are interested in
extracting both frequent and rare associations. In addition, we
need to take into account the fact that the data in our domain is
rare. Every rule (evidence) contributes to the DST belief value of a
proposition if the evidence is applicable to the proposition.
Therefore, controlling the number of rules (evidences) using any
minimum confidence threshold can bias the belief value and
hence, the overall result. That is why we do not use this parameter
to control the number of rules. We have also used a maximum
itemset size of 10 as the computation cost increases exponentially
with the itemset size in association rule mining.
DST-based evidential reasoning. Shafer [21] has expand-
ed Dempster’s work [22] and proposed an evidence theory,
currently referred to as the Dempster-Shafter Theory (DST). DST
is a mathematical tool to express uncertain judgments based on all
available evidences. The main advantages of DST over other
probabilistic approaches are its ability to: [(i)] ‘‘model the
narrowing of a hypothesis set with the accumulation of evidence’’
[23]; provide a representation for ignorance that is not uniformly
distributed across all other alternative propositions; and avoid the
Bayesian restriction according to which the commitment of belief
to a hypothesis implies commitment of the remaining belief to its
negation [23] – i.e., ‘‘Bayesian theory cannot distinguish between
the lack of belief and disbelief’’ [21].
In addition, another important advantage of DST is that it
allows evidence aggregation independent of the order of its
gathering [23]. Finally, as opposed to Bayesian reasoning,
Dempster-Shafer theory does not require an estimation of the
prior and conditional probabilities of the individual constituents of
the set. This is a potentially very important advantage in the
decision making process where precise knowledge is missing. DST
exposes four major functions: [(i)] Basic Belief Assignment (BBA);
Combination of Evidence; Belief (Bel); and Plausibility An
example that illustrates the use of these functions is presented in
Appendix B within Supporting Information S1.
Basic Belief Assignment (BBA). BBA expresses the degree
of belief in a proposition and is the main information carrier. It
does not refer to probability in the classical sense. BBA is assigned
by making use of a mapping function (m) in order to define a
mapping of the power set to the interval between 0 and 1, where
the BBA of the null set is 0 and the summation of the BBA of all
subsets of the power set is 1. The number m(A) refers to the
portion of total belief assigned exactly to proposition A.
Mathematically, we can represent this in the following way:
m : 2x?½0,1,m(w)~0 ð1Þ
X
A[2x
m(A)~1 ð2Þ
where x is the universal set and w is the empty set.
Belief and plausibility functions. In order to infer mean-
ingful information using BBA, it is imperative to impose a
restriction on the total degree of belief in a proposition, as opposed
to a single value of belief. This restriction on a proposition A is
expressed by ½Bel(A),Pl(A) and it lies in the unit interval ½0,1,
where Bel(A) and Pl(A) are given as:
Bel(A)ƒP(A)ƒPl(A) ð3Þ
Bel(A)~
X
BDB(A
m(B) ð4Þ
Pl(A)~
X
BDB\A=w
m(B) ð5Þ
Here, A is a set of items and B is a subset of the set A. Bel(A) is
the lower bound of the total degree of belief in a proposition A and
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is the sum of all BBAs of propositions that are fully included in
proposition A. Pl(A) is the upper bound of the total degree of
belief in a proposition A and is the sum of all BBAs of propositions
whose intersection with proposition A is not empty. The set of all
propositions that are of interest in DST is known as the frame of
discernment.
The combination of evidence. The purpose of Combina-
tion of Evidence is to meaningfully summarize and simplify
evidences, where the evidences are obtained from several
independent knowledge sources over the same frame of discern-
ment. In other words, this represents an evidence fusion. Evidence
fusion refers to the combination of multiple sources to obtain an
improved evidence by aggregating the complementary and/or
redundant evidences. In widely used probability formalisms,
probabilities are combined through the general multiplication
operation. As DST is a generalisation of such probability
formalisms, a more advanced multiplication rule is required for
the combination of evidences. Dempster introduced Dempster’s
rule of combination, which combines multiple evidences through
their Basic Belief Assignments (m). These evidences are defined on
the same frame of discernment and are independent. The rule is
purely a conjunctive operation (AND) and results in a belief
function based on conjunctive pooled evidence. If we obtain two
masses m1 and m2, the combination (called the joint m1,2) is
calculated from two BBA’s m1 and m2 in the following manner:
m1,2(w)~0 ð6Þ
m1,2(A)~
P
B\C~A=w
m1(B) m2(C)
1{K
ð7Þ
where
K~
X
B\C~w
m1(B) m2(C) ð8Þ
Here, B and C are propositions from different knowledge sources,
and K is a measure of the amount of conflict between the two
masses m1 and m2. An example that illustrates the use of these
functions is presented in Appendix B within Supporting Informa-
tion S1. In practice, we model DST to express uncertain
judgments about a set of conclusions in the presence of a set of
observations, based on all available association rules (evidences).
Belief and plausibility function for a conclusion in the
presence of a subset of observations. If we consider
O~fo1,o2,:::omg a set of observations and C~fC1,C2,:::,Ckg a
set of conclusions, our goal is to find the overall belief of a
conclusion in the presence of a subset of observations (the subset of
observations that causes the conclusion). A proposition in our
setting consists of a subset of observations O, named A, and an
element of the conclusion set C, named Ci. Hence, the proposition
is (fAg,fCig). To achieve this, we have constrained the belief and
plausibility function of Dempster-Shafer theory. We define the
constrained belief, denoted by CBel(fAg,fCig), and the con-
strained plausibility, denoted by CPl(fAg,fCig), as follows:
CBel(fAg,fCig)~
X
BDB(A
m(fBg,fCig) ð9Þ
with A being a subset of observations O, B a subset of A and Ci a
conclusion in the set C. The belief CBel(fAg,fCig) for the
proposition (fAg,fCig) is defined as the sum of all masses of both
subsets of A and Ci
CPl(fAg,fCig)~
X
BDB\A=w
m(fBg,fCig) ð10Þ
CBel(fAg,fCig) is the lower bound of the total degree of belief of
a conclusion in the presence of a subset of observations. It is the
sum of all BBAs of those proposition subsets that have their
observation elements fully included in proposition A and have the
conclusion Ci. CPl(fAg,fCig) is the upper bound of the total
degree of belief of a conclusion in the presence of a subset of
observations. It is the sum of all BBAs of those proposition subsets
that have observation elements included in proposition A (i.e.,
their intersection with A is not empty) and have the conclusion Ci.
If we consider a proposition to be a particular dysplasia in a
patient, in the presence of a subset of observations, by calculating
the belief and plausibility values, we can get the overall belief and
plausibility degrees of the dysplasia in that patient. The soundness
of the provided evidences is pivotal in medical decision-making.
The plausibility value calculation takes into account the evidence
that may exist or occur, while the belief value calculation relies on
the evidence that must exist. Therefore, it is crucial to use only the
belief value for decision-making and, hence avoid plausibility.
Appendix C within Supporting Information S1 presents an
example of the computation of these values extracted from the
ESDN dataset.
Other Classification Approaches Applied on the Dataset
Decision trees is a classification technique that maps observa-
tions about an item to conclusions about the item’s target value.
Based on the training data, the decision tree learning algorithm
constructs a tree-shaped model using inductive reasoning. To
classify input data, each leaf of the tree represents a class label and
the branches represent conjunctions of features that lead to those
class labels. On the positive side of things, decision trees require no
domain knowledge or parameter setting, and are easier to read
and interpret. On the negative side of things, decision trees are
unstable, in addition to being a hard classification model – i.e., it is
limited to one output attribute. An improvement to the original
algorithm has been brought by Quinlan, who proposed the
Interactive Dichotomiser 3(ID3) [21]. ID3 uses information gain to
select attributes to build the tree structure. Consequently, the
process may result in a bias towards attributes with higher values.
Random forest is an ensemble classifier constructed from a
number of decision trees [25]. Similar to the direct decision trees,
random forest maps input data points to leafs in the tree, however,
in this case, each tree in the forest assigns class label. The final
class label for a point is assigned via voting, i.e., the class label that
receives the most votes within the entire set of trees in the forest.
For standard trees, nodes are split using the best split among all
variables, whereas for random forests, nodes are split using the best
among a subset of predictors randomly chosen at that node.
Random forest has a number of advantages, such as the capability
of handling high dimensional data, the effective method for
estimating missing data, or the ability of generating an internal
unbiased estimate of the generalisation error. Among the
disadvantages, we can mention that it is, subject to the input data
sets, prone to overfitting the data.
The naive Bayes classifier [26] is a classifier based on
conditional probabilities and that is governed by the feature
independence assumption. Despite this unrealistic assumption, the
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resulting classifier is remarkably successful in practice, often
competing with much more sophisticated techniques [26]. It has
proven results in most real-world applications, including text
categorisation, medical decision support, and systems performance
management [26]. The Naive-Bayes classifier features an ex-
tremely fast learning process that requires a single pass through the
data. In addition, it usually requires a fairly small amount of
training data, when compared to other approaches that achieve
similar results. In our setting, since the skeletal dysplasia data is
sparse, we have used the Laplace estimator to assign prior
conditional probabilities when an attribute occurs zero times.
Medical decisions in the bone dysplasia domain are difficult as
data is sparse. Subsequently, the representation of this sparse
knowledge acts as a critical and differentiating factor between the
methods that can be used as foundation for the decision support. A
relevant example is the comparison between Bayesian and DST-
based methods. A Bayesian method implies a precise value for
prior probabilities. A critical difference, hence, between Bayesian
and Dempster-Shafer-driven approaches lies in the representation
of ignorance. In the computational phase of DST, all prior
probabilities can be left unspecified, as opposed to a Bayesian
method, which often requires an estimator to assign prior
probabilities to random variables (e.g., by adding 1 where an
attribute occurs zero times, so that its prior probability is non-
zero).
Support Vector Machine (SVM) is a widely used machine
learning technique, pioneered by Vapnik [27]. SVM trades off
accuracy for the generalisation error. For pattern classification,
SVM constructs a multidimensional hyperplane that optimally
discriminates between two classes by maximising the margin
between the two data clusters. To achieve a high discriminative
power, SVM employs special nonlinear functions named kernels to
convert the input data into a high-dimensional space.
The k-nearest neighbour algorithm (k-NN) [28] is a method for
classifying an object by associating each data point of the object
with its k-nearest neighbours. k-NN is unfortunately unable to
provide a meaningful interpretation of high dimensional data. As
the dimensionality of the data increases, the distance to the nearest
point approaches the distance to the most distant point. k-NN also
suffers from the data sparseness problem [29]. In the bone
dysplasia domain, patients exhibit only a handful of clinical
features from the entire range of possible phenotypic character-
istics associated with bone dysplasias. Hence, each feature vector
attached to a patient is very sparsely filled, while the missing
features are different among the vectors. As a result, no similarity
measures (e.g., Euclidean Distance, Hamming Distance, etc.) can
provide meaningful interpretations to gauge similarity of samples
in this domain. Support vector machines [27] also use similarity
measures.
Experimental Design
We compared our results against the initial diagnoses
established by clinicians and against a set of well-known Machine
Learning techniques. In order to provide the same experimental
conditions, each approach used the same training and testing
subsets. Some additional details associated with this comparative
evaluation include: (i) Support Vector Machines (SVM) have been
used with Sequential Minimal Optimisation for training and a
polynomial kernel; (ii) the Naive Bayes classifier required the
Laplace estimator to fix the absence of prior probability that
occurs in sparse data; (iii) for k-NN we used k = 3; (iv) in the case
of decision trees, we have used the ID3 algorithm.
Dataset. In order to achieve realistic results Using machine
learning methods, from the 114 existing types of dysplasias
described in the ESDN dataset, we chose the types, each of which
is represented by more than 20 patient cases. Table 2 displays the
list of dysplasias (with . 20 patient cases) and the associated
number of cases and other attributes. In total, 283 patient
descriptions were considered (around 22% of the total cases). As
shown in Table 2, the characteristics of the dataset we have chosen
is similar to the general characteristics of the entire ESDN dataset.
Cross-validation. To estimate the predictive accuracy of
diagnostic models, the dataset is usually split into two parts: a
training set and a test set. The training set is used to establish the
decision support model, while the test set is used to test the
generalisation capability of the model. In this study, we applied a
5-fold cross-validation method to assess the model’s performance –
training sets contain 80% of the cases and test sets contain 20% of
the cases. As the dataset is very sparse, with some skeletal
dysplasias having only 20 to 30 cases, 5-fold cross validation has
the advantage that the resulting test sets are reasonably sized and
have a fair distribution of clinical features for each bone dysplasia
that we consider. The data listed in Table 2 was thus equally
divided into five folds (F1 to F5) and five different sets of
experiments were performed. Each of the 5 random partitions of
the data serves as a test set for the diagnostic model trained with
the remaining four partitions. The overall accuracy, precision and
recall reported later in the paper represent an average across all 5
training set partitions.
The actual formulae used to compute these metrics are the
following:
Table 2. Characteristics of the skeletal dysplasias with more than 20 cases.
Diagnosis Symbol No. cases Total features Min Max Average Max coverage
Largest
common set
coverage
Hypochondroplasia SD1 22 69 1 15 5 (7.24%) 54.54% 27% (3)
SEDC SD2 75 151 1 17 4.65 (3%) 40% 26% (2)
Pseudoachondroplasia SD3 33 72 1 12 4.15 (5.76%) 57.77% 12% (3)
Cartilage-hair-hypoplasia SD4 28 80 1 11 4.89 (6.11%) 46.42% 10% (4)
MED (AD) SD5 101 128 1 20 3 (2.34%) 28.71% 19% (3)
rMED SD6 24 59 1 13 3.87 (6.55%) 25% 25% (2)
The set of dysplasias used within our experiments follow, in principle, the general characteristics of the ESDN dataset. The average maximum coverage of phenotypes is
around 43%, while the average largest common set (i.e., the set of phenotypes common to all cases diagnosed with a particular disorder) is around 20%.
doi:10.1371/journal.pone.0050614.t002
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where N is the total number of patient cases, L is the total number
for correct predictions, M is the total number of incorrect
predictions, and N~LzM. Nx is the total number of dysplasia
Dx in N, CDx is total number of correct Dx predictions, IDx is total
number of incorrect Dx predictions.
Results
In this section we discuss some experimental results we have
achieved by applying our method to the ESDN dataset to examine
its predictive capability in identifying classes of skeletal dysplasia.
Table 3 displays the accuracy, precision and recall for each cross
validation experiment with their corresponding intervals and mean.
(each CVx column refers to cross-validation on fold Fx). The
accuracy rate across the five folds is fairly constant, resulting in a
mean of 47.43%. Unlike accuracy, precision and recall are less
stable, resulting in a fairly large interval of values with a mean of
39.34% for precision and 34.89% recall. To examine the prediction
capability of the approach in a clinical setting, we compared the
achieved accuracy against the initial diagnoses assigned to patient
cases in ESDN. The comparison result, i.e., our average accuracy of
47.43% vs. the accuracy of the initial diagnoses –39.66%, shows
that our approach outperforms these initial diagnoses by around
9%, which is an average decrease in error of 12%.
Discussion
In the previous section, we described the cross validation result
of our approach, which has mean accuracy of 47.43% on the
ESDN dataset and outperforms the clinicians’ initial diagnoses by
around 9%. While the comparison of our approach against initial
diagnosis is tempered because we have only considered six bone
dysplasias, in practice, this level of improvement is realistic
because for the initial diagnosis phase, on average only the 20 most
common dysplasias are considered.
In the rest of this section, we provide a compare the results
achieved by our solution against other Machine Learning
approaches, and then we discuss our main findings, some related
work and the limitations of our approach.
Comparison Against other Machine Learning Approaches
For completeness purposes, we have compared our solution
against the five most common Machine Learning approaches.
Table 4 presents the experimental results. Overall, our approach
outperforms all the other approaches. There are, nevertheless,
some features that are worth noting. The Naive Bayes classifier
performed well on SD2, SD3 and SD5, which is expected since it
overfits the classes that provide more data at the expense of those
that don’t. These dysplasias were the top three in terms of number
of cases (see Table 2). Consequently, SD6 has 0% precision and
0% recall, while SD4 has 20% precision and 4% recall using the
Naive Bayes classifier compared to 50% precision and 32% recall
achieved by our approach. On a different note, our approach and
SVM both performed uniformly across all classes, because they
both generate an evenly distributed model – an overall best effort
approach. Moreover, in the case of our solution, it can be clearly
seen that precision and recall increase with the amount of data
provided, reaching a maximum of 58.47% precision with only 101
patient cases provided for MED (AD).
Decision tree (ID3), on the other hand, prefers features with
many values. The coverage of clinical features is an indicator of
the data sparseness (i.e., features with a few or many values). The
diagnoses built using a few examples, specifically SD1 (22), SD4
(28), SD6 (24), have an average coverage of 7.24%, 6.11% and
6.55%. These are greater than the average coverage of SD2 (75),
SD3 (33) and SD5(101) –3%, 5.76%, 2.35% – which represent
diagnoses with many examples. Consequently, we can infer that
the SD1, SD4 and SD6 data is dense when compared to the SD2,
SD3 and SD5 data. We believe that this is the reason behind the
good performance achieved by the decision tree (ID3) approach.
Finally, when compared to the naive Bayes classifier, our
approach shows improvements in the average accuracy from
44.12% to 47.43%, average precision from 29.54% to 39.34% and
average recall from 25.08% to 34.89%. The justification of these
results is the following: [(i)] unlike in Bayesian reasoning,
ignorance is not represented as an uniform distribution in DST,
and as opposed to DST, Bayesian reasoning uses Laplace
estimator to estimate prior conditional probabilities when an
attribute occurs zero times (sparse data). Both our approach, as
well as the Bayesian classifier shows significant improvements in
average accuracy, average precision and average recall over k-NN,
which suffers from both the data sparseness and the high-
dimensional data problems. A similar behaviour is observed also in
the comparison against decision trees and random forests. As a
final remark, while these performance indicators may seem low,
they are in reality an improvement on the state of the art in
decision support methods for rare disorders.
Table 3. Experimental results: Accuracy per cross-validation
per fold.
CV1 CV2 CV3 CV4 CV5 Interval
Mean
(%)
Accuracy (%) 41.5 46 49.05 52.97 47.16 [41.5,
52.94]
47.43
Average
precision (%)
31.08 51.63 51.61 41.69 20.71 [20.71,
51.63]
39.34
Average
recall (%)
28.4 38.67 38.31 42.11 26.95 [26.95,
42.11]
34.89
doi:10.1371/journal.pone.0050614.t003
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Main Findings
We have presented an approach that combines association rule
mining with the Dempster-Shafer theory (DST) to compute
probabilistic associations between sets of clinical features and
disorders. These can then serve as support for medical decision
making (e.g., diagnosis). Experimental results show that the
proposed approach is able to provide meaningful outcomes even
on small datasets with sparse distributions. Moreover, the result
shows that the approach can outperform other Machine Learning
techniques and behaves slightly better than an initial diagnosis by
a clinician. To test the accuracy of the approach, we have
performed several experiments comparing human-mediated initial
and final diagnoses, as well as outputs produced by other machine
learning algorithms, in which we have treated our approach as a
traditional classifier. The results show that we can achieve a top-1
accuracy of 47.43% (i.e., the accuracy calculated only via the
candidate with the highest probability) by using disorder
descriptions for 20 to more than 100 cases. This represents an
increase in accuracy of around 7% when compared to the initial
human-made diagnosis, and around 4% when compared to the
next best machine learning approach.
Related Work
The literature contains a few relevant approaches that are very
similar to our general methodology. For example, the research
presented in [30] employs association rule mining, Dempster’s rule
of combination and pignistic approximation for the prediction of
what else the customer is likely to buy. Once the rules are
discovered, they use Dempster’s rule of combination to combine
overlapping rules, followed by pignistic approximation for the final
prediction. As opposed to our approach, the authors don’t use
DST, per se, as they do not calculate any belief or plausibility
values for prediction. However, when predictions systems need to
calculate the joint probability of a set of items, where the items of
the set are present in different association rules, it is imperative to
use the DST believe value calculation. In their approach, the
authors prune the overlapping antecedent rules as both the
antecedent and consequent hold similar types of data (e.g.,
shopping items) in their discovered association rules. This is
different to the way we have modelled the data, as in our case, the
antecedent contains clinical features (observations), while the
consequent holds the diagnosis (an action based on observation).
In [31], the proposed framework discovers interesting associa-
tion rules and use the discovered rules for prediction. The rules get
assigned basic belief values (BBAs) and are combined using
Dempster’s rule of combination. Finally, maximum belief with
non-overlapping interval strategy (maxBL) [32] or pignistic
probability are used for prediction. In short, the authors use
Dempster’s rule of combination to facilitate uncertainty manage-
ment, without calculating belief and plausibility values as per DST.
The both of the above mentioned related works do not use DST
to its full extent, but rather only Dempster’s rule of combination,
in order to prune the number of rules. Instead of combining
multiple evidences using a belief function, they choose the best
evidence using a pignistic probability. Another significant differ-
ence is that they perform association rule mining for each query,
whereas we generate evidences only once and use them as a
knowledge base for all queries. The targeted domain of the first
related work is market basket analysis. Like other classification
algorithms, they do not measure accuracy to show the perfor-
mance of their classification system. However, they measure
precision and recall.The precision and recall is in the range of 40%
to 60% and 50% to 60%, respectively, based on their synthetic
dataset. The targeted domain of the second related work is sensor
data analysis. The average accuracy of their proposed system is
47% based on the recorded sensor data. The characteristics of the
data in our domain are significantly different than those of data in
their domains. This makes it impossible to perform a fair
performance comparison against them.
Finally, the research described in [33] employs evidence-based
confidence, as opposed to traditional confidence, in the association
rule mining, in order to describe evidences in a more sophisticated
way. Their assumption is that some co-occurrences might be
contingent in some datasets. The authors leverage DST to
compute evidence-based confidence by introducing various kinds
of ‘a posteriori’ pragmatic knowledge. Consequently, they focus on
discovering sophisticated association rules, while we focus on using
rules in conjunction with DST for classification purposes.
Table 4. Experimental results: Overall comparative accuracy across all considered approaches.
Our approach Naive Bayes SVM Decision trees Random forests k-NN (K=3)
P (%) R (%) P (%) R (%) P (%) R (%) P (%) R (%) P (%) R (%) P (%) R (%)
SD1 6.67 5 20 5 11.66 10 13.16 15 15.54 15 10 5
SD2 47.71 70.12 53.66 34.72 38.12 40.46 29.78 32.98 36.98 33.08 31.92 38.34
SD3 42.41 27.78 41.66 9.16 36.42 25.26 25.18 26.94 25.8 24.98 5.84 11.66
SD4 50.67 32 20 4 33.08 32 44 24 21.42 20 20 4
SD5 58.47 59.43 41.94 97.64 47.07 64.14 52.88 45.52 50.64 59.2 45.04 62.52
SD6 30 15 0 0 40 15 21.68 31.66 10 10 0 0
Average
recall (%)
34.89 25.08 31.14 29.35 27.55 20.25
Average
prec. (%)
39.34 29.54 34.38 31.11 26.8 18.8
Accuracy
rate (%)
47.43 44.12 41.08 33.83 36.89 34.23
Our solution outperforms the five Machine Learning approaches we have considered within our experiments: around 4% more accuracy than Naive Bayes and around
6% more accuracy than SVM. Although Naive Bayes has performed very well, its results are boosted by overfitting the classes that had more data (e.g., ) at the expense
of others, such as for which it achieved 0 precision and recall. Unlike Naive Bayes, our approach has performed fairly uniform and consistent across all classes.
doi:10.1371/journal.pone.0050614.t004
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Limitations
Two limitations are directly observable in the context of the research
presented within this paper. Firstly, the ESDN dataset used within our
experiments is based strictly on patients suspected to have a bone
dysplasia. These patient cases are usually highly challenging, and thus,
are submitted for evaluation by the ESDN panel of experts. Moreover,
clinicians submitting cases to ESDN usually focus on providing only
dysplasia-relevant data. Consequently, our experiments frame the
underlying research question only to patient data that has a high
probability to be associated with a bone dysplasia.
Secondly, our current analysis features only the combination of
association rule mining with DST, and hence it does not reveal the
results attributable individually to the association rule mining or to
DST. As a remark, within our framework, we discover association
rules that, by nature, cannot be used for classification (i.e., we do
not discover classification rules similar to a branch in decision
trees). To achieve this goal, such association rules require the
conjunction with a prediction technique, e.g., voting [34],
weighted voting [34], CMAR [35] or DST. In this paper, we
have shown how to create an ensemble that combines association
rules with DST. Future work will include also the evaluation of the
other prediction techniques, in order to obtain an general view
over the best classification method in our domain.
Conclusion
The decision support method presented in this paper combines
association rule mining with the Dempster-Shafer theory to produce
probabilistic candidate phenotype–disease rankings. The experimen-
tal results we have presented demonstrate that, given a reasonable
amount of data (considering the focus on rare diseases), our approach
can outperform other Machine Learning techniques and behaves
slightly better than an initial diagnosis by a clinician – which is often
enough to guide further research on the case in the correct direction.
Future research will focus on the use of semantic relationships
between patient phenotypes, expressed via the Human Phenotype
Ontology, when mining association rules. For example, we will
consider generalisations (i.e., is-a relationships) and partnonomies
(i.e., part-of relationships) between the patient clinical and
radiographic features. At the same time, we intend to incorporate
and experiment with additional types of related data, such as, gene
mutation data – in order to predict correlations between sets of
phenotypes and gene mutations in the context of bone dysplasias.
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3.3 Discussion and Implications of Findings 
This chapter proposed a novel machine-learning approach, which aims to identify possible skeletal 
disorder candidates from a set of phenotypes associated with a newly arrived patient case. This 
research demonstrates how the combination of association rule mining and the Dempster-Shafer 
theory can be applied to improve diagnosis of disorders in the skeletal dysplasia domain. The 
experimental results showed that, compared to other machine learning algorithms (such as, Naive 
Bayes, SVM, Decision trees, Random forest and K-NN) and the initial diagnosis by a clinician, this 
approach achieved a significant increase in accuracy (i.e., number of correct predictions divided by 
the total number of cases requiring prediction). For example, the accuracy of the algorithm was 
14% better than Decision trees, 11% better than Random forest and 7% better than the initial 
human-specified diagnosis. The experimental results satisfy the first objective of this thesis, i.e., to 
improve the speed and accuracy of the decision-making process by automating the analysis of 
existing case studies and presenting the most likely ranked candidate disorders, given a set of 
symptoms/clinical features (aka phenotypes).  
A number of related approaches are present in the literature. The most relevant related prior 
research [79, 80] don’t employ DST as they do not calculate any belief or plausibility values for 
prediction. Instead, they employ Dempster’s rule of combination to prune the number of resulting 
rules and focus on selecting a single rule (for market basket analysis and sensor data analysis 
applications, respectively). However, when prediction systems need to calculate the joint 
probability of a set of items, where the items of the set are present in different association rules, it is 
imperative to use the DST belief value calculation. To this extent, no previous approach has 
employed a combination of association rule mining and DST for classification purposes. 
The design decisions behind the algorithm discussed in this chapter were motivated by the 
underlying characteristics of the bone dysplasia patient data (see Sec. 2.2.3): rareness, sparseness 
and high dimensionality. Whilst the evaluation has focused only on the skeletal dysplasia domain, it 
is very likely that the approach is also applicable to other domains that share the same data 
characteristics – for example, any other rare disorder area, such as muscular dystrophies. 
Consequently, a promising direction for future research is to apply the method in other domains to 
assess its versatility and the ease with which it can be re-configured and adapted. 
Decision support approaches that use traditional methods, such as the one presented here, operate 
on a symbolic level. More concretely, two phenotypes listed in different patient cases have to be 
exactly the same if they are to be consolidated in the context of a particular disorder. This limitation 
can be overcome by semantically annotating patient cases using ontological concepts. Semantic 48  
annotation of patient cases provides a novel way of comparing and consolidating phenotypes that 
would otherwise be incomparable. Ontological concepts enable similar or equivalent phenotypes 
that are specified differently across patient cases to be assimilated.  
The second phase of the decision support framework proposed by this thesis (in Chapter 4) aims to 
exploit this semantic similarity between the ontological concepts to further improve the 
determination of disorder candidates from a given set of phenotypes. 
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Chapter 4: Disorder Classification via Semantic 
Similarity 
4.1 Introduction 
The previous chapter focused on developing a novel machine learning approach to produce 
probabilistic disorders rankings to aid medical decision-making. This chapter advances the general 
decision-support framework proposed in this thesis by employing semantic similarity in computing 
the disorder candidate ranking. Semantic Similarity enables the comparison between concepts based 
on the relationships defined by an underlying ontology. Most existing semantic similarity 
approaches (e.g., Resnik [14], Jiang and Conrath [15] and Lin [16]) rely on the primordial 
ontological relationship is-a, which represents the foundation of the taxonomical organization of an 
ontology. Other relationships could also be used (e.g., part-of), however, their semantics is usually 
restricted to the definition provided by the specific ontology and hence, would make the semantic 
similarity less versatile. 
The research described here takes advantage of the semantics defined by the Human Phenotype 
Ontology [3] and the Bone Dysplasia Ontology (BDO) [4] in the context of the bone dysplasia 
domain and proposes an innovative semantic similarity-driven decision support method. This 
method is validated using both standard (e.g., Resnik [14]) as well as custom-tailored semantic 
similarities to predict disorders on undiagnosed patient cases – as per the second objective of this 
thesis. Two sources of knowledge are compared: domain knowledge emerging from the BDO and 
raw knowledge present in annotated European Skeletal Dysplasia Network (ESDN) patient cases.  
The aim of this work is to address the second and third research questions of this thesis: “How can 
semantic similarity methods be developed to compare/align the concepts (e.g., features, phenotypes, 
disorders) used within the skeletal dysplasia domain?” and “How can a semantic similarity-driven 
decision support method be developed to predict disorders on undiagnosed patient cases in the 
skeletal dysplasia domain?”.  
The following section describes the proposed method and the experimental results and represents a 
paper published in the peer-reviewed 11th International Semantic Web Conference (ISWC) 2012 
[81]. 
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4.2 Conference 1 - Semantic Similarity-Driven Decision Support in the 
Skeletal Dysplasia Domain  
R. Paul, T. Groza, A. Zankl, and J. Hunter, "Semantic similarity-driven decision support in the 
skeletal dysplasia domain," in The Semantic Web–ISWC 2012, ed: Springer, 2012, pp. 164-179. 
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Abstract. Biomedical ontologies have become a mainstream topic in
medical research. They represent important sources of evolved knowl-
edge that may be automatically integrated in decision support methods.
Grounding clinical and radiographic findings in concepts defined by a
biomedical ontology, e.g., the Human Phenotype Ontology, enables us
to compute semantic similarity between them. In this paper, we focus
on using such similarity measures to predict disorders on undiagnosed
patient cases in the bone dysplasia domain. Different methods for com-
puting the semantic similarity have been implemented. All methods have
been evaluated based on their support in achieving a higher prediction
accuracy. The outcome of this research enables us to understand the fea-
sibility of developing decision support methods based on ontology-driven
semantic similarity in the skeletal dysplasia domain.
1 Introduction
Similarity plays a central role in medical knowledge management. Like most
scientific knowledge, medical knowledge is also inferred from comparing different
concepts (such as phenotypes, populations, and species) and analyzing their
similarities and differences. However, medical science is unlike other sciences
in that its knowledge can seldom be reduced to a mathematical form. Thus,
medical scientists usually record their knowledge in free form text, or lately
in biomedical ontologies. New concepts that emerge in the domain are firstly
compared and judged based on their degree of similarity to existing concepts
before being integrated into the overall domain knowledge.
Biomedical ontologies are knowledge bases that have emerged and evolved over
time following this process. Most of them are used not only to model and cap-
ture specific domain knowledge, but also to annotate, and hence enrich, diverse
resources like patient cases or scientific publications. The adoption of biomedi-
cal ontologies for annotation purposes provides a means for comparing medical
P. Cudre´-Mauroux et al. (Eds.): ISWC 2012, Part II, LNCS 7650, pp. 164–179, 2012.
c© Springer-Verlag Berlin Heidelberg 2012
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concepts on aspects that would otherwise be incomparable. For example, the
annotation of a set of disorders (directly or via patient cases) using the same
ontology enables us to compare them, by looking at the underpinning annota-
tion concepts. The actual comparison is subject to a semantic similarity measure,
i.e., a function that takes two or more ontology concepts and returns a numerical
value that reflects the degree of similarity between these concepts.
Over the course of the last decade, there has been significant research per-
formed on semantic similarities over biomedical ontologies. One key remark that
needs to be taken into account is that meaningful similarity measures are de-
pendent on the domain knowledge, as only by using the explicit semantics of
the domain one can compare concepts in an appropriate manner. In this paper
we report on our experiences with using semantic similarity over domain knowl-
edge and annotated patient cases for disorder prediction in the skeletal dysplasia
domain.
Skeletal dysplasias are a group of heterogeneous genetic disorders affecting
skeletal development. There are currently over 450 recognised bone dysplasias,
structured into 40 groups. Patients suffering from such disorders have complex
medical issues, ranging from bowed arms and legs to neurological complications.
Since most dysplasias are very rare (< 1:10,000 births), data on clinical presen-
tation, natural history and best management practices is very sparse. A different
perspective on data sparseness is introduced also by the small number of clinical
and radiographic phenotypes typically exhibited by patients from the vast range
of possible characteristics globally associated with these disorders.
Decision support methods can usually assist clinicians and researchers both
in the research, as well as in the decision making process, in general, in any
domain. However, building efficient or meaningful decision support methods in
a domain affected by data sparseness, such as bone dysplasias, is a very chal-
lenging task. On the other hand, semantic similarity measures can facilitate the
objective interpretation of clinical and radiographic findings by using knowledge
captured in biomedical ontologies or annotated patient cases to provide decision
support. In this paper we aim to bridge the two worlds, by investigating different
approaches for determining the semantic similarity between sets of phenotypes
encoded as ontological concepts and its application to disorder prediction.
The context of our work is provided by the SKELETOME project that de-
velops a community-driven knowledge curation platform for the bone dysplasia
domain [1]. The underlying foundation of the platform is a two-phase knowl-
edge engineering cycle which enables: (1) semantic annotation of patient cases
– connecting domain knowledge to real-world cases; and (2) collaborative di-
agnosis, collaborative knowledge curation and evolution – evolving the domain
knowledge, based on real-world cases. The semantic annotation process relies on
clinical and radiographic findings grounded in the Human Phenotype Ontology
(HPO) [2] – an emerging de facto standard for capturing, representing and anno-
tating phenotypic features encountered in rare disorders. At the same time, the
domain knowledge is modeled via the Bone Dysplasia Ontology (BDO) [3], which
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at a conceptual level associates bone dysplasias and phenotypes represented by
HPO terms.
These two sources of knowledge, i.e., domain knowledge from BDO and raw
knowledge from annotated patient cases, together with the structure of HPO,
which underpins the formalization of phenotypes, enable us to investigate the use
of several semantic similarity measures in order to achieve disorder prediction.
More concretely, this paper: (i) analyzes which semantic similarity performs
better on each of the two types of data, and (ii) performs an extensive empirical
evaluation of the application of these semantic similarities for disorder prediction,
using a real-world dataset.
The remainder of the paper is structured as follows: Section 5 discusses exist-
ing related work, Section 2 provides a comprehensive background on the knowl-
edge and data sources used within our experiments, while Section 3 details our
methodology. Before concluding in Section 6 we present an extensive evaluation
and discuss the experimental results in Section 4.
2 Background
This section provides a brief overview of the background of our work. It intro-
duces the Human Phenotype Ontology (HPO) and discusses some of its char-
acteristics (Section 2.1), then describes the two knowledge sources used in our
experiments, i.e., the Bone Dysplasia Ontology and the largest bone dyspla-
sia patient dataset (Section 2.2) and finally, presents briefly some of the most
commonly used similarity measures (Section 2.3).
2.1 Human Phenotype Ontology
The Human Phenotype Ontology 1 is a controlled vocabulary that captures
and represents clinical and radiographic findings (or phenotypes in general), in
principle, in hereditary diseases listed in Online Mendelian Inheritance in Man
(OMIM) database 2. The ontology consists of around 9,000 concepts describing
modes of inheritance, onset and clinical disease courses and phenotypic abnor-
malities. This last category represents around 95% of the ontology and is the
main subject of our study. Phenotypic abnormalities are structured in a hierar-
chical manner (via class–subclass relationships) from generic (e.g., HP 0000929
– Abnormality of the skull) to specific abnormalities (e.g., HP 0000256 – Macro-
cephaly).
One aspect that needs to considered when using the structure of HPO is the
multiple inheritance. All children of a particular class share some information
(which is logical in a typical ontology), however, the type of this shared in-
formation (i.e., not the specific information) can be different. More concretely,
abnormalities may share their anatomical localization or they may share the
1 http://www.human-phenotype-ontology.org/
2 http://www.omim.org/
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Fig. 1. An example of multiple inheritance in HPO (arrows denote class–subclass
relations)
intrinsic type of abnormality. Fig. 1 depicts an example of such multiple inher-
itance. HP 0009244 (Distal/middle symphalangism of 5th finger) is a sibling of
HP 0009178 (Symphalangism of middle phalanx of 5th finger) – they represent
the same type of abnormality, i.e., Symphalangism, and hence are both chil-
dren of HP 0004218 (Symphalangism of the 5th finger), but also a sibling of
HP 0009240 (Broad distal phalanx of the 5th finger) – they share the anatomi-
cal localization of the abnormality, and hence are both children of HP 0004225
(Abnormality of the distal phalanx of the 5th finger). This remark is important
because it influences the computation of the most specific common ancestor for
two concepts, a central element of most semantic similarity measures.
2.2 Bone Dysplasia Knowledge Sources
As mentioned in Section 1, in the context of the SKELETOME project, we have
two major knowledge sources: the Bone Dysplasia Ontology (BDO) 3 and a set
of semantically annotated patient cases. The clinical and radiographic findings
that characterize both are underpinned by the Human Phenotype Ontology.
BDO has been developed to model and capture essential (and mature) knowl-
edge in the skeletal dysplasia domain. As depicted in Fig. 2, it associates bone
dysplasias to gene mutations and phenotypic characteristics, which are then fur-
ther specialised via concepts defined by external ontologies, such as HPO. In [3]
we provide a comprehensive overview of the design process of BDO. With re-
spect to the work described in this paper, there is one remark that is worth
being noted. BDO describes associations (via class axioms) between more than
250 disorders (out of the 450 in total) and around 2,000 findings (represented by
HPO concepts). These associations have been created from the clinical synopses
of the corresponding disorders in OMIM and represent, in principle, the current
state of conceptual understanding of their clinical manifestations. As a result,
the phenotypic findings listed there are a mixture of more generic (e.g., abnormal
3 http://purl.org/skeletome/bonedysplasia
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Fig. 3. A snapshot of the Patient Ontology from [1]
femoral neck) and fairly specific (e.g., short, broad femoral neck) terms. This re-
flects the balance achieved by capturing both the clinical interpretation of sets of
patient cases (for the more common disorders), as well as singular or particular
patient cases (for those that are extremely rare).
In addition to the domain knowledge, SKELETOME focuses also on captur-
ing instance data, i.e., annotated patient cases. The actual modeling is done
via the Patient Ontology (depicted in Fig. 3), which associates patients to clin-
ical and radiographic findings, gene mutations and bone dysplasias. The main
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source of patient data is the registry of the European Skeletal Dysplasia Network
(ESDN) 4, which is a pan-European research and diagnostic network aimed to
provide community driven help and diagnostic expertise for rare bone disorders.
Our current dataset comprises a total of 1,200 semantically annotated closed
ESDN cases. Each patient case has been modeled using the Patient Ontology
and captures HPO concepts denoting clinical and radiographic findings and BDO
dysplasias denoting the final diagnosis. In contrast to the knowledge in BDO,
the level of specificity present in the clinical descriptions is, as expected, fairly
high, i.e., the general tendency is to find more specific findings rather than more
generic ones.
2.3 Semantic Similarity
As mentioned earlier, there has been a great amount of research done on semantic
similarities. Here, we intend only to introduce some basic concepts and to provide
a brief overview of the measures used within our experiments. A detailed survey
on semantic similarity on biomedical ontologies can be found in [4].
There are two main types of semantic similarities: (1) node-based similarities
and (2) edge-based similarities. The former uses nodes and their properties as
information source, whereas the latter focuses on edges and their types.
Node based approaches rely on the notion of Information Content (IC) to
quantify the informativeness of a concept. IC values are usually calculated by
associating probabilities to each concept in ontology by computing the negative
likelihood of its frequency in large text corpora. The basic intuition behind the
use of the negative likelihood in the IC calculation is that the more probable
the presence of a concept in a corpus is, the less information it conveys. IC is
expressed in Eq. 1, with p(c) being the probability of occurrence of c in a specific
corpus. In our case p(c) represents the probability of occurrence of an HPO
concept in the context of a bone dysplasia, either from the domain knowledge,
or from the raw patient cases.
The foundational node based similarity measures are Resnik [5], Lin [6] and
Jiang and Conrath [7]. Resnik was the first to leverage IC for computing semantic
similarity and expressed semantic similarity between two terms as the IC of
their most informative common ancestor (MICA – Eq. 2). The intuition is that
similarity depends on the amount of information two concepts, c1 and c2, share.
This, however, does not consider how distant the terms are in their information
content and from a hierarchical perspective. Consequently, Lin (Eq. 3) and Jiang
and Conrath (Eq. 4) have proposed variations of Resnik’s similarity to take into
account these aspects.
IC(c) = −logp(c) (1)
simRes(c1, c2) = IC(cMICA) (2)
4 http://www.esdn.org
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simLin(c1, c2) =
2 ∗ IC(cMICA)
IC(c1) + IC(c2)
(3)
simJC(c1, c2) = 1− IC(c1) + IC(c2)− 2 ∗ IC(cMICA) (4)
Edge-based approaches take into account the paths existing between the con-
cepts in the ontology. Subject to the domain and ontology, such paths could
be considered by following is-a relationships (the most common approach) or
other types of relationships defined by the ontology. Examples of such similarity
measures include: (i) Wu & Palmer [8] (Eq. 5), where LCS is the least common
subsumer of c1 and c2 and N1 is the length of the path from c1 to root, N2
the length of the path from c2 to root and N3 the length of the path from LCS
to root; or (ii) Leacock-Chodorow [9] (Eq. 6), where D is the overall depth of
the ontology. A more recent measure has been described in [10] and considers,
among other aspects, the number of changes in direction of the shortest path
between two concepts (i.e., how many times on the shortest path the traversing
direction changes from child to parent and vice-versa).
simW&P (c1, c2) =
2 ∗N3
N1 +N2 + 2 ∗N3
(5)
simL&C(c1, c2) = −log
len(c1, c2)
2 ∗D
(6)
A third category of similarity measures could be considered for the hybrid ap-
proaches, i.e., combining node and edge-based similarities (e.g., [11] or [12]). Our
work aims to integrate both information content and structural relationships in
order to gain as much as possible from the semantics provided by HPO. As de-
scribed in the following section, we also propose a series of such hybrid measures
tailored on specific requirements emerged from our knowledge sources.
3 Methodology
The goal of our work is to predict disorders given an annotated patient case de-
scription. More concretely, given a background knowledge base (i.e., BDO or the
annotated patient dataset) and a set of HPO concepts (representing clinical and
radiographic findings of a new patient case), we aim to predict the most plausible
bone dysplasias, ranked according to their probability. This is a typical multi-
class classification problem, however, due to data sparseness that characterises
the skeletal dysplasia domain, typical Machine Learning algorithms achieved a
very low accuracy 5. Our intuition is that by using semantic similarity measures
on patient findings (i.e., HPO concepts) we are able to leverage and use intrinsic
5 A series of classification experiments we have performed revealed a maximal accuracy
of around 35% for Naive Bayes, in a setting in which we have considered only six
disorders, i.e., those that had more than 20 cases.
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Fig. 4. Block diagram of the prediction methodology
associations between phenotypes that cannot, otherwise, be acquired by typical
Machine Learning methods (due to their term-based matching process). As an
example, if the background knowledge base lists HP 0000256 (Macrocephaly) as
a phenotype of Achondroplasia and a new patient exhibits HP 0004439 (Cran-
iofacial dysostosis) we want to use the semantic similarity between HP 0000256
and HP 0004439 to also associate the later to Achondroplasia with a certain
probability 6. The semantic similarity between the two concepts could be inferred
via their most common ancestor HP 0000929 (Abnormality of the skull). Such
an association is not possible when employing typical Machine Learning meth-
ods since each term would be considered individually and only in the context
provided by the background knowledge base.
Fig. 4 depicts the overall methodology. In the first step, we compute the
semantic similarity between all HPO concepts representing clinical and radio-
graphic findings of the given patient case and all phenotypes associated with
bone disorders in the background knowledge base (please note that we do not
make any assumptions about the background knowledge base). If we consider
{S1, S2, . . . , Sn} to be patient findings and {P1, P2, . . . , Pn} phenotypes of
bone dysplasia D, the best similarity match between Si and D is given by:
BestMatch(Si, D) =
n
argmax
j=1
{sim(Si, Pj)} (7)
The semantic similarity in Eq. 7 can be any of the classical similarities mentioned
in Section 2 or, for example, one of the measure we introduce later in this section.
The evaluation described in Section 4 has been performed on multiple such
similarity measures. Once the best matches have been computed, we calculate
the final probability by aggregating them:
P (S1, S2, . . . , Sn|D) =
1
n
∗
n∑
i=1
BestMatch(Si, D) (8)
6 As a remark, there is no direct relationship in HPO between the concepts HP 0000256
and HP 0004439. A relationship exists only via the parent of HP 0000256 (i.e.,
HP 0000240 – Abnormality of skull size), which is a sibling of HP 0004439.
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As mentioned previously, a good semantic similarity measure needs to take into
account the specific aspects of the target domain. Below we have summarized
a series of requirements for the similarity measure that have emerged from the
bone dysplasia domain and the structure of HPO:
– Given two HPO concepts and their LCA (lowest common ancestor), we con-
sider the concept closer to the LCA to be more similar to the LCA than the
concept located at a bigger distance. E.g., HP 0004439 (Craniofacial dysos-
tosis) will be considered more similar to HP 0000929 (Abnormality of the
skull) than HP 0000256 (Macrocephaly), because it is a direct descendent of
HP 0000929;
– The information content of an LCA is dependent on its specificity (i.e., its
location in the overall hierarchy). More concretely we consider the more
specific LCA to be more informative. E.g., HP 0004439 (Craniofacial dysos-
tosis) (as an LCA) should be considered more informative than HP 0000929
(Abnormality of the skull), which is in this case, its direct parent.
– A smoothing parameter may be required to deal with missing LCA infor-
mation content. As described in [12], one of the main issues of IC is that
its values are derived by analyzing large corpora (in our case a given back-
ground knowledge base), which may not even contain certain concepts. This
is also the case with LCAs computed on certain pairs of findings, aspect
dependent on the background knowledge base. Unfortunately, neither the
intrinsic information content defined in [13], nor the extended information
content defined in [12] can be employed in our domain, because we need the
IC of a concept to be defined in the context of a given disorder (see below)
and not only based on its children or surrounding concepts in the ontology.
In other terms, we cannot use only the local IC definition provided by HPO
without the scope provided by and associated disorder.
In addition to these requirements, we need to define the Information Content
(IC) of a finding in the context of a disorder. Independently of the background
knowledge base used for experiments, we have considered IC(CP ) (i.e., the IC
of the concept C grounding phenotype P) to be:
IC(P ) = −log
NDP
ND
(9)
where NDP represents the number of disorders associated with P and ND is the
total number of disorders.
In the following we define a series of hybrid semantic similarities that take
into account the above listed requirements.
HSS1 quantifies the semantic similarity between concepts according to the
information content of the LCA and the position of LCA in regards to the
concepts. HSS1 neglects the specificity of LCA.
HSS1(C1, C2) =
Any −Node−Based− Similarity
DIST (C1, LCA) +DIST (C2, LCA)
(10)
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where DIST (C,C) = 0 and DIST (C1, C2) = len(SPath(C1, C2)) (SPath =
shortest path).
For example, HSS1 used with Resnik (simRes) would be:
HSS1(C1, C2) =
IC(LCA)
DIST (C1, LCA) +DIST (C2, LCA)
(11)
HSS2 introduces the specificity of LCA, however, it neglects the missing LCA
information content. HSS2 is defined below.
HSS2(C1, C2) =
L
D
∗HSS1 (12)
where L is the length of the path from the root to LCA and D is the depth of
the ontology.
HSS3 and HSS4. In order to fulfil the last requirement, we have experimented
with two additional measures (HSS3 and HSS4 defined below), that introduce
different smoothing parameters: HSS3 uses a constantK, where K = 1/ND (ND
= total number of disorders), while HSS4 considers a joint information content
of the two concepts.
HSS3(C1, C2) =
L
D
∗ (IC(LCA) +K)
DIST (C1, LCA) +DIST (C2, LCA)
(13)
HSS4(C1, C2) =
L
D
∗ (IC(LCA) +
IC(C1) ∗ IC(C2)
IC(C1) + IC(C2)
)
DIST (C1, LCA) +DIST (C2, LCA)
(14)
4 Experimental Results
Taking into account the context provided by the SKELETOME project, i.e., a
platform used by clinicians, we have tested the disorder prediction on a sub-
set of the patient dataset described in Section 2. We performed three different
experiments, described in the following:
– Firstly, we used a part of the patient dataset as knowledge source,
– Secondly, we used the Bone Dysplasia Ontology as knowledge source,
– Thirdly, we compared the semantic similarity-based prediction against a
term matching-based prediction (i.e., an approach that uses only the fre-
quency of the patient findings in the context of each disorder).
Each experiment tested different semantic similarity measures (applied in a HPO
concept to concept setting). To assess the efficiency provided by the semantic
similarity, we have calculated the overall accuracy of the disorder prediction.
Node-based similarities have used the information content calculated on the
background knowledge used in the experiment (i.e., IC on BDO or on patient
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Table 1. Experimental results of disorder prediction using patient cases as background
knowledge
Similarity A@1 (%) A@2 (%) A@3 (%) A@4 (%) A@5 (%)
Resnik 10.96 21.92 32.88 35.62 41.10
Lin 6.85 12.33 17.81 28.77 34.25
J&C 2.74 9.59 12.33 13.70 20.55
HSS1 31.51 46.58 54.79 64.38 71.23
HSS2 32.87 49.32 56.16 64.38 69.86
HSS3 39.73 52.05 61.64 69.86 75.34
HSS4 39.73 52.05 60.27 68.49 73.97
cases), while the hybrid similarities have used both this information content and
the structure of HPO.
In Section 2 we have discussed some of the foundational differences between
the two knowledge sources with respect to the phenotypes’ specificity. Another
aspect that needs to be mentioned is that, since the raw knowledge we are
using emerges from real patient cases, it will contain clinical and radiographic
features that are directly related to the disorder, but also phenotypes that are
not necessarily relevant. This is a normal phenomenon, because clinicians record
all their findings before considering a diagnosis. For example, a clinical summary
may contain findings such as, bowed legs,macrocephaly and cleft palate, which are
relevant for the final Achondroplasia diagnosis, but it may also contain fractured
femur and decreased calcium level, which are not relevant in the context of the
final diagnosis. The set of unrelated findings are termed as noise.
Noise is the one of the most important contributing factors to the prediction
accuracy, and it is inverse proportional to it. Hence, the prediction accuracy
depends on the noise introduced both by the background knowledge, as well
as the test data. As we are considering both the domain knowledge (via BDO)
and patient cases as background knowledge bases in two different assessments,
we will be able to judge which of the two types of knowledge contains more
noise. This is realized by testing both on the set test dataset and comparing the
resulted accuracy.
In all experiments detailed below we compute the prediction accuracy as the
overall percentage of correctly predicted disorders at a given recall cut-off point
(i.e., by taking into account only the top K predictions, for different values of
K, where K is the recall cut-off point). Hence, a success represents correctly
predicted disorder (the exact same, and not a sub or super class of it), while
a miss represents an incorrectly predicted disorder. If N is the total number of
test cases and L is the number of corrected predicted disorders, then Accuracy
A = L/N . This is expressed in percentages in Tables 1, 2 and 3.
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Table 2. Experimental results of disorder prediction using BDO as background
knowledge
Similarity A@1 (%) A@2 (%) A@3 (%) A@4 (%) A@5 (%)
Resnik 2.74 4.10 4.10 6.84 8.21
Lin 1.37 2.74 2.74 4.10 4.10
J&C 0 0 0 0 0
HSS1 16.43 21.91 32.87 43.84 47.95
HSS2 10.96 16.43 17.80 24.66 27.40
HSS3 10.96 16.44 19.18 23.29 27.40
HSS4 10.96 17.80 19.18 21.92 28.77
4.1 Experiment 1: Patient Data as Knowledge Base
This first experiment considers patient cases as background knowledge. As dis-
cussed in Section 2, we collected a dataset of 1,200 patient cases from ESDN and
annotated them with HPO terms. In order to provide an accurate view over the
prediction, the experiment has been performed as a 5-fold cross validation with
an 80-20 split (80% knowledge base, 20% test data). Table 1 lists the resulted
average accuracy at five different recall cut-off points.
Overall, HSS3 has performed the best in this experiment, more or less on par
with HSS4, and has confirmed that it is important for all three requirements
listed in Section 3 to be fulfilled. Moreover, this experiment shows the improve-
ment brought by a hybrid method over traditional information content based
approaches. HSS1 outperforms the IC-based similarities because it considers the
distance to the LCA and not only the IC of the LCA – i.e., the closer the two
terms are to the LCA (and implicitly between them) the more similar they are.
At the same time, HSS3 outperformed HSS1 because it smooths the missing
information content, while at the same time introducing the specificity (L/D)
– which is characteristic to the background knowledge. Finally, the similarity
between HSS3 and HSS4 (that can also be observed in experiment 2) shows
that the parameter K = 1/ND is a good approximation of the joint information
content of the two concepts.
4.2 Experiment 2: BDO as Knowledge Base
The second experiment evaluated the disorder prediction with BDO as back-
ground knowledge. We have performed the same rounds of experiments as in the
first case, i.e., we tested the prediction accuracy for the exact same 5 test folds
resulted from experiment 1 and computed the final average accuracy for each
semantic similarity. Results are listed in Table 2.
As in the case of the first experiment, all hybrid similarities outperformed the
classical information content approaches. This time, however, HSS1 has achieved
the best result, proving that the HPO concepts captured by BDO are more
generic, as we have expected. The specificity factor L/D in HSS2, HSS3 and
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Table 3. Experimental results on term matching vs. semantic similarity
Method A@1 (%) A@2 (%) A@3 (%) A@4 (%) A@5 (%)
Patient cases as background knowledge
Term matching 26.02 38.36 50.68 56.16 61.64
Semantic similarity 39.73 52.05 61.64 69.86 75.34
BDO as background knowledge
Term matching 8.21 15.06 21.91 26.02 27.4
Semantic similarity 16.43 21.91 32.87 43.84 47.95
HSS4 takes low values because L is generally smaller (i.e., terms are located
higher in the hierarchy and hence more generic) which leads to smaller values for
these measures. This is also the reason why, the same similarities have performed
worse when BDO was considered background knowledge, as opposed to using
patient cases as background knowledge. The specificity of the ancestor improves
the accuracy on patient cases but it decreases it on domain knowledge. Finally, a
different reason for the lower accuracy is the multiple inheritance used in HPO,
which leads to additional missing information content for LCAs.
4.3 Experiment 3: Term Matching vs. Semantic Similarity
Finally, in order to gain insight in the importance of using semantic similar-
ity measures in disorder prediction, we have compared the results of the best
performing similarity for each background knowledge against prediction calcu-
lated on term-based matching. Firstly, the results listed in Table 3 show that
using semantic similarity is generally a good strategy as the overall accuracy is
improved when compared to term-based matching, independently of the back-
ground knowledge. Interestingly, in this comparison, the specificity factor that
heavily influences the accuracy based on the background knowledge has proved
to be beneficial in the context of BDO, when compared against term matching.
Secondly, returning to the comparison based on background knowledge, we can
conclude that the domain knowledge introduces more noise than patient cases,
which seems to contradict our initial belief (since clinicians will list in a case
all observed findings, including those that may turn out to be irrelevant for the
final diagnosis). In reality, in this case we are dealing with a different kind of
noise, as the domain knowledge has the tendency to dilute the discriminatory
findings when aggregating the information resulted from analyzing groups of pa-
tients. We intend to deal with this issue by including knowledge on differential
diagnosis in the Bone Dysplasia Ontology.
5 Related Work
The research presented in [14] is the most relevant related work in the context
of this paper. Kohler et al. have developed a semantic similarity search applica-
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tion named Phenomizer, which takes as input a set of HPO terms and returns
a ranked list of diseases from OMIM, to their semantic similarity values. Phen-
omizer uses the Resnik semantic similarity and arithmetic mean as aggregation
strategy (similar to our approach). According to the experiments discussed in
the paper, their solution outperforms term-based matching approaches that do
no consider any relationships between terms. Our research follows closely the
work done in Phenomizer, however, we use real patient data to test the disorder
prediction (as opposed to the synthetically generated data in their case), and
we try to tailor the semantic similarity to map onto the requirements emerging
from the domain. Furthermore, we test several semantic similarities in order to
get a better understanding of the most appropriate combination that serves our
prediction goal. Finally, we evaluate the prediction accuracy using two types of
background knowledge – domain and raw knowledge, as opposed to only domain
knowledge in their case.
Additional related work includes [15], where the authors use a threshold of
lowest semantic similarity value to find best-matching term pairs with the goal
of predicting molecular functions of genes in Gene Ontology (GO) [16] annota-
tions. Similar to our work, the authors tailor the semantic similarity measures
according to fit the structure of GO and their application requirements. Lei et
al. [17] assess protein similarity within GO to predict the subnuclear location.
They compared the prediction accuracy of several similarity measures, includ-
ing classical ones such as Resnik, and term-based matching to find insignificant
differences between them. The authors also evaluate several aggregation strate-
gies for the similarity values (e.g., sum, average, multiplication) and have found
that the sum of the term-based matching method produces the best predictive
outcome. Subnuclear location of a gene is associated with specific GO terms in
most of the cases. As a result, using the hierarchical structure of the ontology
via semantic similarity methods may not bring significant improvements.
In [18], the authors use ontological annotations and a proposed semantic sim-
ilarity measure to find a correlation between protein sequence similarity and
semantic similarity across GO. Similarly, Washington et al. [19] investigate the
ontological annotation of disease phenotypes and the application of semantic
similarities to discover new genotype-phenotype relationships within and across
species. Finally, Ferreira et al. [20] use semantic similarity measures to classify
chemical compounds and have showed that employing such techniques improves
the chemical compound classification mechanisms. To achieve this, they em-
ployed measures tailored on the semantics of the Chemical Entities of Biological
Interest Ontology (ChEBI).
6 Conclusion
In this paper we have reported on our experiences in using semantic similarity
measures for disorder prediction in the skeletal dysplasia domain. The SKELE-
TOME project provides two types of knowledge sources: (1) domain knowledge,
modeled by and captured in the Bone Dysplasia Ontology and (2) raw knowledge
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emerging from patient cases. In both cases the clinical and radiographic find-
ings are grounded in Human Phenotype Ontology concepts. The data sparseness
that characterises this domain required us to consider alternative approaches in
performing disorder prediction. Hence, we took advantage of the semantics pro-
vided by HPO and experimented with different semantic similarity measures,
using both types of knowledge sources.
The experimental results have led to the conclusion that applying only infor-
mation theoretic approaches in computing semantic similarity over the Human
Phenotype Ontology, in our domain, does not provide the optimum result. In-
stead, we need to take into account particular requirements that emerge from the
data characteristic to the bone dysplasia domain, i.e., a combined path between
findings and their common ancestor, the specificity of this common ancestor and
a smoothing parameter for the cases when the information content of the com-
mon ancestor is missing. Another conclusion of our experiments has been the
need for differential diagnosis information in the domain knowledge in order to
increase the weight of the discriminatory findings. Finally, we have shown that
using semantic similarities improved the prediction accuracy when compared to
term-based (frequency) matching prediction.
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4.3 Discussion and Implications of Findings 
This chapter investigated the application of a range of both standard and novel semantic similarity 
approaches to predict and rank candidate disorders given a set of phenotypes. The experimental 
results showed that the proposed best semantic similarity method (HSS3) at recall cut-off point 5, 
achieved 75.34% accuracy. This was a 34.24% improvement on the best performing existing 
semantic similarity method which is Resnik (which achieved 41.1%). 
The evaluation also revealed that using raw knowledge emerging from annotated patient cases 
improves the disorder prediction accuracy on average by 34.64% at recall cut-off point 5 over the 
use of domain knowledge – defined within the Bone Dysplasia Ontology. The lesson learned from 
this is that the domain knowledge externalized by BDO introduces more noise (e.g., features 
unrelated to disorders) than the real-world patient cases. Furthermore, semantic similarity methods 
achieved an improved prediction accuracy (improvements of 13.7% using patient cases and 20.55% 
using domain knowledge) compared to exact matching, and thus it can be concluded that this 
approach represents a promising strategy. 
Other existing approaches have employed semantic similarities for similar goals. For example, 
Robinson et al. [82] developed a diagnosis application using the Resnik semantic similarity and 
arithmetic mean as a phenotype aggregation strategy. However Robinson et. al used synthetically 
generated test data. The research described in this thesis uses real patient data to test the disorder 
prediction, employs tailored semantic similarity methods to match the requirements of the domain 
and, finally, investigates several standard semantic similarity approaches in order to get a better 
understanding of the most appropriate combination that satisfies the prediction goal.  
The research discussed in this chapter addresses the second research objective of this thesis: “to 
develop semantic similarity methods to compare phenotypes used within the skeletal dysplasia 
domain and employ these methods to build a semantic similarity-driven decision support method to 
provide a ranked list of disorders, given a set of phenotypes”. The resulting approach satisfies a set 
of requirements that have emerged from the bone dysplasia domain and the structure of the Human 
Phenotype Ontology. It has led to the development of four novel semantic similarity metrics. The 
evaluation phase has shown that the proposed technique displays increased accuracy in comparison 
to both exact matching and standard semantic similarity metrics. 
Taking into account causal associations between features (e.g., phenotypes) and classes (e.g., 
disorders) is an important criterion in the context of classifying newly arrived data. Otherwise, an 
assumption needs to be made in relation to the causal associations between every class and every 
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feature. An open research area is to take the causal associations between features and classes into 
consideration in developing the semantic similarity driven decision support method.  
Within association rule mining, employing concept similarity metrics instead of exact matching for 
the interestingness measures enables a comparison between concepts based on semantics. To 
exploit semantics in the knowledge discovery operations of the skeletal dysplasia domain, the third 
phase of the decision support framework, reported in next chapter, discovers association rules by 
combining concept similarity metrics together with traditional interestingness measures, in order to 
relate phenotypes and disorders in the phenotype-disorder lifecycle. 
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Chapter 5: Association Rule Mining using Semantic 
Similarity and Semantic Rule Interestingness Measures 
5.1 Introduction 
Existing association rule mining methods on annotated datasets employ traditional interestingness 
measures, which cannot take advantages of the semantics present in the underlying annotations [39, 
83-85]. For instance, Neonatal short-limb short stature and Rhizomelic short stature defined by the 
Human Phenotype Ontology are fairly similar because they have a direct common ancestor - 
Disproportionate short-limb short stature, but they are not exactly the same. Traditional 
interestingness measures cannot take this into account because of their reliance on exact matching. 
To date, no approach has exploited the advantages of using ontologies in computing interestingness 
measures. This chapter, and hence the third phase of decision support framework described in this 
thesis, proposes a novel approach which combines semantic similarity methods with the traditional 
interestingness measures within association rule mining to take advantage of the semantics 
formalised in the skeletal dysplasia domain. 
This research aims to address the third objective stated in Sec. 1.4, i.e., to “Combine concept 
similarity metrics, formulated using the intrinsic structure of domain ontologies, with traditional 
interestingness measures to compute semantic interestingness measures in order to discover 
association rules in the skeletal dysplasia domain”. Furthermore, it answers the research question: 
“How can the relationships among the concepts of the skeletal dysplasia domain be leveraged 
within the process of association rule mining?” 
The outcome of this work provides clinicians with a way of verifying known associations, as well 
as discovering new, previously unknown associations between clinical attributes (phenotypes) and 
disorders. At the time of writing this thesis, the actual methodology and experimental results was in 
minor revision stage with the peer-reviewed “BMC Journal of Biomedical Semantics”. 
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5.2 Journal 2 - Semantic Interestingness Measures for Discovering 
Association Rules in the Skeletal Dysplasia Domain  
R. Paul, T. Groza, J. Hunter, and A. Zankl, "Semantic interestingness measures for discovering 
association rules in the skeletal dysplasia domain," Journal of Biomedical Semantics, vol. 5, 2014. 
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Abstract
Background: Lately, ontologies have become a fundamental building block in the process of formalising and storing
complex biomedical information. With the currently existing wealth of formalised knowledge, the ability to discover
implicit relationships between different ontological concepts becomes particularly important. One of the most widely
used methods to achieve this is association rule mining. However, while previous research exists on applying
traditional association rule mining on ontologies, no approach has, to date, exploited the advantages brought by
using the structure of these ontologies in computing rule interestingness measures.
Results: We introduce a method that combines concept similarity metrics, formulated using the intrinsic structure of
a given ontology, with traditional interestingness measures to compute semantic interestingness measures in the
process of association rule mining. We apply the method in our domain of interest – bone dysplasias – using the core
ontologies characterising it and an annotated dataset of patient clinical summaries, with the goal of discovering
implicit relationships between clinical features and disorders. Experimental results show that, using the above
mentioned dataset and a voting strategy classification evaluation, the best scoring traditional interestingness measure
achieves an accuracy of 57.33%, while the best scoring semantic interestingness measure achieves an accuracy of
64.38%, both at the recall cut-off point 5.
Conclusions: Semantic interestingness measures outperform the traditional ones, and hence show that they are
able to exploit the semantic similarities inherently present between ontological concepts. Nevertheless, this is
dependent on the domain, and implicitly, on the semantic similarity metric chosen to model it.
Introduction
Over the course of the last decade, ontologies have
become a fundamental building block in the knowledge
acquisition and capturing processes in the biomedical
domain. Repositories such as BioPortal [1] or the OBO
Foundry [2] currently offer a varied range of ontologies,
in addition to tool support to visualise, query and inte-
grate concepts hosted by these ontologies. Subsequently,
this enables the construction of decision support meth-
ods that use ontological background knowledge in order
to produce more accurate and more refined outcomes.
*Correspondence: tudor.groza@uq.edu.au
1School of ITEE, The University of Queensland, St. Lucia, Queensland 4072,
Australia
Full list of author information is available at the end of the article
Ontologies provide structured and controlled vocabu-
laries and classifications for domain specific terminolo-
gies. Their adoption for annotation purposes provides a
means for comparing medical concepts on aspects that
would otherwise be incomparable. For example, the anno-
tation of a set of disorders (directly or via patient cases)
using a particular ontology enables us to compare these
disorders, by looking at the underpinning annotation con-
cepts. The actual comparison can be done in an exact
or inexact manner. More concretely, one may take into
account only those identical concepts that appear in all
or some disorders, or may use a semantic similarity mea-
sure that relaxes the constraint on identical concepts.
Such a semantic similarity measure represents a function
that takes two or more ontology concepts and returns
a numerical value that reflects the degree of similarity
© 2014 Paul et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Paul et al. Journal of Biomedical Semantics 2014, 5:8 Page 2 of 13
http://www.jbiomedsem.com/content/5/1/8
between these concepts in a given ontology. This com-
parison process represents a key aspect of typical data
mining algorithms that form the core of any decision
support method. For example, two ontological concepts,
such as HP:0004481 (Progressive macrocephaly) and
HP:0004482 (Relative macrocephaly) from the Human
Phenotype Ontology (HPO) [3], would be treated differ-
ently by any classical data mining algorithm because of
their symbolic (i.e., lexical grounding) difference. How-
ever, these two concepts, like any other two entities in an
ontology, are to a certain extent semantically similar – a
similarity that can be encoded via an existing or custom-
made metric. Replacing exact matching with semantic
similarity measures provides novel and exciting oppor-
tunities in knowledge discovery and decision support on
annotated datasets [4-6].
Association rules [7] are valuable patterns that can dis-
covered from annotated datasets. An association rule
denotes an implication relationship (or a directed co-
occurrence) between two sets of items within a transac-
tion. A widely used algorithm to discover such association
rules is Apriori [7]. However, regardless of the particu-
lar algorithm used, the discovery process has two major
challenges: (i) too many rules may be generated (the rule
quantity problem); (ii) not all rules are necessarily inter-
esting (rule quality problem). The solution to the rule
quality problem relies on specifying an interestingness
measure [8-10] to encode the utility or significance of a
pattern. These measures are intended for selecting and
ranking patterns according to their potential interest and
enables highly ranked rules to be immediately presented
or used for particular purposes.
Existing work on interestingness measures takes into
account only exact matching [10]. Semantic similarities,
however, enable novel ways of interpreting data items, and
hence may lead to the identification of association rules
that are otherwise not discoverable via exact matching. In
this manuscript, we advance the state of the art by explor-
ing the application of semantic similarities in widely used
interestingnessmeasures in the context of association rule
mining. In other terms, we aim to use existing taxonomic
relations to calculate so-called “semantic interestingness
measures”.
The context of our research is provided by the SKELE-
TOME project [11], which aims to create a community-
driven knowledge curation platform for the skeletal
dysplasia domain. Skeletal dysplasias are a heterogeneous
group of genetic disorders affecting skeletal development.
Currently, there are over 450 recognised bone dysplasias,
structured in 40 groups. Patients with skeletal dysplasias
have complex medical issues including short stature,
bowed legs, a larger than average head and neurological
complications. Since most skeletal dysplasias are very rare
(< 1:10,000 births), data on clinical presentation, natural
history and best management practices is sparse. To date,
we have developed an ontology, the Bone Dysplasia Ontol-
ogy (BDO) [12], and a series of decision support methods
[6,13]. BDO has been built using the latest nosology of
bone dysplasias [14] that groups disorders according to
their overlapping clinical and genetic features. For exam-
ple, Achondroplasia and Diastrophic dysplasia are similar,
and are both part of the FGFR3 Group, because they share
a range of clinical features (i.e., short stature with very
short arms and legs).
Within this manuscript, we investigate both tradi-
tional, as well as semantic interestingness measures in the
context of association rule mining, to discover implicit
relationships between clinical features and disorders in
skeletal dysplasia domain. The main contributions of this
work are the following: (i) firstly, we analyse which of
the existing traditional interestingness measures enables a
more accurate discovery of association rules in the skele-
tal dysplasia domain; (ii) secondly, we propose a series
of interestingness measures based on semantic similarity
metrics using existing ontologies as background knowl-
edge; and (iii) finally, we perform an extensive empirical
evaluation to measure the quality of the resulting rules,
using an annotated dataset built on real patient data.
At the same time, we show that, given an appropriate
semantic similarity metric, the semantic interestingness
measures outperform the traditional ones.
As alreadymentioned, our work focuses only on skeletal
dysplasias, and hence it investigates the efficiency of the
above-described methods only in this domain. However,
the generic definition of a semantic interestingness mea-
sure proposed in this manuscript is directly applicable in
any other domain, while the rest of the research can be
used as a guideline for choosing an appropriate domain-
specific semantic similarity metric to be applied as part of
the overall measure.
Background
This section provides an overview of the foundational
blocks of the experiments performed in the context of
our research. We start by introducing the Human Pheno-
type Ontology and the Bone Dysplasia Ontology – i.e., the
ontologies used as background knowledge for the seman-
tic similarity metrics. Then, we describe some of the basic
notions of semantic similarities, and finally, we discuss
some of the traditional interestingness measures.
Human Phenotype Ontology
The Human Phenotype Ontology (HPO) [3] has lately
become the de facto controlled vocabulary to capture and
represent clinical and radiographic findings. The ontol-
ogy consists of around 9,000 concepts describingmodes of
inheritance, onset and clinical disease courses and pheno-
typic abnormalities. This last category represents around
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95% of the ontology and it is the main subject of our
study. HPO structures phenotypic abnormalities in a hier-
archical manner (via class-subclass relationships) from
generic (e.g., HP:0000929 (Abnormality of the skull) to
specific concepts (e.g., HP 0000256 – Macrocephaly).
For instance, HP:0001629 (Ventricular septal defect) is a
subclass of the concept HP:0010438 (Abnormality of the
ventricular septum) in the sense that a ventricular septal
defect is a kind of abnormality of the ventricular septum
and hence. every person with a ventricular septal defect
can also be said to have an abnormality of the ventricular
septum. This goes along the line of theTrue path rule [15],
which states that an annotation with a particular concept
implies the path from that concept to the root to be “true”,
or more concretely, a valid annotation with all ancestors
of that concept.
One obvious advantage of capturing phenotypic infor-
mation using ontologies is that it enables the design of
association mining algorithms that can exploit the seman-
tic relationships between concepts. For instance, an algo-
rithm can be designed to support not only the patterns
associated with a concept like HP:0001671 (Abnormal-
ity of the cardiac septa), but also those associated with
its children, HP:0010438 (Abnormality of the ventricu-
lar septum) and HP:0011994 (Abnormality of the atrial
septum).
Bone Dysplasia Ontology
The International Skeletal Dysplasia Society (ISDS –
http://www.isds.ch/) Nosology lists all recognised skele-
tal dysplasias and groups them by common clinical-
radiographic characteristics and/or molecular disease
mechanisms. The Nosology is revised every 4 years by
an expert committee and the updated version is usually
published in a medical journal. This is widely accepted as
the “official” nomenclature for skeletal dysplasias within
the biomedical community, with the latest version being
published in 2010 [14].
The Bone Dysplasia Ontology [12] aims to comple-
ment the spectrum of existing ontologies and address
the specific knowledge representation shortcomings of
the ISDS Nosology. Its main role is to provide the scaf-
folding required for a comprehensive, accurate and for-
mal representation of the genotypes and phenotypes
involved in skeletal dysplasias, together with their spe-
cific and disease-oriented constraints. As opposed to the
ISDS Nosology, the ontology enables a shared conceptual
model, formalised in a machine-understandable descrip-
tion, in addition to a continuous evolution and a founda-
tional building block for facilitating knowledge extraction
and reasoning. Currently, the structure of the ontology
follows closely the grouping of the disorders imposed by
the expert committee via the Nosology by using class-
subclass relationships between the 40 groups and their
associated bone dysplasia members. These groups are
then linked via the root concept Bone_Dysplasia.
Semantic similarity
Annotations using Bio-ontologies allow us to compare
concepts on various aspects by using their intrinsic
semantic similarity. Semantic similarity represents the
quantification of the degree of similarity between two
or more ontological concepts. For example, the annota-
tion of two bone dysplasias with concepts emerging from
the same ontology, e.g., HPO, enables their comparison
by looking at the semantic similarity between the con-
cepts used for annotation. In addition to this implicit role,
semantic similarity measures can also be used to discover
association rules in annotated datasets.
In principle, there are two types of approaches for
computing semantic similarity measures: node-based and
edge-based. The former uses the nodes and their proper-
ties as the data source whereas the latter uses the edges
between nodes and their associated types as data source.
The node-based approaches usually rely on the notion of
Information Content (IC) to quantify informativeness of a
concept. An IC value of a node is calculated by comput-
ing the negative likelihood of its frequency in a large text
corpora (IC(c) = −log(p(c))), with the intuition that the
more probable is the appearance of a concept in a corpus,
the less information it conveys.
A large number of node-based measures have been pro-
posed using Information Content as a central element,
some of the most widely used being listed below, i.e.,
Resnik [16], Lin [17] and Jiang and Conrath [18]. As a note,
in the equations below,MICA denotes the Most Informa-
tive Common Ancestor, i.e., the common ancestor of the
nodes with the highest Information Content.
Resnik : SIMRes(c1, c2) = IC(cMICA) (1)
Lin : SIMLin(c1, c2) = 2 ∗ IC(cMICA)IC(c1) + IC(c2) (2)
Jiang and Conrath : SIMJC(c1, c2)
= 1 − IC(c1) + IC(c2) − IC(cMICA) (3)
In the other category, i.e., edge-based approaches, Wu
& Palmer [19] proposed a measure based on the length
of the shortest path between the Least Common Ances-
tor (LCA) and the root and on the length of shortest path
between each of the concepts and that common ancestor.
DisW&P(c1, c2) = 2 ∗N3N1+ N2+ 2 ∗N3 (4)
where, N3 is the length of path from LCA to the root; N1
is the length of path from c1 to LCA; N2 is the length of
path from c2 to LCA.
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Association rule mining
Association rules [7] provide knowledge in the form of
probabilistic “if-then” statements, e.g., I → Q. The head
of the association rule (i.e., the if part – I) is called
antecedent, while the body (i.e., the then part –Q) is called
consequent. The antecedent and consequent of an asso-
ciation rule are disjoint – they do not have any items in
common. To express uncertainty in association rules, i.e.,
I → Q with a certain degree of certainty, several metrics
can be used, two of themost widely adopted being Support
and Confidence (discussed below). A set of association
rules aimed for classification is called predictive associ-
ation rule set. A class association rule set is a subset of
association rules with the specified classes as their conse-
quences. Predictive association rules form a small subset
of class association rules. Generally, mining predictive
association rules undergoes the following two steps: (i)
Find all class association rules from a database, followed
by (ii) Prune and organise the found class association rules
to return a sequence of predictive association rules.
Traditional interestingness measures. As mentioned
earlier, the rule discovery process is usually associated
with two challenges, one of them being the rule quality
problem, i.e., quantifying which of the discovered rules are
more interesting. Interestingnessmeasures play an impor-
tant role in data mining, regardless of the kind of patterns
being mined. They are intended for selecting and rank-
ing patterns according to their potential interest to the
user. Below, we present a number of existing association
rules interestingness measures [10], which we have also
applied in our experiments. This set of measures rely on
the foundational Support and Confidencemetrics.
Let T = {t1, t2, . . . , tn} be a database of n transactions
with a set of attributes (or items) I = {i1, i2, . . . , im}. For
an itemset IX ⊆ I and a transaction t ∈ T , we say that t
supports IX if t has values for all the attributes in IX . By
TIX we denote the transactions that contain all attributes
in IX .
The Support of IX is computed as
Support(IX) = TIXn (5)
or the fraction of transactions that include all attributes in
IX .
The Confidence of an association rule IX → Q, where Q
is also an itemset (Q ⊂ I) and Q ∩ IX = φ, is defined by:
Confidence(IX → Q) = Support(IX ,Q)Support(IX) (6)
or the ratio between the number of transactions that
include all items in the consequent (Q), as well as in the
antecedent (IX) – namely, the Support of the union of IX
and Q – and the number of transactions that include all
items in the antecedent (i.e., the Support of IX).
Confidence alone may not be enough to assess the
descriptive interest of a rule, as rules with high confi-
dence may occur by chance. Such spurious rules can be
detected by determining whether the antecedent and the
consequent are statistically independent. This inspired a
number of measures, including Lift, Conviction, Leverage,
Jaccard, Cosine and Correlation Coefficient [8-10]. We
provide their mathematical definitions in the following
sections.
Materials andmethods
Annotation dataset
The rare nature of bone dysplasias makes the data collec-
tion particularly challenging. In 2002, the European Skele-
tal Dysplasia Network (ESDN, http://www.esdn.org/) was
created to alleviate, at least partly, the data sparseness
issue. At the same time it aimed to provide a collabo-
rative environment to help with the diagnosis of skele-
tal dysplasias and to improve the information exchange
between researchers. To date, ESDN has gathered over
1,200 patient cases, which have been discussed by its panel
of experts. The ESDN case workflow consists of three
major steps: (i) a patient case is uploaded and an initial
diagnosis is set by the original clinician that referred the
case; (ii) the panel of experts discusses the case until an
agreement is reached; (iii) the panel of experts recom-
mends a final diagnosis. Among the total number of cases,
744 have a final bone dysplasia diagnosis (the remaining
cases were not thought to be true bone dysplasias by the
experts), with a total of 114 different skeletal dysplasias
covered.
Patient clinical summaries in ESDN are represented in
a free text format. The language used within the ESDN
clinical summaries suffers from several issues, such as
synonymy (several terms having the same meaning) or
hyponymy (one term beingmore specific than another). In
order to be able to use this data, we extracted patient phe-
notypes by annotating the text with corresponding terms
from the Human Phenotype Ontology (HPO). The actual
annotation process was performed using the National
Centre for Biomedical Ontology (NCBO) Annotator [20],
an ontology-based web service for annotation of tex-
tual sources with biomedical concepts. A bone dysplasia
expert (one of the co-authors) has manually validated the
resulting HPO annotations to ensure their correctness
and to eliminate, in particular, false positives.As a remark,
the false negatives resulted from the annotation process
may be under-estimated, and could not be validated since
we were not able to perform a full-fledged annotation of
the clinical summaries. The diagnosis associated with the
patient cases has also been annotated with concepts from
the Bone Dysplasia Ontology (BDO). More concretely,
the final diagnosis set by the panel of experts has been
converted to the corresponding BDO concept.
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In order to achieve realistic results using association
rule mining, from the 114 types of dysplasias present in
the ESDN dataset, we chose only those that were repre-
sented by more than 10 patient cases. This has reduced
our dataset to 394 annotated patient cases (i.e., around
33% of the total number) diagnosed with 15 different bone
dysplasias. The set features a total of 441 distinct pheno-
types, with an average of 63.67 distinct phenotypes per
disorder and an average of 4.49 distinct phenotypes per
case. The experiments described in this manuscript use
this dataset for training and testing purposes.
Proposed approach
Our goal is to discover association rules from anno-
tated and diagnosed patient cases in order to observe
co-occurrence relationships between clinical features and
disorders. In other words, we aim to find association rules
of the form {ICF } → {IBD}, where ICF represents the set
of clinical features of a patient and IBD is a bone dys-
plasia diagnosis. From a conceptual perspective, ICF will
comprise annotations assigned to patient cases, or more
concretely, HPO concepts. We have adapted the Apriori
algorithm by adding two constraints, required to match
our aim: (i) every desired itemset must have one set of
clinical features and a single dysplasia, and (ii) both candi-
date itemsets and frequent itemsets can have at most one
dysplasia item.
Following the discovery of the desired itemsets, these
are partitioned into two components: a component con-
taining the skeletal dysplasia and one containing the phe-
notypes. A Boolean function that determines the type of
a component is used to perform this classification. Sub-
sequently, we calculate the different traditional or seman-
tic interestingness measures between the bone dysplasia
component and the phenotype set of the rule.
Modelling traditional support in the context of semantic
annotations
If an itemset consists of the items I = {i1, i2, i3, . . . , im}
for the reference concept RC and there are n transactions
in the knowledge base KB, Support is defined as the pro-
portion of instances of the reference concept RC in the
knowledge base which contain the itemset I.
Support(I,RC,KB)
= Number of instances of concept RC that contain the itemset IThe total number of instances of the concept RC
(7)
In our case, the reference concept (RC) is represented
by the patient (P) and KB is annotated dataset. Below we
present an example of traditional Support calculation.
Let us consider the following set of clinical features rep-
resented by HPO concepts (cf ∈ ICF ), in addition to a
bone dysplasia:
• cf1 – HP:0008921 (Neonatal short-limb short
stature)
• cf2 – HP:0008905 (Rhizomelic short stature)
• cf3 – HP:0000772 (Abnormality of the ribs)
• cf4 – HP:0000774 (Narrow chest)
• bd1 – BDO:Achondroplasia
Let us also consider three reference concepts (i.e.,
patients) p1, p2 and p3 and assume that the KB contains
the following itemsets:
• I(p1) = {Icf1(p1), Icf3(p1), bd1}• I(p2) = {Icf1(p2), Icf4(p2), bd1}• I(p3) = {Icf2(p3), Icf3(p3), bd1}
where Icfx(px)={cfx|exhibits(px, cfx)}. Our goal is to com-
pute the support of the itemset I(p)={Icf1 (p), Icf3(p), bd1}.
We can quickly observe that there is one patient instance
that contains this pattern – i.e., p1. Since the total
number of patient instances is 3, traditional support is
then:
Support(I, P,KB) = 13 = 0.33 (8)
However, a close look at cf1 and cf2 in HPO reveals that
these concepts are fairly similar (they have a direct com-
mon ancestor in HP:0008873 – Disproportionate short-
limb short stature), but not exactly the same. cf3 and cf4
are in a similar situation, with the parent of HP:0000774
(i.e., HP:0005257 – Thoracic hypoplasia) being a sibling
of cf3. Unfortunately, traditional Support cannot leverage
this semantic similarity information as it relies on exact
matching. To overcome this issue, we propose an alter-
native set of semantic interestingness measures (Semantic
Support, Semantic Confidence, etc.).
Semantic similarity of items
Our intuition is that by using semantic similarity mea-
sures on patient findings (i.e., HPO concepts) we are able
to leverage and use the semantic relationships between
phenotypes that cannot, otherwise, be acquired by typical
data mining processes (due to their term-based match-
ing process). As an example, if the background knowledge
base lists HP:0000256 (Macrocephaly) as a phenotype of
Achondroplasia and a new patient exhibits HP:0004439
(Craniofacial dysostosis), we want to use the semantic
similarity value between the two concepts to associate
the later to Achondroplasia with a certain probability.
The semantic similarity between the concepts could be
inferred, for example, via their most common ancestor –
HP:0000929 (Abnormality of the skull). Such an associa-
tion is not possible when employing a typical data mining
process since each term would be considered individu-
ally and only in the context provided by the background
knowledge base.
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In principle, a good semantic similarity measure needs
to take into account the specific aspects of the target
domain. There are, nevertheless, a series of requirements
– emerging also from the bone dysplasia domain and the
structure of HPO – that are generally applicable:
• Given two HPO concepts, we consider them to be
more similar if they are closer to each other (i.e., the
path between them is shorter). E.g., HP:0004481
(Macrocephaly progressive) will be considered more
similar to HP:0000256 (Macrocephaly) than
HP:0004488 (Macrocephaly at Birth ), because the
distance between HP:0004481 and HP:0000256
is 1 whereas the distance between HP:0004481 and
HP:0004488 is 2.
• Several strategies have been used in choosing the
semantic similarity function. Li et al. [21], in their
work on modelling and capturing semantic similarity
in WordNet, have employed an exponent function to
transfer the path length between concepts into a
similarity value and have showed that the exponential
measure significantly outperforms traditional
similarity measures. Given that the design philosophy
of HPO andWordNet are similar, we derive the
similarity between two phenotypes as an exponent
function of the path length between their
corresponding HPO concepts. The same rationale is
valid also for BDO.
• In order to be able to calculate the semantic
interestingness measures, semantic similarity needs
to take values between 0 to 1. At the same time, an
exact match should be signalled by a semantic
similarity value of 1.
• The semantic similarity value of two concepts should
be dependent on the specificity of their LCA (i.e., its
location in the overall hierarchy). More concretely,
we consider the more specific LCA to be more
informative. E.g., HP:0004439 (Craniofacial
dysostosis) (as an LCA) should be considered more
informative than HP:0000929 (Abnormality of the
skull ), which is in this case, is its direct parent.
In the following we describe a set of domain-oriented
semantic similarity functions that satisfy the above-listed
requirements.
Domain-specific semantic similarity measures. If i1
and i2 are two items, we define the semantic similarity
between them as:
SemSim(i1, i2) = Dist(LCA(i1, i2),Root)Dist(i1, i2) + Dist(LCA(i1, i2),Root)
(9)
where Dist(LCA(i1, i2),Root) is the length of path from
LCA(i1, i2) to the root and Dist(i1, i2) is a distance
measure between i1 and i2 that depends on the underlying
types of the items.
If the items under scrutiny are phenotypes, we define
Dist(i1, i2) as shown in Eq. 10.
Dist(i1, i2) =
⎧⎨
⎩
2lx , if i1 = i2
0, if i1 = i2 = root
1, if i1 = i2 = root
(10)
where lx is the shortest path between i1 and i2. This
formula determines the semantic similarity of two HPO
terms based on both the distance between these terms
and the location of their LCA in the HPO structure. It can
also be observed that the larger the distance between the
terms, the less similar they will be. Finally, if two concepts
are the same but do not denote the root, the value of the
function is 0, while if they do denote the root, the value of
the function is 1, to avoid the division by 0 case.
In Eq. 10 the shortest path length is scaled by an expo-
nential function to providemore weight to distance rather
than depth. Furthermore, the base and the exponent of
this power function aim to overemphasise the similarity
between phenotypes when taking into account the HPO
structure. Generally, this similarity decreases faster than
the distance. For instance, the distance between Macro-
cephaly and Macrocephaly progressive is 1 and they are
very similar, while the distance between Abnormality of
Skull and Macrocephaly progressive is 3, with the former
being much more generic and different to Macrocephaly
progressive than any of the other macrocephalies.
Similar to the phenotype distance described above, if we
consider two disorders using the Bone Dysplasia Ontol-
ogy, we define the same Dist(i1, i2) as shown in Eq. 11 –
the semantic similarity equation remains unchanged (i.e.,
as per Eq. 9).
Dist(i1, i2) =
⎧⎨
⎩
10lx−2, if i1 = i2
0, if i1 = i2 = root
1, if i1 = i2 = root
(11)
where lx is again the shortest path between i1 and i2.
The rationale behind Eq. 11 is the same as for Eq. 10 (see
above), with the remark that the overall similarity between
disorders decays at an even higher rate (with the distance
in BDO) because of their coarse grained nature, which has
led to a fairly flat structure of the ontology. The structure
of the ontology, and more concretely its maximum depth
(i.e., 2), has influenced the constant (2) in the exponent of
the formula (lx − 2). The intuition is that concepts that
belong to the same group, i.e., they are at the second level
in the hierarchy and the distance between them is 2 (via
the LCA), should receive the highest similarity, after the
exact match.
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Semantic support
Given a knowledge base and an itemset, our goal is to
automatically derive a score that indicates the proportion
of transactions in the knowledge base that contain the
itemset at a semantic level, thus going beyond the exact
matching methods traditionally used for this task. This
needs to take into account the relations between items.
We attempt to model the semantic support of an item-
set as a function of the semantic similarity of the terms
present in the knowledge base and the itemset.
If we consider a database T with n transactions
{t1, t2, . . . , tn} and m items {i1, i2, . . . , im}, Semantic Sup-
port of {i1, i2, . . . , ip} (p ≤ m) is calculated as follows:
SemSupport(i1, i2, . . . , ip) = 1n ∗
n∑
q=1
p∏
j=1
argmax
v=1to|tq|
||SemSim(ij , iv)||
(12)
The value of the Semantic Similarity (SemSim) ranges
from 0 to 1 and so does the value of the Semantic Support.
Semantic interestingnessmeasures
Semantic interestingness measures take into account how
data items are semantically related. To do so, it makes use
of the underlying structure of the ontology that hosts the
corresponding items (e.g. generalisation, specialisation,
etc). Hence, if we replace the traditional Support element
in the confidence calculation with Semantic Support we
get Semantic Confidence. The same process can be applied
for the other well-known interestingness measures, such
as lift, conviction, etc. Below we list the corresponding
semantic calculation for thesemeasures for an association
rule IX → Q.
SemConfidence(IX → Q) = SemSupport(IX ,Q)SemSupport(IX ) (13)
SemLift(IX → Q) = SemConfidence(IX ,Q)SemSupport(Q) (14)
SemConviction(IX → Q) = 1− SemSupport(Q)1 − SemConfidence(IX → Q)
(15)
SemLeverage(IX → Q) = SemSupport(IX ,Q)
− SemSupport(IX ) ∗ SemSupport(Q)
(16)
SemJaccard(IX → Q)
= SemSupport(IX ,Q)SemSupport(IX ) + SemSupport(Q) − SemSupport(IX ,Q)
(17)
SemCosine(IX → Q) = SemSupport(IX ,Q)√SemSupport(IX) ∗ SemSupport(Q))
(18)
SemCorrelationCoeff (IX → Q)
= SemLeverage(IX → Q)√
S Supp(IX)∗S Supp(Q)∗(1− S Supp(IX) ∗ (1− S Supp(Q))
(19)
S Supp in Eq. 19 denotes Semantic Support.
Experimental design
We have carried out a series of experiments with the
following goals:
• Firstly, we aim to analyse the accuracy of the
resulting association rules when using existing
traditional interestingness measures;
• Secondly, we are interested in finding out the same
accuracy, but when using the proposed semantic
interestingness measures;
• Finally, we aim to observe the difference between the
accuracies produced via the two methods.
The quality of discovered rules depends on their ability to
determine the correct diagnosis. Tomeasure accuracy, we
have employed a voting strategy, which is described below.
The purpose of evaluating the discovered rules is to
understand the utility of the interestingness measures.
Voting allows all firing association rules to contribute to
the final prediction. This strategy combines the associ-
ations KF( px) that fire upon a new patient case px. A
simple voting strategy considers all the rules in KF( px),
groups the rules by antecedent, and for each antecedent
IX obtains the class corresponding to the rule with high-
est confidence. We will denote the class voted by an
antecedent Ii with a binary function vote(Ii, bd) that takes
the value 1 when Ii votes for disorder bd, and 0 for the any
other class – {bdn1, bd2, . . . , bdn} ∈ BD represent a set of
bone dysplasias. The disorder that receives the maximum
vote is the most probable diagnosis for patient case x.
TotalVote(bdi) =
∑
Ii∈antecedents(KF(px))
Vote(Ii, bdi) (20)
Weighted voting is similar to simple voting, however,
each vote is multiplied by a factor that quantifies the qual-
ity of the vote. In the case of association rules, this can be
done using one of the above defined measures.
TotalVote(bdi) =
∑
Ii∈antecedents(KF(px))
Vote(Ii , bdi) ∗QVote(Ii , bdi)
(21)
In our case, QVote(Ii, bdi) is the quality of vote, or more
concretely themaximum interestingness of that particular
antecedent group.
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We have performed individual experiments for each of
the interestingness measures previously described, using
the voting strategy. To assess their efficiency, we have
calculated the overall accuracy of the discovered associa-
tion rules. In all experiments, we compute the prediction
accuracy as the overall percentage of correctly predicted
disorders at a given recall cut-off point (i.e., by taking into
account only the top K predictions for different values of
K, where K is the recall cut-off point). Hence, a success
represents a correctly predicted disorder (the exact same,
and not a sub or super class of it), while a miss represents
an incorrectly predicted disorder. If N is the total number
of test cases and CP is the number of correctly predicted
disorders, then Accuracy = CP/N . This is expressed in
percentages in Tables 1, 2 and 3 in the Results section.
As mentioned earlier in the manuscript our annotated
dataset consisted of over 300 patience cases, with the clin-
ical features annotated using HPO and the disorders using
BDO. In order to provide an accurate view over the pre-
diction of the discovered rules, each experiment has been
performed as a 5-fold cross validation with an 80-20 split
(80% knowledge base, 20% test data). Tables 1, 2 and 3 lists
the resulted average accuracy at five different recall cut-off
points.
Within each experiment, we have used a relatively low
minimum Support of 5/N , where N is the total number
of cases, because we are interested in extracting both fre-
quent and occasional associations. Every rule was able to
contribute to the voting. Controlling the number of rules
using any minimum interestingness threshold can bias
the voting and hence, the overall result. Consequently, we
have not used this parameter to control the number of
rules. Finally, we have used a maximum itemset size of 10
as the computational cost increases exponentially with the
itemset size in the association rule mining process.
Results
In this section we present and discuss the experimental
results achieved using traditional and semantic interest-
ingness measures. We start with the semantic similarity
proposed in the previous sections and then compare its
results against a series of classic semantic similarity mea-
sures.
Proposed semantic similarity metric
In order to observe the quality improvements brought
by semantic interestingness measures over the traditional
ones, we have evaluated the discovered rules against real
world patient data. As already mentioned, we performed
two sets of experiments. Firstly, we have compared and
evaluated different traditional interestingness measures.
Then, we performed the same experiment but by using
semantic interestingness measures. This has enabled us to
perform an overall comparison between the two types of
measures.
Table 1 lists the experimental results for the traditional
measures. A first observation is that Confidence has the
overall best behaviour. At any recall cut-off point greater
than 2 (K > 1) Confidence outperforms or scores simi-
larly to the other measures. For example, it achieves an
accuracy of 46.58% for K = 2 and 53.42% for K = 3, both
with 1.37% higher than the second scoring measure, Jac-
card. The only exception appears for K = 1, where Jaccard
outperforms Confidence by 2.74%. A second, interesting,
observation is that with the increase in the recall cut-off
point, the measures reach a common ground, and hence,
achieve the same performance – for K = 5, six of the seven
measures score the same accuracy (57.53%).
Each of the measures we have considered in our exper-
iments studies certain properties of the data. Conse-
quently, the above-listed results enable us to reach a
better understanding of the underlying nature of the rela-
tionships manifested by the data in our bone dysplasia
annotated dataset. For example, Confidence measures the
level of causality (implication), while Jaccard measures the
degree of overlap among the given sets, or in our cases
patient phenotypes. This leads to the conclusion that the
bone dysplasia data seems to be governed more by causal-
ity and overlap, rather than, for example, co-occurrence,
which is described by Lift.
Table 1 Experimental results on finding the quality of association rules, discovered using traditional interestingness
measures
Traditional Accuracy Accuracy Accuracy Accuracy Accuracy
interestingness measures K = 1 K = 2 K = 3 K = 4 K = 5
Confidence 28.77 46.58 53.42 54.79 57.33
Lift 26.03 36.99 42.47 49.32 57.53
Conviction 28.77 43.84 46.58 49.32 57.53
Correlation coefficient 27.40 36.99 45.21 52.05 57.53
Cosine 28.76 43.84 49.31 54.79 58.90
Jaccard 31.51 45.21 52.05 54.79 57.53
Leverage 24.66 35.62 46.58 54.79 57.53
The voting strategy has been used as classification method and the association rules have been used as background knowledge.
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Table 2 Experimental results on finding the quality of association rules, discovered using semantic interestingness
measures
Semantic Accuracy Accuracy Accuracy Accuracy Accuracy
Interestingness measures K = 1 K = 2 K = 3 K = 4 K = 5
Semantic confidence 31.51 49.32 57.53 61.64 64.38
Semantic lift 27.40 38.36 47.95 57.53 61.64
Semantic conviction 32.88 43.84 53.42 56.16 58.90
Semantic correlation coefficient 23.29 38.36 45.21 57.53 64.38
Semantic cosine 31.51 47.95 52.05 57.53 61.64
Semantic jaccard 34.25 46.58 56.16 61.64 64.38
Semantic leverage 26.02 36.99 53.42 58.90 63.01
The voting strategy has been used as classification method and the association rules have been used as background knowledge.
Table 2 lists the experimental results for the semantic
interestingness measures. We can easily observe that the
results follow the same trend as in the previous exper-
iment. Semantic Confidence has, again, an overall best
behaviour for K > 1, outperforming Semantic Jaccard with
1.37% for K = 2 (49.32%) and K = 3 (57.53%) and achieving
the same accuracy for K = 4 (61.64%) and K = 5 (64.38%).
Semantic Jaccard achieves a better accuracy for K = 1,
i.e., 34.25%, with 2.74% higher than Semantic Confidence.
Finally, as in the previous experiment, we observe that the
increase in the recall cut-off point leads to a more uniform
accuracy across all measures, although slightly less aligned
as they do not achieve the exact same accuracy.
A comparative overview of the two types of measures is
presented in Table 3, where we can observe that semantic
measures achieve better results than the traditional ones.
Furthermore, the increase in the recall cut-off point leads
to a bigger difference in accuracy, from 2.74% for K = 1 to
6.85% for K = 5.
The main reason behind the increase in accuracy is the
use of similarity matching between terms. For instance,
an ESDN patient diagnosed with Achondroplasia had the
following phenotypes: Rhizomelic short stature,Muscular
hypotonia, Hypoplasia involving bones of the extremities
andMalar flattening. The classifier using traditional con-
fidence measures was not able to classify correctly this
case, while the classifier using semantic confidence did.
The semantic similarity employed by the latter found
an association between Rhizomelic short stature and
Achondroplasia based on the more generic Short stature
phenotype, which is common in Achondroplasia. This
Table 3 Comparative overview of the experimental results
achieved by the traditional and semantic interestingness
measures
Interestingness Accuracy Accuracy Accuracy Accuracy Accuracy
measures K = 1 K = 2 K = 3 K = 4 K = 5
Traditional 28.77 46.58 53.42 54.79 57.53
Semantic 31.51 49.32 57.53 61.64 64.38
represents a clear example where the exact matching used
by traditional classifiers fails. Another similar instance
was in the case of a MED patient that exhibited the
following phenotypes: Pes planus (i.e., flat feet), Rhi-
zomelic shortening and Frontal bossing. As in the previous
example, the classifier using traditional confidence failed
to classify this instance correctly, while the one using
semantic confidence did, based on the semantic similar-
ity between Pes planus and the diverse feet abnormalities
that characterise MED.
In order to have an accurate view over the classifica-
tion results, we have checked the statistical significance
of the increase in accuracy at recall cut-off point 5. The
purpose of this statistical significance testing was to assess
the performance of the classification using semantic rules
against the performance of the classification using tradi-
tional rules, both on the ESDN dataset. Such a test would
validate the observed increase in accuracy of 6.85% and
would show that it has not been obtained by chance.
Since the comparison is between two different
approaches on a single domain (skeletal dysplasias), we
have used the McNemar’s Chi-squared test with conti-
nuity correction [22]. The null hypothesis was that the
number of patient cases correctly classified by the classi-
fier using semantic confidence but not by the one using
traditional confidence is equal to the number of patient
cases correctly classified by the classifier using traditional
confidence but not by the one using semantic confidence.
Table 4 shows the distribution of the 394 patient cases
used in our experimental classification setting: (i) 205
patient cases were correctly classified by both classifiers;
(ii) 118 patient cases were misclassified by both classifiers;
(iii) 51 patient cases were correctly classified using seman-
tic confidence; and (iv) 20 patient cases were correctly
classified using traditional confidence. From this data, the
McNemar test statistic with continuity correction is:
χ2McNemar =
(|51− 20| − 1)2
51+ 20 = 12.67 (22)
Paul et al. Journal of Biomedical Semantics 2014, 5:8 Page 10 of 13
http://www.jbiomedsem.com/content/5/1/8
Table 4 Distribution of classification results in the
McNemar’s statistical significance test
Semantic confidence based
classifier
Positive Negative Total
Traditional confidence
based classifier
Positive 205 20 225
Negative 51 118 169
Total 256 138
A McNemar test value of 12.67 corresponds to a p-
value of 0.00037157, which provides strong evidence to
reject the null hypothesis. We can, hence, conclude that
the semantic interestingness measures we have proposed
are able, with the help of the underlying domain ontolo-
gies, to take advantage of the similarity matching between
the terms in the skeletal dysplasia domain.
Classic semantic similarity metrics
In order to understand the role carried by the semantic
similarity metric in the classification based on semantic
interestingness we have experimented with three classic
semantic similarities, defined earlier in the paper: Resnik,
Lin and Wu & Palmer. The results achieved by each of
these metrics are discussed below.
Table 5 lists the experimental results achieved by the
semantic interestingness measures employing Resnik as
semantic similarity. A first observation is that all measures
have performed uniformly, while from a comparative per-
spective, they performed worse than exact matching and
our proposed semantic similarity method. As in the previ-
ous experiments, we observe that the increase in the recall
cut-off point leads to a more uniform accuracy across
all measures. The Resnik semantic similarity method is
primarily dependent on the frequency of the most infor-
mative common ancestors. If any of the ancestors does not
exist in the corpus, the similarity value becomes infinity,
i.e., the concepts under scrutiny are completely dissimilar.
In the case of our dataset, this is the main issue behind
the failure of the Resnik semantic similarity – being a
real-world dataset, most patient cases will feature con-
crete (very specific) phenotypes, while common ancestors
represent more generic/abstract concepts rarely found in
clinical summaries. For example, the semantic similarity
of Dolichocephaly and Full cheeks is ∞, due to the fact
that the frequency of all their ancestors (Abnormality of
the head, Abnormality of head and neck and Phenotype
abnormality) in the patient cases is 0.
The experimental results for the semantic interesting-
ness measures using the second semantic similarity –
Lin – have led 0% accuracy on all measures and all five
recall cut-off points – consequently we have have included
them in a table. As in the case of Resnik, Lin is also heavily
dependent on the IC of the common ancestors, and hence
suffers from the same issue discussed above. Another
problematic aspect of the Lin measure is that, in the con-
text of the ESDNdata, it assigns higher similarity values to
partial matches than to exact matches. A similarity value
of 1 is achieved when the concepts being measured are
the exact same – e.g., Short long bones. However, when
the concepts are different and any of their ancestors is
present in the underlying corpus, the similarity value will,
usually, be greater than 1. This is because the frequency
of the ancestors (more abstract concepts) will be less than
the frequency of the actual concepts and IC is inversely
proportional to frequency.
For instance, the semantic similarity value between
Macrocephaly and Hypoplasia involving bones of the
extremities is 2.19 because the frequency of their most
informative common ancestor – Abnormality of the skele-
tal system is less than that of both concepts. The latter
occurs only 5 times in the corpus whereas Macrocephaly
andHypoplasia involving bones of the extremities occur 41
and 70 times, respectively. The Resnik measure is able to
avoid this issue by treating exact and partial matches in the
samemanner – i.e., directly and only via the IC of themost
informative common ancestor and not by further diving it
by the IC of the actual concepts. In an ideal scenario, exact
matches should assign higher similarity values that partial
matches.
Table 5 Experimental results on finding the quality of association rules discovered using semantic Interestingness
measures that employed Resnik as semantic similaritymethod
Semantic interestingness measures Accuracy Accuracy Accuracy Accuracy Accuracy
(Employing Resnik) K = 1 K = 2 K = 3 K = 4 K = 5
Semantic confidence 5.48 6.85 9.59 10.96 10.96
Semantic lift 5.48 8.22 9.59 9.59 10.96
Semantic conviction 2.74 6.85 9.59 9.59 10.96
Semantic correlation coefficient 5.48 8.22 9.59 9.59 10.96
Semantic cosine 5.48 8.22 9.59 10.96 10.96
Semantic jaccard 5.48 8.22 9.59 9.59 10.96
Semantic leverage 5.48 8.22 9.59 9.59 10.96
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Finally, Table 6 lists the experimental results for the
semantic interestingness measures using the last seman-
tic similarity – Wu & Palmer. We can observe that
the results follow fairly closely the trend present in our
experiments with the traditional interestingness mea-
sures and the semantic interestingness measures employ-
ing our proposed metric. Similarly to those results,
there is an increase in accuracy with the increase in
the recall cut-off point, which also leads to a more
uniform accuracy across all measures. Semantic Con-
fidence has an overall best behaviour for K > 1,
while Semantic Leverage achieves a better accuracy for
K = 1, i.e., 23.29%, with 2.74% higher than Semantic
Confidence.
TheWu & Palmer similarity score ranges between 0 and
1, with 1 denoting an exact match and the rest of the val-
ues being assigned based on the depth in the hierarchy and
distance between the concepts. This is the main reason
behind its good performance – i.e., it uses only struc-
tural distances instead of information content. It is, how-
ever, biased more towards depth than the actual distance
between concepts, or more concretely it is influenced by
the depth of the common ancestor of the concepts. In
the case of out dataset, and using HPO as background
knowledge, this represents an issue because most com-
mon ancestors are located at fairly uniform depths (due
to the inherent specificity of the terms) and, as such,
do not provide enough variety for the final similarity
score.
In conclusion, none of the classic semantic similari-
ties perform better than the approach we have proposed:
node-based similarities are heavily influenced by the pres-
ence, or more precisely absence, of the common ancestor
in the dataset (which leads to complete dissimilarity),
while the edge-based similarity we have experimented
with focuses more on the depth of the common ancestor,
as opposed to the distance between the concepts, which
is more appropriate given our dataset and background
knowledge.
Discussion and conclusions
Main findings
In conclusion, based on the annotated bone dysplasia
dataset, Confidence appears to be the best interesting-
ness measure regardless of way in which is computed, i.e.,
traditional or semantic. The use of semantics provides a
marginal, but consistent, improvement in accuracy over
traditional measures. Since the semantic similarity relies
on the structure of the underlying ontology, this improve-
ment is heavily dependent on the reflection provided by
the domain ontology over the real domain knowledge.
Limitations and generalisation
Every domain is governed by a set of rules. A good seman-
tic similarity measure needs to take into account the
rules of the target domain. In our case, we have pro-
posed and used two particular similarity measures, one
tailored on the knowledge externalised by HPO and one
on the structure of bone dysplasias, provided by BDO.
These semantic similarity measures are not necessarily
directly applicable to other domains. Consequently, while
the definition of semantic support is generic, in order to
apply our approach in a different domain, an investigation
is required to determine the most appropriate semantic
similarity for that domain.
Relatedwork
The literature contains a number of studies on using
association rule mining to identify relationships among
medical attributes using biomedical ontologies [23-26].
Kumar et al. [23] used association rules to indicate
dependence relationships between Gene Ontology terms
using an annotation dataset and background knowl-
edge. Myhre et al. [24], on the other hand, have focused
entirely on proposing an additional gene ontology layer
via discovering cross-ontology association rules from GO
annotations. However, none of these approaches use the
biomedical ontologies and, in particular, their hierarchical
structure to compute interestingness measures. Another
Table 6 Experimental results on finding the quality of association rules discovered using semantic Interestingness
measures that employedWu & Palmer as semantic similaritymethod
Semantic interestingness measures Accuracy Accuracy Accuracy Accuracy Accuracy
(EmployingWu and Palmer) K = 1 K = 2 K = 3 K = 4 K = 5
Semantic confidence 20.55 35.62 36.99 42.47 54.79
Semantic lift 13.70 26.03 28.77 39.73 52.05
Semantic conviction 16.44 24.66 26.03 34.25 52.05
Semantic correlation coefficient 20.55 28.77 32.88 39.73 43.84
Semantic cosine 21.92 32.88 34.25 42.47 54.79
Semantic jaccard 20.55 35.62 38.36 41.10 54.79
Semantic leverage 23.29 30.14 32.88 38.36 45.21
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set of existing research on applying association rule min-
ing to biomedical ontologies includes studies on mining
single level, multi-level and cross-ontology association
rules [27-29]. Carmona-Saez et al. [27], for example, mine
single level associations between GO annotations and
expressed genes from microarray data integrated with
GO annotation information. However, as in the previous
case, the inherent information provided by the ontology
structure is not considered when computing the interest-
ingness measures, and hence limit, to some extent, the
knowledge discovered.
Interestingnessmeasures play an essential role by reduc-
ing the number of discovered rules and retaining only
those with the best utility, in a post-processing step. Dif-
ferent rule interestingness measures have different qual-
ities or flaws. There is no optimal measure and one way
to solve this challenge is to try to find a good compro-
mise. Research has been performed on finding optimal
measures for different datasets [8,9], but by taking into
account only traditional interestingness measures.
In summary, prior efforts in association rule mining
applied to datasets annotated with biomedical ontology
concepts focus on mining normal, cross-ontology and
multi-level association rules, but leave out the use of the
semantic relationships between the target concepts from
the computation of the interestingness measures.
Conclusion
Concepts defined and described by biomedical ontologies,
e.g., the Human Phenotype Ontology, enable us to com-
pare medical terms at a semantic level – a comparison
that is otherwise not possible. Our research has focused
on the use of semantic relationships between patient phe-
notypes, annotated by HPO entities, in the process of
mining association rules. In this manuscript, we have pro-
posed a method that integrates concept similarity metrics
into the computation of traditional interestingness mea-
sures, with application to finding association rules in the
bone dysplasia domain. This method has been applied on
an annotated patient dataset and used domain-specific
semantic similarities.
Experimental results have led to the conclusion that, for
our domain, Confidence is the most accurate measure,
independently on the underlying computation method,
i.e., traditional or semantic. On the other hand, Semantic
Confidence was able to take advantage of structure of the
domain ontologies and of the custom semantic similarity
to achieve better results (up to 6.85% better accuracy
over the traditional Confidence). In conclusion, these
results suggest that, given an appropriate domain-specific
ontology, semantic similarities are able to improve the
efficiency of traditional interestingness measures in the
association rule discovery process, hence enabling a
valuable semantic interestingness measures framework.
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5.3 Discussion and Implications of Findings 
This chapter presented an original approach for discovering semantic similarity-based association 
rules. The methodology details how to combine semantic similarities with traditional 
interestingness measures to compute semantic interestingness measures in the process of association 
rule mining. The experimental results showed that compared to traditional interestingness measures, 
such as Confidence, Lift, Conviction, Correlation Coefficient, Cosine, Jaccard and Leverage, the 
proposed semantic interestingness measures (i.e., Semantic Confidence, Semantic Lift, Semantic 
Conviction, Semantic Correlation Coefficient, Semantic Cosine, Semantic Jaccard and Semantic 
Leverage) achieve a consistent improvement in accuracy, which ranges from an increase of 1.37% 
(for Semantic Conviction) to an increase of 7.05% (for Semantic Confidence). More concretely, the 
best scoring traditional measure (Confidence) achieved an accuracy of 57.33%, while the best 
scoring semantic measure (Semantic Confidence) achieved an accuracy of 64.38%. 
The results described above show that semantic similarity-based approaches should be the preferred 
method for computing interestingness measures, provided that appropriate domain-specific 
semantic similarity measures are employed. This research component satisfies the third objective of 
this thesis (listed in Sec. 1.4): “Combine concept similarity metrics, formulated using the intrinsic 
structure of domain ontologies, with traditional interestingness measures to compute semantic 
interestingness measures in order to discover association rules in the skeletal dysplasia domain”, as 
well as provides a response to the research question: “How can the relationships among the 
concepts of the skeletal dysplasia domain be leveraged in the process of association rule mining?” 
Since the semantic similarity measure relies on the structure of the underlying ontology, this 
improvement is heavily dependent on the ability of the domain ontologies (HPO and BDO) to 
precisely and comprehensively capture the real domain knowledge.  
A number of past studies have employed association rule mining to identify associations among 
medical attributes using biomedical ontologies [39, 83-85]. However, none of these studies use the 
semantic relationships between the target concepts of the biomedical ontologies and, in particular, 
their hierarchical structure (superclass and subclass relationships) to compute interestingness 
measures. In these previous studies, the inherent information provided by the ontology structure is 
not considered when computing the interestingness measures, and hence the potential knowledge 
discovery is limited. 
As semantic similarity relies on the structure of the underlying domain ontology (e.g., the Human 
Phenotype Ontology), so does the accuracy of computational approaches employing these semantic 
similarities. HPO has been constructed using the clinical synopses defined by the Online Mendelian 85  
Inheritance in Man knowledge base [72], and to date, no experiment has been conducted to 
determine the accuracy of the phenotypic information captured in the corresponding disorder 
descriptions. Hence, a critical open challenge is to identify those phenotypes that are characteristic 
of each disorder both from a general, as well as from a differential diagnosis perspective. For 
example, some phenotypes might always be present in a particular disorder, whilst other phenotypes 
are only sometimes present in that disorder. Of those phenotypes that are always present, if they 
rarely occur in other disorders or rarely occur in combination with other phenotypes in other 
disorders – then they are characteristic phenotypes that are significant in making a diagnosis. The 
next chapter of the thesis investigates optimum methods for defining these characteristic phenotypes 
and proposes an innovative method to discover such features from patient data.  
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Chapter 6: Characteristic Feature Mining via Class 
Association Rules 
6.1 Introduction 
A characteristic feature represents a single phenotype or a set of phenotypes that define a particular 
disorder and enable the differentiation of this disorder from others. For instance, {short stature, 
osteoarthritis} is a characteristic feature of diastrophic dysphasia. The characteristic features of a 
disorder represent a key aspect in the diagnosis process in the skeletal dysplasia domain. This 
chapter details the fourth phase of the decision support framework and focuses on discovering 
characteristic features from past patient cases via a novel class association rule mining approach. As 
such, the work described in this chapter closes the loop of the phenotype-disorder lifecycle and 
addresses the final objective of the thesis - by generating a ranked list of characteristic 
features/phenotypes for a given disorder through analysis of the available corpus of raw data. 
This paper begins by providing a definition of “characteristic features”. It then describes the actual 
algorithm used to identify characteristic features. The proposed algorithm takes advantage of the 
fact that the dataset is labelled, i.e., every data row has a class attribute, as opposed to traditional 
association rule mining approaches (e.g., Apriori [86], FP-growth [87], Eclat [88] ) that are 
designed for unlabelled data. For example, this approach begins by modelling patient cases as data 
rows in the form {short stature, short arms, clinodactyly, osteoarthritis, diastrophic dysplasia}, 
where diastrophic dysplasia is the class attribute. It then filters and ranks those phenotypes that are 
discriminative, and thus characteristic for the given disorder (class). A novel class association 
mining algorithm is developed - that combines the confidence interestingness measure (to model the 
discriminative aspect of characteristic features) with a new measure (commonality) for pruning and 
finding class-based common features. 
The work presented in the next section has been published as a manuscript in the peer-reviewed 
“Journal of Biomedical Informatics” in 2013 [89] . 
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6.2 Journal 3 - Inferring Characteristic Phenotypes in the Bone 
Dysplasia Domain 
R. Paul, T. Groza, J. Hunter, and A. Zankl, "Inferring characteristic phenotypes via class association 
rule mining in the bone dysplasia domain," Journal of Biomedical Informatics, vol. 48, p. 73-83, 
2014. 
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Finding, capturing and describing characteristic features represents a key aspect in disorder definition,
diagnosis and management. This process is particularly challenging in the case of rare disorders, due
to the sparse nature of data and expertise. From a computational perspective, finding characteristic fea-
tures is associated with some additional major challenges, such as formulating a computationally tracta-
ble definition, devising appropriate inference algorithms or defining sound validation mechanisms. In
this paper we aim to deal with each of these problems in the context provided by the skeletal dysplasia
domain. We propose a clear definition for characteristic phenotypes, we experiment with a novel, class
association rule mining algorithm and we discuss our lessons learned from both an automatic and
human-based validation of our approach.
 2013 Elsevier Inc. All rights reserved.1. Introduction
Finding, capturing and describing characteristic features (or
symptoms) represents a key aspect in disorder definition, diagnosis
and management. In general, such features are directly recognised
by experts via repeated observations in patient cases. On the other
hand, when the disorders are very similar, and share most of their
phenome space, determining discriminative features is done in a
pair-wise differential manner. This process is particularly impor-
tant for rare disorders, as it may provide an initial screening and
diagnosis direction, which could then prove to be vital. However,
the sparse nature of the phenome space in rare disorders, and
the limited number of experts makes this process very difficult.
Hence, identifying characteristic features from existing patient
cases in a (semi-) automatic manner would be highly beneficial
for improving the understanding of and the shared agreement on
the definition and characterisation of rare disorders.
From a computational perspective, these features raise two ma-
jor challenges: (i) defining them in a computationally tractable
way and (ii) devising appropriate algorithms to infer them, by
exploiting their sparse nature. An additional, orthogonal, challenge
is defining a sound validation mechanism that takes into account
both the computational definition as well as the human expert
opinion. In this paper, we describe our experiments and lessonslearned from inferring characteristic features in the bone dysplasia
domain.
Skeletal dysplasias [1] are a heterogeneous group of genetic dis-
orders affecting skeletal development. Currently, there are over
450 recognised such disorders, structured in 40 groups. Patients
with bone dysplasias have complex medical issues including skel-
etal deformations, impaired development and neurological compli-
cations. Since most skeletal dysplasias are very rare (<1:10,000
births), data on clinical presentation, natural history and best man-
agement practices is sparse. Another reason for data sparseness is
clinical variability, i.e., the small number of clinical features typi-
cally exhibited by patients from the large range of possible pheno-
typic and radiographic characteristics usually associated with
these disorders. Due to the rarity of these conditions and the lack
of mature domain knowledge, correct diagnosis is often very diffi-
cult. In addition, only a few centres worldwide have expertise in
the diagnosis and management of these disorders.
Different research groups around the world have, over time,
built small patient registries that are neither open nor interopera-
ble. In 2002, the European Skeletal Dysplasia Network (ESDN,
http://www.esdn.org/) was created to alleviate, at least partly,
the data sparseness issue, and at the same time to provide a collab-
orative environment to help with the diagnosis of skeletal dyspla-
sias and to improve the information exchange between
researchers. To date, ESDN has gathered over 1200 patient cases,
which have been discussed by its panel of experts.
We have used the data acquired by ESDN to study a set of bone
dysplasias with the above-mentioned goal of designing an
74 R. Paul et al. / Journal of Biomedical Informatics 48 (2014) 73–83approach to automatically infer characteristic phenotypes. The
high degree of subjectivity makes the understanding and capturing
of the attributes that define such phenotypes problematic even for
human experts. Hence, in order to provide a computationally trac-
table definition for them, we have considered a characteristic fea-
ture to be one that is (i) frequent for the disorder under scrutiny,
i.e., its absence would rule out the current disorder and (ii) rare
in other closely-related disorders, i.e., specific or discriminative
for the current disorder. As a side remark, a feature is called patho-
gnomonic for a disease if it identifies that disease beyond any
doubt. Our ultimate aim is to find the set of features that come
as close as possible to being pathognomonic. Another way of look-
ing at characteristic features is by providing them a probabilistic
interpretation of the form: the presence of feature F increases the
probability of disorder D, or if F then D is more likely. Taking this
probabilistic interpretation a step further allows us to map the pro-
cess of inferring characteristic features to the problem of discover-
ing class associations in the data mining field [2–4].
Association rules [5] provide knowledge in the form of probabi-
listic ‘‘if-then’’ statements. The head of the association rule (i.e., the
if part) is called antecedent, while the body (i.e., the then’’ part) is
called consequent. The antecedent and consequent of an associa-
tion rule are disjoint: they do not have any items in common. To
express the uncertainty in association rules, two measures are
used: support and confidence. Support represents the number of
transactions that include all items in the antecedent and conse-
quent, and confidence is the ratio between the number of transac-
tions that include all items in the consequent, as well as in the
antecedent (namely, the support) and the number of transactions
that include all items in the antecedent. A set of association rules
for the purpose of classification is called class association rule
set. A class association rule set is a subset of association rules with
the specified classes as their consequents.
Over the course of last decade, the database community inves-
tigated the problem of rule mining with the specified classes as
their consequences extensively, under the name of class or pre-
dictive association rule mining (these rules have the form:
{A1;A2; . . . ;An ! Class}). The aim here is focused on using exhaus-
tive search techniques to find all rules with the specified classes
as their consequences that satisfy various interesting measures,
such as minimum support and minimum confidence. Although
class association rules can be discovered to a certain extent, they
suffer from some drawbacks inherited from association rule min-
ing. Firstly, both traditional and class association rule mining
uses minimum support as an interestingness measure in the fre-
quent itemset generation phase, which is inadequate for unbal-
anced class distribution: if the minimum support is high, class
association miming will not generate sufficient rules for infre-
quent classes, while if the minimum support is too low, class
association mining will generate over-fitting rules for frequent
classes. Secondly, a large number of association rules in the
training dataset will lead to a combinatorial explosion in the
class association mining algorithms, which in turn, will not be
able to generate rules that are important for the purpose of
classification.
In our medical context, class association rule mining algorithms
can be used to discover top K associations of the above mentioned
form, where {A1;A2; . . . ;An} would be features/phenotypes and
Class would be the disorder. However, due to the above listed rea-
sons, these are not able to deal with characteristic features as per
our definition. In this paper, we propose a novel class association
mining algorithm that exploits an established interestingness mea-
sure – confidence – to model the discriminative aspect of charac-
teristic features in conjunction with a new measure for pruning
and finding class-based frequent features, hence addressing the
first requirement of the definition of characteristic features.Experimental results show that, based on a voting strategy clas-
sification evaluation, our proposed approach achieves a 3–10% in-
creased accuracy when compared to traditional class association
rule mining (from 30.94% to 47.50% against 27.04–37.24%), both
subject to the recall cut-off point. In fact, our approach is able to
discover more accurate characteristic features with an accuracy
growth of 27.55%, a precision growth of 63.64% and a recall growth
of 27.68% at recall cut-off point 5. Human-based validation, on the
other hand, shows a positive correlation between the features
deemed to be discriminative in a pair-wise disorder context and
the pair-wise sensitivity and specificity of that disorder.2. Materials and methods
2.1. Data characteristics
As mentioned previously, we have used the ESDN patient repos-
itory within our experiments. This consists of more than 1200 pa-
tient cases collectively acquired and discussed. The ESDN case
workflow comprises three major steps: (i) a patient case is up-
loaded and an initial diagnosis is set by the original clinician that
referred the case – patient cases contain a free text clinical sum-
mary and associated X-rays; (ii) the panel of experts discusses
the case until an agreement is reached; and (iii) the panel of ex-
perts recommends a diagnosis.
In ESDN, each patient case includes a free text description of the
clinical features, the relevant family history and a set of radio-
graphic (X-ray) images. The free text clinical summary comprises
all observed and relevant phenotypes of the patient, which can
usually be validated via the radiographic images. The ESDN experts
use this information to discuss possible diagnoses, and once an
agreement is reached, the case receives a final diagnosis and is
closed. The approach described in this paper uses ESDN’s unique
source of data for training and testing purposes. More specifically,
we extracted clinical features from 1281 patient clinical summa-
ries and recorded the initial and final diagnoses.
Since ESDN clinical summaries are in a free text format, they
pose obvious challenges when aiming for efficient and automated
knowledge discovery. Using the NCBO Annotator [6] and the
Human Phenotype Ontology (HPO) [7] as background knowledge,
we have performed automated concept extraction from the free
text and defined phenotype feature sets for all patient cases. These
extracted feature sets have then been used as input for knowledge
discovery process. In order to get a better understanding of the
concept recognition process, we refer the reader to Jonquet et al.
[6].
More concretely, we have performed two data preprocessing
steps. Firstly, we extracted patient phenotypes by annotating the
text with corresponding terms from the Human Phenotype
Ontology (HPO). In recent years, phenotype ontologies have been
seen as an invaluable source of information, which can enrich
and advance evolutionary and genetic databases [8]. HPO is
currently the most comprehensive source of such information,
comprising more than 10,000 terms organised in a hierarchical
structure based on the anatomical localisation of the abnormality.
The actual annotation process was performed using the NCBO
Annotator [6], an ontology-based web service for annotation of
textual sources with biomedical concepts. The annotation of a
clinical summary resulted in a set of HPO terms. These have then
been manually validated by a bone dysplasia expert, which led to
a 100% correctness of the data used as input in our algorithm. Fur-
thermore, to increase the processing speed, we have transformed
both the HPO concepts, as well as the bone dysplasia diagnoses
into a symbolic vector. For example, short stature is mapped to
S1, cleft palate to S2, Achondroplasia to D1, and so on. The symbolic
Table 1
Distribution of cases per disorder in the dataset used within our experiments.
Bone dysplasia Number of cases
Achondroplasia 14
Cartilage-Hair-Hypoplasia 28
Cleidocranial dysplasia 10
Diastrophic dysplasia 11
Hypochondroplasia 22
Kniest dysplasia 14
Metaphyseal dysplasia, Schmid type 17
Multiple epiphyseal dysplasia 88
Osteogenesis Imperfecta 16
Osteopetrosis 11
Pseudoachondroplasia 44
rMED 20
Spondyloepiphyseal dysplasia congenital 71
Stickler syndrome 12
Thanatophoric dysplasia 16
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ture mining process. Each symbolic vector is also labelled with a
disorder (class).
The ESDN dataset features 114 different types of skeletal dys-
plasias. The result of the preprocessing phase enabled us to per-
form a quantitative and qualitative analysis of the data. Firstly,
we have found that the patient cases are not evenly distributed,
i.e., less than half of the disorders had more than two cases. This
has serious implications on any data mining algorithm as the gen-
eral tendency will be to give preference to those disorders (classes)
that are better represented. Fig. 1 shows the relative distribution of
disorders according to the number of cases. It can be observed that
70% of the bone dysplasias have a very small number of cases (i.e.,
1–2 or 3–5) and only 4% of the disorders are very well represented,
i.e., they have more than 50 cases.
Secondly, by looking at the coverage of the clinical features, we
have found (as expected) that the data is sparse. The coverage of a
single feature can be defined as the percentage of cases diagnosed
with a particular dysplasia in which this phenotype is present. For
example, cystic hygroma has coverage of 50% in case of Achondro-
genesis type 1A because it appears in 2 of total 4 cases diagnosed
with this disorder. As a remark, we excluded from our analysis
all cases that had listed a single phenotype. The maximum cover-
age achieved was 50% (e.g., subglottic stenosis), while the minimum
was 0.99% (e.g., immunodeficiency). The average coverage was
11.33%, with a median of 8% and a mode of 0.99%. This exhibits
the high sparsity of the data.
In order to achieve realistic results in our algorithm, from the
114 types of dysplasias present in the ESDN dataset, we chose only
those that were represented by more than 10 patient cases. This
has reduced our dataset to 394 annotated patient cases diagnosed
with 15 different bone dysplasias (i.e., around 33% of the total
number of cases). These cases are characterised by a total of 441
distinct phenotypes, with an average of 63.67 distinct phenotypes
per disorder and an average of 4.49 distinct phenotypes per case.
The final list of disorders and their associated number of cases is
listed in Table 1.
2.2. Methodology
The goal of our work is to discover a set of key features given a
disorder. More concretely, given a background knowledge base
(i.e., annotated patient dataset) and a disorder, we aim to predict
the top K characteristic features, ranked according to their proba-
bility. This is a classical problem of reasoning on disorder-featureFig. 1. Relative distribution of bone dysplasias according to the number of cases.
More than 84% of the bone dysplasias present in the ESDN dataset have a very small
number of cases (up to 10), while those that are well represented (i.e., over 50
cases) represent a mere fraction of the total number – 4%.associations in which class association rule mining algorithms
are employed. However, since these rely on computing the fre-
quency in the entire knowledge base, instead of using a class
(disorder)-oriented fragmentation, they are unable to satisfy the
first condition specified in our definition for characteristic features,
and hence also the joint presence of both conditions. In order to
comply with our definition, frequency needs to be considered in
the context of a single disorder, i.e., frequency at class/disorder
level. We, hence, propose a novel characteristic features ranking
algorithm that uses a level wise search method to discover the
interesting features.
The exact workflow of our method is listed below: (i) from a
given set of free text clinical summaries, we extract a set of pheno-
types corresponding to each patient case; (ii) these are then
re-grouped according to the underlying diagnosis (disorder) and
used in the process of discovering characteristic features; and
(iii) finally, the resulting features are evaluated against the results
produced by a typical class association mining algorithm.
Given a set of m patient cases: {P1; P2; . . . ; Pm}, each patient case
consisting of n phenotypes and a diagnosed disorder D, our algo-
rithm uses a scoring function SðiÞ to compute the probability of
each phenotype to represent a characteristic feature of the under-
lying disorder D. By convention, we assume higher probabilities/
scores to correspond to more valuable characteristic features. As
per the definition introduced earlier, the scoring function SðiÞ takes
into account, at the same time, two perspectives for each
phenotype: frequency in the context of disorder D and
discriminative power in the context of the other closely-related
disorders.
We employ a measure named Commonality to take into account
the frequency of the feature sets at class/disorder level, rather than
the widely used support, which takes into account the frequency of
the feature sets at the dataset level. The commonality of a pheno-
type set in the context of a particular disorder (class) represents
the number of cases that include all phenotypes in the phenotype
set and the disorder among the total number of phenotypes asso-
ciated with that disorder. In other words, the commonality of a pat-
tern for a class is the ratio between the number of transactions that
include all features in the pattern and the class and the total num-
ber of transactions of that class. If there are n disorder classes
{D1;D2; . . . ;Dn} and p is a set of phenotypes, commonality is defined
using the equation below.CommonalityðpjDiÞ ¼ Total number of cases featuring p in DiTotal number of cases of Di
ð1Þ
This measure is very intuitive when it comes to discovering
characteristic features and it can easily be controlled by experts,
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context of any given disorder. On the other hand, this measure
cannot be computed via standard class association mining algo-
rithms, as they perform support calculation at the dataset level.
To define the second condition of our definition, i.e., discrimina-
tive power, we adapted the confidence measure. The confidence of a
phenotype set in the context of a particular disorder represents the
number of cases that include all phenotypes in the phenotype set
and the disorder in the entire dataset. In other words, the confi-
dence of a feature set for a class is the ratio between the number
of transactions that include the feature set and the class and the to-
tal number of transactions that include the feature set in the entire
dataset. If there are n disorder classes {D1;D2; . . . ;Dn} and p is a set
of phenotypes, confidence is defined using the equation below.
ConfidenceðpjDiÞ ¼ Total number of cases featuring p in DiTotal number of cases featuring p ð2Þ
The following section describes the novel algorithm we have
designed to mine characteristic phenotypes from the ISDS dataset
using the above defined measures.
2.3. The CFML algorithm
In order to discover characteristic phenotypes (class association
rules), CFML (Characteristic Feature Mining algorithm) mines the
training data by performing a class-wise grouping of the pheno-
types that have the confidence over a certain threshold. Since min-
ing is done class-wise, the algorithm will not be influenced by the
uneven class distribution of the dataset. Furthermore, this makes it
highly scalable and efficient, as the candidate generation phase can
be massively parallelized.
Generally, all the algorithms interested in discovering feature
sets in the data make multiple passes over the training set. In
our case, in the first pass, we count the commonality measure of
individual phenotypes in each class and determine which of them
are frequent, i.e., have a minimum commonality. In each subse-
quent pass of a class, we start with a seed set of phenotype sets
(previously found as frequent), generate new potentially frequent
phenotype sets (i.e., candidate phenotype sets) and compute their
commonality. At the end of the pass, we determine which of the
candidate phenotype sets are actually frequent for each class,
and use these as seeds for the next pass. The process stops when
no new frequent phenotype sets are found.
The CFML algorithm is listed in Algorithm 1. The symbols used
in the algorithm are defined below:
 n – number of classes
 K – level number
 G – number of all classes
 gi – class i (a particular class)
 IGK – desired feature sets at level K for all classes G
 IG – desired feature sets for all levels and all classes G
 CGK – candidate feature sets at level K for all classes G
 Cgi;k – candidate feature sets at level K for the class gi
 TG – characteristic feature sets for all classesAlgorithm 1. Discovery of characteristic features
Require: DataRows;min commonality; topK
Ensure: Top ranked characteristic features for each class.
K ¼ 1
IGK = Select all 1-feature_sets with commonality greater or
equal to min commonalitywhile Ik – / do
K++
for all i 2 1 : n do
Cgi;k = Candidate_generation (Igi;k1)
end for
Calculate Class-wise Count (CGK ;DataRows)
IGK = Frequent FeatureSet Selection (CGK ;mincommonality)
IG ¼ IG [ IGK
end while
IG = Measure Confidence Of Frequent Feature Sets (IG)
IG = Rank Features For Each Class (IG)
TG = Select TopK Feature Sets From Each Class (IG; topK)
return TGAlgorithm 2. Candidate_generation
Require: Ik1
Ensure: Candidates.
for all i 2 Ik1 do
for all j 2 Ik1 do
CF ¼ i [ j
if sizeðCFÞ ¼¼ k then
Add to Ck if every subset of CF is frequent.
end if
end for
end for
return CkAlgorithm 3. Calculate Class-wise Count
Require: CGK ;DataRows
Ensure: Count.
for all transaction t in DataRows do
gt = find the class of t
Ct = Find candidates of Cgo;k from the subsets of t
for all c 2 Ct do
CountðcÞ++
end for
end for
return Count
The first pass of the algorithm counts feature occurrences in
each class to determine the frequent 1-featureset of each class. A
subsequent pass, say pass k, consists of two phases. Firstly, the fre-
quent feature sets Igi;k1, mined in the k 1th pass for class g, are
used to generate the candidate feature set Cg;k, using the Candi-
date_generation function (Algorithm 2). This procedure is applied
for every given class. Secondly, the dataset is scanned and the pres-
ence of candidates of each class is counted (Algorithm 3). The com-
monality of each candidate is calculated and the frequent feature
set is constructed based on those candidates that are over a certain
commonality threshold (using the FrequentFeatureSetSelection
method – Algorithm 4). This process continues until there are no
large frequent feature sets left. Once all the frequent feature sets
are discovered, we compute the confidence value of each feature
set (Algorithm 5), we rank the feature sets, sort them in a descen-
dant order and finally return the top K items.
The actual ranking of the features in each class is computed in
the following manner: given two frequent feature sets, Fa and Fb
of a class C; Fa precedes Fb if:
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2. the confidence values of Fa and Fb are the same, but the com-
monality of Fa is greater than that of Fb
3. the commonality and confidence values of Fa and Fb are the
same, but RCðFa;CÞ > RCðFa;CÞ, where RCðF;CÞ is the number
of records of class C that match the conditions of X
4. the confidence, commonality and RC values of Fa and Fb are the
same, but Fa has fewer conditions in its left hand side than of Fb
5. all criteria above are identical for Fa and Fb, but Fa was gener-
ated before Fb.
A novelty of our proposed algorithm is that it generates the can-
didate feature sets of a class in a pass by using only the feature sets
of the particular class found frequent in the previous pass, without
considering the feature sets of other classes in the dataset. The ba-
sic intuition is that any subset of a frequent feature set of a class
must be frequent in that class. Therefore, the candidate feature
set of a class having k features can be generated by joining frequent
feature sets of the same class having k 1 features. This procedure
results in the generation of a very small number of candidate fea-
ture sets.
Algorithm 4. Frequent Feature Set Selection
Require: CGK ;DataRows
Ensure: Frequent feature sets.
IG ¼ fg
for all i 2 1 : n do
for all c 2 Cgi;k do
CommonalityðcÞ ¼ CountðcÞ 2 giTotal number of transactions ingi
if CommonalityðcÞ >¼ min commonality then
Add to c to IG
end if
end for
end for
return IGAlgorithm 5. Measure Confidence Of Frequent Feature Sets
Require: IG
Ensure: Confidence of Frequent feature sets.
I ¼ fg
for all k 2 1 : sizeðIGÞ do
for all i 2 1 : n do
for all f 2 Igi;k do
Confidenceðf Þ ¼ Countðf Þ 2 giCountðf Þ in all groups
end for
end for
end for
return ITable 2
Experimental results: CFML vs. traditional class association rule mining (CARM).
Algorithm Accuracy@1 (%) Accuracy@2 (%)
CFML 30.95 40.33
CARM 27.04 33.39
Growth (%) 14.42 20.782.4. Experimental setting
The quality of discovered characteristic features depends on
their ability to determine the correct diagnosis. To measure accu-
racy, we have employed a weighted voting strategy [9], which al-
lows all firing characteristic feature sets to contribute to the final
prediction and is described below in more detail.
A voting-based classification method classifies a new instance
according to the number of characteristic feature sets covering it.
Voting allows all firing characteristic feature sets to contribute to
the final prediction. This strategy combines the characteristic fea-
ture sets CFðxÞ that fire upon a new patient case x. A simple voting
strategy considers all the rules in CFðxÞ. Given D a set of n disorders
{d1; d2; . . . ; dn}, we denote the class voted by a characteristic feature
set k with a binary function voteðk; diÞ that takes the value 1 when
k votes are received for disorder di, and 0 for the any other class.
The disorder that receives the maximum number of votes is the
most probable diagnosis for case x.TotalVoteðdiÞ ¼
X
k2CFðXÞ
Voteðk; diÞ ð3Þ
Weighted voting is similar to simple voting, however, each vote
is multiplied by a factor that quantifies the quality of the vote.TotalVoteðdiÞ ¼
X
k2CFðXÞ
Voteðk; diÞ  qðk;diÞ ð4Þ
where qðk;diÞ is the quality of vote.
To assess the efficiency of our proposed algorithm against a
standard class association rule mining algorithm (CARM), we have
calculated the overall accuracy of the discovered characteristic fea-
tures. In all experiments, we compute the prediction accuracy as
the overall percentage of correctly predicted disorders at a given
recall cut-off point (i.e., by taking into account only the top K pre-
dictions for different values of K, where K is the recall cut-off
point). Hence, a success represents a correctly predicted disorder
(the exact same, and not a sub or super class of it), while a miss
represents an incorrectly predicted disorder. If N is the total num-
ber of test cases and L is the number of correctly predicted disor-
ders, then accuracy A ¼ L=N. This is expressed in percentages in
Table 2 and in the Results section. CARM has been implemented
as an adapted Apriori algorithm [10].
In order to provide an accurate view over the prediction of the
discovered key features, each experiment has been performed as a
5-fold cross validation with an 80–20 split (80% knowledge base,
20% test data). Table 2 lists the resulted average accuracy at five
different recall cut-off points. Finally, we have used a maximum
size for the characteristic feature sets of 10 as the computational
cost increases exponentially with the feature set size and item
set size in both our proposed algorithm, as well as in the standard
class association rule mining process. The goal of our approach is to
discover the top K characteristic features, and within our experi-
ments K has been set to 5.
A final remark should be made with respect to the different
parameters that can be tuned in both algorithms. To ensure a fair
and correct evaluation, we performed experiments to determineAccuracy@3 (%) Accuracy@4 (%) Accuracy@5 (%)
44.74 46.68 47.50
35.86 37.24 37.24
24.76 25.34 27.55
Table 3
Experimental results: overall comparative precision and recall across the both
approaches.
CFML CARM
P (%) R (%) P (%) R (%)
Achondroplasia 0.00 0.00 6.67 40.00
Cartilage-Hair-Hypoplasia 44.67 46.67 6.50 36.67
Cleidocranial dysplasia 80.00 60.00 0.00 0.00
Diastrophic dysplasia 36.67 60.00 45.00 60.00
Hypochondroplasia 29.33 30.00 0.00 0.00
Kniest dysplasia 30.00 20.00 29.00 30.00
Metaphyseal dysplasia, Schmid type 25.00 20.00 28.33 30.00
Multiple epiphyseal dysplasia 26.40 16.98 0.00 0.00
Osteogenesis Imperfecta 0.00 0.00 0.00 0.00
Osteopetrosis 20.00 20.00 0.00 0.00
Pseudoachondroplasia 25.00 19.50 32.86 27.74
rMED 24.00 18.33 16.67 18.33
Spondyloepiphyseal dysplasia congenital 26.94 18.69 20.00 7.27
Stickler syndrome 20.00 10.00 40.00 30.00
Thanatophoric dysplasia 13.00 30.00 20.00 10.00
Average 26.73 24.68 16.33 19.33
Average precision growth 63.64%
Average recall growth 27.68%
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ters that discover the highest quality characteristic features. These
parameters have subsequently been used within our experiments.
For our approach, we had to determine the best commonality value,
and as shown in Fig. 2, a value of 14% provides the best character-
istic features. Similarly, for the CARM approach, we had to deter-
mine the optimal support value, where support is defined as the
coverage of the feature sets in the total number of cases. As shown
in Fig. 3, the best support value is 1.07% (i.e., 4/374  100  4
feature sets, 374 total number of cases). For clarification purposes,
the best set of characteristic features is defined as the set that
provides the best classification accuracy.
3. Results and discussion
In this section we discuss the experimental results achieved by
applying both CFML and CARM on the ESDN dataset. We start by
looking at the classification results via macro accuracy and
class-based precision and recall, then we discuss the pair-wise
discriminative power of our algorithm and finally, we perform a
human-based evaluation of the resulting characteristic features.
3.1. Classification results
As previously mentioned, class association rule mining uses
rules of the form fS! Dg to discover characteristic features, where
S is a set of features/phenotypes and D is the set of disorders. InFig. 2. Experimental results to determine the optimum commonality value for our appr
value across all disorders for which the overall accuracy is maximised.
Fig. 3. Experimental results to determine the optimum support value for standard class a
at the number of cases that list a particular phenotype normalised by the total numberorder to rank and compare the resulting features we have applied
the same methodology to both CFML (our algorithm) and CARM
(an implementation of standard class association rule mining) –
i.e., by using confidence as a primary measure for ranking purposes.oach. The optimal commonality value is achieved by considering the commonality
ssociation rule mining algorithm. The optimal support value is computed by looking
of cases in the dataset for which the accuracy is optimal.
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is one of the most important contributing factors in the prediction
accuracy, and it is proportional to it. To take support into account,
both CARM and CFML use a minimum threshold – CARM for stan-
dard support and CFML for commonality (i.e., the class-oriented
support). The other contributing factor is the rarity of the charac-
teristic features, which is represented by confidence in both CARM
and CFML.
Using the optimal commonality and support described in the
previous section (see Figs. 2 and 3), we have performed a fivefold
cross validation with stratification and computed the average
macro accuracy of the two methods at five different recall cut-off
points. Table 2 lists the results. Overall, it is clear that the sparsity
of the data has heavily affected both approaches, as the final accu-
racies are fairly low (this aspect is also shown in the phenotype
distribution discussed in the Data characteristics section). Never-
theless, CFML has outperformed CARM, hence showing that it is
able to discover patterns specific to particular classes/disorders, in-
stead of patterns frequent in the entire dataset. Furthermore, this
result is achieved in the context of an unbalanced distribution ofFig. 4. CFML pair-wise specificity–sensitivity analysis. Each graph depicts the specificity
specificity and the Y-axis denotes sensitivity). The higher the values, in particular the clu
characteristic features chosen by CFML were highly or sufficiently discriminative in 12classes in the ESDN dataset, which causes more issues to CARM
rather than our approach. Finally, we can observe a bigger growth
in accuracy with the increase in the recall cut-off point, from
14.42% at K = 1 to 27.55% at K = 5.
The feature sets of each disorder in our dataset have different
underlying characteristics, and hence it is expected to achieve dif-
ferent results for different classes, with the relative distribution of
the features in the set of cases being an influencing factor. In order
to understand the efficiency of the two methods at a lower level,
we have computed the class-based precision and recall, as listed
in Table 3. Overall, our approach outperforms CARM with an aver-
age precision growth of 63.64% and an average recall growth of
27.68%. CFML achieves a 26.73% average precision and 24.68%
average recall, whereas CARM achieves a 16.33% average precision
and 19.33% average recall.
There results reveal a series of aspects that are worth noting.
Firstly, CARM is unable to get any result in the case of four disor-
ders where CFML scores reasonably high. Secondly, the situation
is being inverted in the case of one disorder – i.e., Achondroplasia.
Unlike CARM, CFML has performed fairly uniform across all classesand sensitivity of the disorder under scrutiny against all other (the X-axis denotes
sters in the upper-right corner, the more discriminative the current disorder is. The
our of the total 15 disorders.
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quency. Infrequent disorders, such as Cleidocranial dysplasia and
Osteopetrosis, have only 10–11 cases in the dataset, while the
average number of cases per disorder is 26.67. Hence, they are par-
ticularly problematic for the dataset-oriented approach followed
by CARM. For example, CARM discovered short stature, sparse hair
or frontal bossing as being characteristic for Cleidocranial dysplasia,
however they did not have enough discriminative power, as seen
also from their confidence values 0.1, 0.09 and 0.04 respectively.
On the other hand, in the case of Osteopetrosis CARM was not able
to mine any features because the set of phenotypes corresponding
to this disorder are not sufficiently frequent when compared to the
overall set of phenotypes in the dataset.
If the average phenotype coverage of a particular disorder is
lower than the overall average coverage of phenotypes, CARM
tends to select those features present in many other disorders,
whereas CFML treats the phenotype set of each disorder indepen-
dently. For example, the average phenotype coverage of Hypo-
chondroplasia and Multiple epiphyseal dysplasia is 7.4% and 2.7%
respectively and the overall mean coverage is 9.35%. CARMFig. 5. CFML pair-wise specificity–sensitivity analysis. Each graph depicts the specificity
specificity and the Y-axis denotes sensitivity). The higher the values, in particular the clu
characteristic features chosen by CFML were highly or sufficiently discriminative in 12discovered short stature to be characteristic for Multiple epiphyseal
dysplasia and eight other disorders, which clearly shows its low
discriminative power. In the case of Hypochondroplasia, CFML se-
lected relative macrocephaly (0.27) and short palm (0.19) – charac-
teristic features of this single disorder – and achieved much better
results.
As shown, Achondroplasia was problematic for CFML, although
the selected characteristic features (e.g., lumbar kyphosis, trident
abnormality or low nasal bridge) had very high confidence values
(1.0, 1.0 and 1.0). Here, the commonality of the features – on aver-
age 0.17 in all Achondroplasia patient cases – raised issues because
it was too low. CARM selected macrocephaly, rhizomelic shortening
and frontal bossing, which did not have high confidence values
(0.07, 0.06 and 0.05) but were very frequent in the entire dataset
– with an average support of 0.45.
Osteogenesis imperfecta proved to be an issue for both ap-
proaches since none of them was able to correctly classify corre-
sponding cases. CARM selected a very generic feature to be
characteristic – skeletal dysplasia – with an extremely low confi-
dence value of 0.04 – not enough to identify the underlyingand sensitivity of the disorder under scrutiny against all other (the X-axis denotes
sters in the upper-right corner, the more discriminative the current disorder is. The
our of the total 15 disorders.
Table 4
Legend of disorder symbols used in the experimental results.
Symbol Disorder
ACH Achondroplasia
CAR Cartilage-Hair-Hypoplasia
CLE Cleidocranial dysplasia
DIA Diastrophic dysplasia
HYP Hypochondroplasia
KNI Kniest dysplasia
MET Metaphyseal dysplasia, Schmid type
MUL Multiple epiphyseal dysplasia
OSI Osteogenesis Imperfecta
OST Osteopetrosis
PSE Pseudoachondroplasia
RME rMED
SPO Spondyloepiphyseal dysplasia congenital
STI Stickler syndrome
THA Thanatophoric dysplasia
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short femur or short lower limbs as features, with high confidence
values – 1.0, 0.5 and 0.67 respectively – but with low commonality
(18.75%), which led to the patient cases being classified in different
other classes.
3.2. Pair-wise sensitivity and specificity
As we have seen in the previous section, from a macro perspec-
tive, our approach performs uniformly across all disorders (with a
few exceptions). In order to get a better insight into the individual
discriminative power of the characteristic features selected by
CFML, we have compiled pair-wise confusion matrices for each dis-
order and computed the pair-wise sensitivity and specificity. Figs. 4
and 5 depict 15 sensitivity–specificity graphs corresponding to theFig. 6. CFML pair-wise discriminative power as established by an expert. In average 4
discriminative.15 disorders in our dataset (the legend of disorder symbols used by
the figure and the description below can be found in Table 4 – also
the X-axis denotes specificity and the Y-axis denotes sensitivity).
In general, sensitivity represents the probability of a positive
outcome given an underlying positive element (e.g., probability
of a positive test, given that the patient is ill), while specificity rep-
resents the probability of a negative outcome given an underlying
positive element (e.g., probability of a negative test, given that the
patient is well). In our context, sensitivity denotes the ability of the
chosen feature set to correctly identify the disorder, while specific-
ity denotes the ability to correctly identify that the real disorder is
not the one from which the feature set has been selected.
Using the characteristic features selected by CFML we can ob-
serve that, in general, most disorders form specific discriminative
pairs that could be applied in a differential diagnosis setting. For
example, MUL is highly sensitive and specific to STI, KNI, DIA and
CLE, PSE is sensitive and specific to THA, OST, STI and RME, or
SPO is sensitive and specific to KNI and OST. However, the high-
lights are provided by two disorders (CLE and DIA) that have a uni-
formly high sensitivity and specificity against more than 85% of the
other disorders (the problematic OSI and ACH are the only ones
missing). This implies that the characteristic features inferred by
CFML are particularly selective and describe very well these disor-
ders. Similarly, the features of four other disorders (KNI, OST, THA
and STI) performed fairly well and led to high sensitivity and spec-
ificity against 65% of the other disorders.
3.3. Human-based validation
In order to validate our results from a real-world perspective
(i.e., to test to some extent the clinical significance of the resulted
characteristic features), we have also performed a human-based1.88% of the key features of all disorder are discriminative, while 58.12% are not
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dysplasia expert and comprised two parts. Firstly, the expert ana-
lysed, individually the set of characteristic features corresponding
to each disorder, in order to determine their meaningfulness. More
concretely, the domain expert went through all characteristic fea-
tures inferred for every disorder and marked them as meaningful,
possibly meaningful or not meaningful. We have then compiled
statistics from this discrete categorisation. Here, the goal was to
validate the selected features by judging if they are, in reality,
phenotypes associated with the particular disorder, or just
observations noted part of the clinical summary.
Secondly, theexpertperformedapair-wisediscriminativeanalysis
and judged towhat extent the characteristic features of a disorder are
discriminative against a second disorder. To be more precise, the do-
mainexpertmarkedeverycharacteristic featureofeverydisorder true
or false to indicate whether it is discriminative against all the other
disorders, in a pairwise manner. For instance, to note that Lumbar
kyphosis is a characteristic feature of Achondroplasia that is
discriminative against Cartilage-Hair-Hypoplasia, the expert marked
it has true in the pairwise context Achondroplasia – Cartilage-
Hair-Hypoplasia. Following this process, we have compiled the
average discriminative values of the characteristics features of
all disorders against all other disorders – these are depicted in
Figs. 6 and 7.
The first part of the experiment revealed very good results. In
average, 79.56% of the selected features were deemed meaningful,
17.78% were considered possibly meaningful, subject to a given
context, while only 2.66% of the features were not meaningful.
More concretely, the disorders that achieved high sensitivity and
specificity scores in the previous experiment also had meaningful
features, e.g., CLE – 80%, DIA – 100%, THA – 80%, STI – 100%, OST
– 100%. Furthermore, not surprisingly, the problematic disorders,
such as OSI achieved low meaningfulness scores – 25%.Fig. 7. CFML pair-wise discriminative power as established by an expert. In average 4
discriminative.The results of the second part of the experiment are depicted in
Figs. 6 and 7, where each graph shows the percentage of features
deemed to be discriminative in the context of a particular disorder
against the others (the legend of disorder symbols can be found in
Table 4). For example, in around 71% of the cases the features se-
lected for STI were 100% discriminative, while in one case (against
PSE) 80% of the features were discriminative and in the rest (21%)
no features were discriminative. Overall, we can observe that 50%
of the disorders achieved uniformly good results, the highlights
being provided by STI, ACH, DIA, CLE and THA. In order to validate
the results of the automatic classification, we tried to find correla-
tions (the Pearson correlation coefficient) between the pair-wise
sensitivity and specificity of the disorders and the percentage of
discriminative features as indicated by the expert. In the case of
sensitivity (i.e., the ability to detect true positives), positive corre-
lations have been found for CLE (0.42), CAR (0.50), MUL (0.51), PSE
(0.31) and STI (0.76), which reinforces the results presented in the
previous experiment, especially for CLE and STI which have been
found highly sensitive to most of the other disorders.
Similarly, in the case of specificity (i.e., the ability to detect true
negatives), we found positive correlations for CLE (0.36), HYP
(0.41), PSE (0.25), RME (0.27) and THA (0.46).
3.4. Related work
In biomedical domain, many researchers used class association
rule mining or predictive association rule mining to solve classifi-
cation problems or to discover various patterns in medical data
[11–15]. All existing previous work relies on a direct application
of the standard association rule mining algorithms, such as Apriori
[10], FP-growth [5] or Eclat [5]. Typically, classes (disorders) of
interest are specified and targeted as consequents of the associa-
tion rules. However, these standard algorithms have been designed1.88% of the key features of all disorder are discriminative, while 58.12% are not
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ner, while class association mining tasks takes advantage of the
fact that the data is labelled, thus making the task supervised. Fur-
thermore, these two types of approaches also differ in the way in
which they use the data – standard algorithms find rules based
on features frequently present in the entire dataset, while class
association mining requires class-specific frequency.
Specific examples of approaches similar to ours, but suffering
from the issues mentioned above include: (i) the work of Osl
et al. [16] on identifying biomarker candidates in prostate cancer
data or of Karabatak et al. [15] on detection of breast cancer –
Apriori has been adapted to find all class association rules with
support and confidence greater than some given thresholds; (ii)
extracting meaningful patterns in Oriental Medicine [17], where
Apriori has been adapted to discover class association rules by
considering symptoms antecedent feature sets, and the herbal
materials as consequent feature sets – classic support and confi-
dence have been again the main underlying measures used; or
(iii) predicting protein–protein interactions (PPI) [18] by generat-
ing class association rules where the consequent of the target class
association is restricted to one of the PPI types in focus – the
methodology and setting is similar to the ones above, i.e., adapted
Apriori with support and confidence thresholds.
The nature of traditional association rule mining algorithms
(i.e., their designated goal of working with unlabelled data) makes
them inadequate for mining class association rules. Consequently,
we have focused on devising an algorithm that takes advantage of
this limitation, by class-specific generating candidates, and hence
reducing the computation time significantly as well as improving
the quality of the results. Furthermore, in the particular context
set by the definition of characteristic phenotypes, our algorithm
is able to mine features both frequent to a given class (instead of
the entire dataset) and rare in the closely-related classes. In prac-
tice, this helps in discovering more specific rules for classes and
to solve the unbalanced class distribution problem of existing class
association algorithms.
4. Conclusion
In this manuscript we have presented a novel algorithm for
mining characteristic phenotypes for skeletal dysplasias. We
started by assigning a clear definition for characteristic phenotypes
and then proposed a set of measures (commonality and confidence),
together with an associated class-driven algorithm, to discover the
top K such phenotypes in the context of a set of disorders and
patient cases present in the ESDN repository. The experimental
results show that, given a reasonable amount of data (considering
the focus on rare diseases), our approach discovers more accurate
characteristic features than a standard class association rule
mining approach, achieving an accuracy growth of 27.55% at recall
cut-off point 5.
Future research will focus on discovering multi-level charac-
teristic features, which will require considering the Human
Phenotype Ontology annotations used to model patient
phenotypes at multiple levels of abstraction. For example, we will
consider using a generalisation strategy for ontology traversalwhere the level of abstraction of the annotations is increased
one level at a time on the each iteration of the characteristic
feature mining process.
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6.3 Discussion and Implications of Findings 
This chapter presented an approach to find, capture and describe characteristic features in the bone 
dysplasia domain. The novelty of the proposed algorithm lies in its ability to take advantage of the 
labelled dataset in the process of mining association rules. The evaluation showed that, compared to 
a standard class association rule mining approach (e.g. the Apriori approach [86]), the proposed 
approach discovered characteristic phenotypes that led to an improvement in classification accuracy 
of 10.28%, an improvement in average precision of 10.4% and an improvement in average recall of 
5.35% . A further analysis of the pair-wise sensitivity and specificity of the discovered 
characteristic features revealed that 80% of disorders form specific discriminative pairs, which can 
then be employed for differential diagnoses. As a result, it can be concluded that this novel method 
attains the final objective of this thesis by providing a ranked list of characteristic features for a 
given disorder. 
The literature contains a number of standard class association rule mining solutions in biomedical 
domain to discover patterns in medical data [90-94]. For instance, Yang et al. [95] adopt Apriori 
and support and confidence as the main underlying measures to mine meaningful patterns. They 
focus on Oriental Medicine and consider symptoms as antecedent feature sets, and herbal materials 
as consequent feature sets. However, these algorithms have been designed for unlabelled data and 
the dataset for class association mining tasks are labelled. As a result, the standard association rule 
mining algorithms cannot take advantage of the fact that the dataset is labelled. Using labelled 
datasets enables the discovery of rules that frequently occur within a given class (instead of the 
entire dataset) and rarely occur within closely-related classes. In practice, this helps to discover 
more specific rules for classes. 
The experimental setup described in this chapter has covered only phenotype – disorder 
associations in the context of existing patient data. The algorithm, however, is applicable to any 
type of labelled data. Consequently, a future potential valuable research direction involves 
expanding the skeletal dysplasia domain knowledge to include genetic data to discover phenotype–
genotype–disorder associations and characteristic gene–phenotype associations to prioritize gene 
testing for new patient cases. 
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 Chapter 7: Conclusion and Future Work 
The research presented in this thesis was motivated by a lack of decision support methods in 
particular in the skeletal dysplasia domain. It focuses on domains in which the analysis and 
interpretation of new patient cases relies on comparisons to past case studies because well-
established domain guidelines do not exist. Consequently, this thesis has proposed a novel 
phenotype-disorder discovery lifecycle that combines diverse techniques, ranging from traditional 
machine learning to semantic similarity-based association rule mining, to provide an exploratory 
framework for analysing and interpreting new patient cases. This chapter re-examines the research 
objectives identified in Chapter 1 and discusses the extent to which they were achieved. A series of 
lessons learned are then presented, followed by a discussion on the potential generalisation of these 
techniques, unresolved open challenges and directions for future research. The chapter concludes 
with an overall summary of the thesis. 
7.1 Objectives and Contributions 
In Chapter 1, four major goals were identified with respect to improving our understanding of 
skeletal dysplasias by identifying (phenotype-disorder associations) and enhancing the decision 
support tools for clinicians who are attempting to diagnose new patient cases. These goals, which 
led to the development of the decision support framework, are briefly discussed in the following 
sections. 
Objective 1: Discover the data characteristics of the skeletal dysplasia domain and develop a 
machine learning approach, tailored to suit these data characteristics, that provides a ranked 
list of diagnoses, for a given set of features/phenotypes.  
Chapter 3 described an approach for the development of a decision support model in the skeletal 
dysplasia domain. The approach begins by analysing the underlying data characteristics of the 
domain in order to obtain meaningful results. The data analysis revealed three important 
characteristics: (i) rareness, (ii) sparseness, and (iii) high dimensionality. Using these 
characteristics, it then mined association rules from patient descriptions (i.e., clinical features + 
diagnosis) and then applies the Dempster-Shafer theory to produce probabilistic candidate rankings, 
which can then serve to support medical decision-making. This work made three significant 
contributions: 
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1. The data characteristics of the skeletal dysplasia domain had not been analysed prior to this 
research. The analysis of the bone dysplasia data revealed three important characteristics: (i) 
rareness, (ii) sparseness, and (iii) high dimensionality. 
2. Previous machine-learning approaches had not been tailored to suit medical training 
corpuses that exhibited such challenging characteristics as rareness, sparseness and high 
dimensionality. 
3. A novel machine learning approach combining association rule mining with the Dempster-
Shafer theory was developed to compute the probabilistic associations between sets of 
clinical features and disorders. The experimental results demonstrated that the proposed 
approach achieved a significant improvement in accuracy over Naive Bayes (by 4%), SVM (by 
7%), Decision tree (by 14%), Random forest (by 11%), K-NN (by 14%) and initial diagnosis 
by a clinician (by 7%). 
Objective 2: Develop semantic similarity methods to compare/align concepts (phenotypes 
and disorders) to build a semantic similarity-driven decision support method that can provide 
a ranked list of disorders, given a set of features/phenotypes.  
Chapter 4 described an investigation into optimized semantic similarity measures to predict 
disorders on undiagnosed patient cases in the skeletal dysplasia domain. Four novel methods for 
computing semantic similarity were developed, implemented and evaluated based on their ability to 
achieve higher prediction accuracy. The four methods were HSS1, HSS2, HSS3 and HSS4 and they 
were novel compared to existing approaches because they take into account different requirements 
that emerge from the data characteristic of the bone dysplasia domain (e.g., a combined path 
between phenotypes and their common ancestor, and the location of concepts in the overall 
hierarchy). For instance, HSS1 takes into account the combined path between phenotypes and their 
common ancestor, whereas HSS2 takes into account the location of the lowest common ancestor in 
the overall hierarchy. HSS3 and HSS4 take into account both the requirements and introduce 
different smoothing parameters based on domain parameters (e.g., total number of disorders). 
This research made three significant contributions: 
1. Four novel semantic similarity methods were proposed by taking into account different 
requirements of the domain as mentioned in the above paragraph. Using the raw knowledge 
emerging from ESDN patient cases, the experimental results led to the conclusion that the  
best scoring novel method (HSS3) in computing the semantic similarity over the HPO 
provided a 34.24% more accuracy at recall cut-off point 5 compared to the best scoring  
standard information-theoretic approach (Resnik).  
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2. A novel method to perform semantic similarity-driven decision support was proposed by 
employing semantic similarity methods instead of exact matching in the decision support 
process in order to provide a ranked list of disorders, given a set of features/phenotypes. In 
order to gain insights into the importance of using semantic similarity-driven decision 
support in disorder prediction, the results of the best performing semantic similarity (HSS1) 
was compared against predictions calculated on term-based matching. The experimental 
results showed that the use of semantic similarity was generally a good strategy as the 
overall accuracy was improved by 23.55% and 13.7% in case of BDO and ESDN patient 
cases respectively. 
3. A comparison between the domain knowledge and the raw knowledge (ESDN patient cases) 
from the skeletal dysplasia domain was performed. The experimental results showed that the 
use of raw knowledge (ESDN patient cases) provided on average a 34.64% improvement in 
accuracy at recall cut-off point 5 than the domain knowledge (BDO). This was mainly 
because the domain knowledge introduced more noise (e.g., features unrelated to disorders) 
than the patient cases. 
Objective 3: Combine semantic similarity metrics with traditional interestingness measures 
to compute semantic interestingness measures that improve the discovery of association rules  
Chapter 5 presented a novel method that combines semantic similarity metrics (i.e., Resnik) with 
traditional interestingness measures to leverage the semantic relationships (e.g., Is-A relationship) of 
phenotypes and disorders – to improve association rule mining. More specifically this method 
enables the discovery of association rules that cannot be identified via typical data mining processes 
that depend on exact term matching. The method was applied and evaluated within the skeletal 
dysplasia domain using the core ontologies (HPO and BDO) and an annotated patient dataset. This 
research work led to one major contribution: 
1. While there is a large body of research that has focussed on finding the semantic similarity 
of concepts in biomedical ontologies, the application of this concept to interestingness 
measure calculation, has not previously been explored. This research work advances the 
state of the art by exploring the incorporation of semantic similarity within interestingness 
measures in the context of association rule mining. The experimental results showed that the 
best scoring semantic measure (Semantic Confidence) achieved 7.05% greater accuracy than 
the best scoring traditional measure (Confidence). 
Objective 4: Infer a ranked list of characteristic features/phenotypes for a given disorder in 
the skeletal dysplasia domain 
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Chapter 6 provided a definition of characteristic phenotypes, and then described a novel class 
association mining algorithm designed to identify characteristic features. The nature of traditional 
association rule mining algorithms (i.e., designed for unlabelled datasets) makes them inadequate 
for mining characteristic features from labelled datasets. The proposed algorithm exploits an 
established interestingness measure, namely, confidence, to model the discriminative aspect of 
characteristic features in conjunction with a new measure, commonality, for pruning and finding 
class-based common features. This research work made two significant contributions to the field: 
1. A clear definition of characteristic features: a characteristic feature is (i) common for the 
disorder under scrutiny, i.e., its absence would rule out the current disorder, and (ii) rare in 
other closely-related disorders, i.e., specific or discriminative for the current disorder.  
2. A novel algorithm for mining characteristic features that is based on a combination of 
confidence and commonality measures. The experimental results showed that the proposed 
approach achieved a 10.28% improvement in classification accuracy, a 10.4% improvement 
in average precision and a 5.35% improvement in average recall compared to traditional 
class association rule mining(Apriori). The pair-wise sensitivity and specificity of the 
characteristic features discovered by the proposed approach revealed that 80% of disorders 
formed specific discriminative pairs, which are highly valuable for differential diagnoses. 
7.2 Lessons Learned 
In addition to the contributions described above, a number of lessons have been learned during the 
course of this research. They are as follows: 
1. The skeletal dysplasia domain suffers from a lack of defined guidelines and a lack of mature 
domain knowledge for diagnosing skeletal dysplasia patients. As rule-based reasoning 
requires the underlying domain to have well-defined rules and mature domain knowledge, 
employing general purpose rule-based reasoning to build decision support methods in this 
domain is very difficult and challenging so new approaches are required. 
2. In the skeletal dysplasia domain, the domain knowledge introduces more noise than the 
patient cases alone. This is because for a given patient, the clinicians list all of the observed 
features/phenotypes, including those that may turn out to be irrelevant to the final diagnosis. 
This noise also occurs because the process of extracting and aggregating structured domain 
knowledge from scientific publications has the tendency to dilute discriminatory 
associations or rules. 
3. Due to the disparate and heterogeneous nature of knowledge sources in medical domains, 
the ability to discover implicit relationships between different ontological concepts has 104  
become particularly important. However, applying only traditional association rule mining 
techniques on ontologies cannot exploit the advantages brought by the encoded semantics in 
ontologies. This is due to the fact that these traditional techniques rely on exact matching 
which cannot make use of the semantics between the terms with the help of the underlying 
domain ontologies. 
4. The employment of semantics in knowledge discovery operations can generate an 
improvement in accuracy. However, the extent of the improvement is heavily dependent on 
the ability of the domain ontology to accurately and completely capture or represent the real 
world domain knowledge. This is due to the fact that the semantic similarity methods rely on 
the domain ontology, specifically, the structure of the underlying ontology and relationships 
among the concepts of the ontology. 
5. Every domain is governed by a different set of rules. A good semantic similarity measure 
needs to take into account the rules of the target domain. Therefore, semantic similarity 
measures designed for one domain may not be directly applicable to other domains. 
6. In the biomedical domain, class association rule mining is a widely-used knowledge 
discovery operation. This operation relies on a direct application of the standard association 
rule mining algorithms (e.g., Apriori). However, these standard algorithms have been 
designed for unlabelled data; therefore they cannot take advantage of labelled datasets. If 
class association rule mining is to take advantage of labelled datasets then it needs to 
generate class-specific candidates and to take into account the frequency of the feature sets 
at class level, rather than at the dataset level which reduce the computation time as well as 
improve the quality of the results. 
7.3 Generalisation of the Decision Support Framework 
The decision support framework presented in this thesis was developed specifically for the skeletal 
dysplasia domain. To generalise the framework for other domains, the four phases of the framework 
need to be considered separately: (1) Disorder classification via machine learning, (2) Disorder 
classification via semantic similarity, (3) Association rule mining using semantic similarity and 
semantic rule interestingness measures and (4) Characteristic feature mining via class association 
rules. 
The first and fourth phases are generalisable to similar domains (e.g. muscular dystrophy [96]). This 
is due to the fact that these two phases only have dependencies on the data characteristics of the 
domain rather than the domain itself.  
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However, the second and third phases would require further effort to migrate to other domains due 
to their dependency on semantic similarity methods, which are heavily dependent on domain 
ontologies. More specifically, new domain-specific ontologies would need to be developed. 
For Disorder classification via machine learning, Chapter 3 employed a number of well-established 
machine learning approaches (Naïve Bayes, SVM, Decision Trees, Random Forests and K-NN) and 
proposed a novel approach which combines association rule mining with the Dempster-Shafer 
theory. The evaluation compared the performance of these different methods within the skeletal 
dysplasia domain. The proposed approach outperformed the other standard machine learning 
approaches primarily because it was tailored for the data characteristics (e.g. sparseness) of the 
domain. This approach should also show improved performance in domains such as muscular 
dystrophy [96], that have similar data characteristics. However, in the case of domains (e.g. 
diabetes) which have dense data, the proposed approach might not be the best approach. 
For Disorder classification via semantic similarity, Chapter 4 presented a disorder classification 
approach which is heavily dependent on the semantic similarity methods. Semantic similarity 
methods are dependent on the availability of domain ontologies and the characteristics of the 
domain. To adapt the semantic similarity methods to other domains (e.g., muscular dystrophy), the 
design and selection of semantic similarity methods also need to take into account the 
characteristics and rules of the new domain. 
For Association rule mining using semantic similarity and semantic rule interestingness measures, 
Chapter 5 employed different semantic interestingness measures (e.g. semantic Support, semantic 
confidence) to discover association rules. Semantic similarity methods are employed to calculate 
semantic interestingness. The process of computing the different semantic interesting measures is 
generic - apart from the semantic similarity measure which depends on the characteristics and rules 
of the domain. In the case of the skeletal dysplasia domain, a large amount of domain knowledge 
was already available through the HPO and BDO. To employ semantic interestingness measures in 
other domains, semantic similarity methods appropriate to the domain need to be adapted to suit the 
characteristics and association rules of that domain.  
For Characteristic feature mining via class association rules, Chapter 6 reported an approach to 
discover characteristic features for a given disorder. The process of discovering the characteristic 
features method was generic and is applicable to other domains. However, domains like skeletal 
dysplasia which suffer from the unbalanced class distribution problem will probably achieve more 
performance benefits from this approach mainly due to its class-specific candidate generation which 
helps to retrieve patterns for infrequent classes. 
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7.4 Open Challenges 
As a relatively novel research direction, the work undertaken in this thesis identified a number of 
issues that remain unresolved, but could lead to interesting future developments with further 
investigation. They are as follows: 
1. Although significant prior research has focussed on finding the semantic similarity of 
concepts in biomedical ontologies, the application of such semantic similarity techniques to 
different data mining and machine learning algorithms has not been fully explored. Existing 
data mining (e.g, Association Rule Mining) and machine learning (e.g. Naïve Bayes) 
algorithms cannot take advantage of the semantics encoded in annotated datasets due to their 
dependency on exact matching. Although this thesis investigates semantic similarity in the 
case of a particular data mining algorithm – specifically, association rule mining – there are 
still a large number of algorithms and techniques ( e.g. Naïve Bayes and K-NN) in the 
machine learning and data mining areas that could usefully exploit semantic similarity. 
Further research in this area could be potentially very productive. 
2. The skeletal dysplasia domain suffers from the problem of data scarcity, and a number of 
relevant related repositories are neither open nor interoperable. These two issues make data 
acquisition, integration and analysis for knowledge discovery and decision support a 
challenging problem. A pragmatic approach to reduce the severity of this problem is the 
development of application interfaces which encourage data sharing and serve the best 
interests of the skeletal dysplasia community. One possible future research direction could 
be developing a plug-in-based distributed decision support framework. Each Web-based 
repository includes a plug-in that enables the discovery, extraction and harvesting of high-
level knowledge hidden within the data stored in the repositories. Such an approach could 
provide clinicians with decision support services, without breaching access controls to the 
actual data stored in the closed repositories. 
3. Mining characteristic phenotypes at different levels in the phenotype ontology (e.g., HPO) is 
an open research area. This would enable identification of the characteristic phenotypes of a 
disorder at different levels of specificity. This would require consideration of the HPO 
annotations at multiple levels of abstraction. For instance, future research in this area could 
consider the use of ontology traversal, where the level of abstraction of the annotations is 
increased one level at a time for each iteration of the characteristic feature mining process. 
4. The domain knowledge for the skeletal dysplasia community is still incomplete and 
imprecise. In particular, the phenotype listings associated with each disorder could be 
significantly improved. For many disorders, there are phenotypes missing, some shouldn’t 107  
be there and the probability of association is unspecified. Further work is required to 
improve the skeletal dysplasia domain knowledge by extracting more precise knowledge 
from scientific publications, integrating it with existing domain knowledge and refining the 
existing domain knowledge through correlation with annotated patient cases. 
5. HPO is the only phenotype ontology related to skeletal dysplasias. According to domain 
from experts (our collaborators on the Skeletome project), the representation of relationships 
between phenotypes within HPO for this domain is immature and incomplete. This is 
probably because HPO has been generated from OMIM data, which in turn was acquired by 
text mining scientific publications. Further research effort is required to improve the 
structure and semantics of the HPO. An improved HPO ontology will help to obtain more 
accurate results in semantic similarity-based knowledge discovery operations. 
7.5 Summary 
The high-level goal of the research presented in this thesis was to alleviate the lack of decision 
support methods in the skeletal dysplasia domain. To achieve this goal, this research proposed a 
framework that comprised four decision support methods to facilitate medical decision-making 
(e.g., verifying known associations between features and disorders, discovering new, previously 
unknown associations, identifying characteristic features/phenotypes and diagnosing disorders). In 
the experiments undertaken during this thesis, both instance knowledge (ESDN patient cases) and 
background knowledge (BDO) were utilized. The experimental results show that the framework 
exhibits both unique and promising capabilities in performing decision support tasks, outperforming 
other available and/or related approaches.  
This thesis led to a number of significant findings. From the skeletal dysplasia domain perspective, 
there are three vital findings. The first one is that the characteristic properties of the data are its 
rareness, sparseness, and high dimensionality. The second one is that the domain knowledge 
introduced more noise into this domain, compared to the noise produced by patient cases. The third 
one is that the semantic similarity based decision support method is a better approach than term-
based matching for this domain. From the algorithmic perspective, there are three significant 
findings. The first of these is that tailoring the machine learning approach so it takes the sparseness 
of the data into consideration improves the overall accuracy of the disorder classification results. 
The second of these is that mining features which are both common to a given class and rare in the 
other classes enables more accurate discovery of characteristic features for disorders than the class 
association algorithm. The third of these is that employing semantic interestingness measures over 
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the traditional interestingness measures brings considerable accuracy improvements in the process 
of discovering association rules. 
The original hypothesis of this thesis is that representing the knowledge and data associated with 
skeletal dysplasias using Semantic Web formalisms, and applying inductive and statistical 
reasoning to the resulting knowledge base, will improve the understanding and decision making 
processes for skeletal dysplasia researchers and clinicians. The evaluations of the decision support 
framework, reported in this thesis, have provided evidence to support this hypothesis. 
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